id	sid	tid	token	lemma	pos
ijpds-7762	1	1	agrawal	agrawal	PROPN
ijpds-7762	1	2	and	and	CCONJ
ijpds-7762	1	3	kulkarni	kulkarni	PROPN
ijpds-7762	1	4	ai	ai	VERB
ijpds-7762	1	5	applications	application	NOUN
ijpds-7762	1	6	in	in	ADP
ijpds-7762	1	7	drug	drug	NOUN
ijpds-7762	1	8	discovery	discovery	NOUN
ijpds-7762	1	9	and	and	CCONJ
ijpds-7762	1	10	development	development	NOUN
ijpds-7762	1	11	online	online	PROPN
ijpds-7762	1	12	first	first	PROPN
ijpds-7762	1	13	indian	indian	PROPN
ijpds-7762	1	14	j	j	PROPN
ijpds-7762	1	15	pharm	pharm	PROPN
ijpds-7762	1	16	drug	drug	PROPN
ijpds-7762	1	17	studies	study	NOUN
ijpds-7762	1	18	|	|	ADV
ijpds-7762	1	19	1	1	NUM
ijpds-7762	1	20	review	review	NOUN
ijpds-7762	1	21	article	article	NOUN
ijpds-7762	1	22	application	application	NOUN
ijpds-7762	1	23	of	of	ADP
ijpds-7762	1	24	artificial	artificial	ADJ
ijpds-7762	1	25	intelligence	intelligence	NOUN
ijpds-7762	1	26	in	in	ADP
ijpds-7762	1	27	drug	drug	NOUN
ijpds-7762	1	28	discovery	discovery	NOUN
ijpds-7762	1	29	,	,	PUNCT
ijpds-7762	1	30	designing	designing	NOUN
ijpds-7762	1	31	,	,	PUNCT
ijpds-7762	1	32	clinical	clinical	ADJ
ijpds-7762	1	33	trials	trial	NOUN
ijpds-7762	1	34	and	and	CCONJ
ijpds-7762	1	35	repurposing	repurpose	VERB
ijpds-7762	1	36	rashmi	rashmi	PROPN
ijpds-7762	1	37	agrawal1	agrawal1	PROPN
ijpds-7762	1	38	,	,	PUNCT
ijpds-7762	1	39	meghashyama	meghashyama	NOUN
ijpds-7762	1	40	kulkarni2	kulkarni2	NOUN
ijpds-7762	1	41	from	from	ADP
ijpds-7762	1	42	,	,	PUNCT
ijpds-7762	1	43	1consultant	1consultant	NUM
ijpds-7762	1	44	,	,	PUNCT
ijpds-7762	1	45	devmata	devmata	NOUN
ijpds-7762	1	46	hospital	hospital	NOUN
ijpds-7762	1	47	,	,	PUNCT
ijpds-7762	1	48	bhopal	bhopal	PROPN
ijpds-7762	1	49	,	,	PUNCT
ijpds-7762	1	50	madhya	madhya	PROPN
ijpds-7762	1	51	pradesh	pradesh	PROPN
ijpds-7762	1	52	,	,	PUNCT
ijpds-7762	1	53	india	india	PROPN
ijpds-7762	1	54	,	,	PUNCT
ijpds-7762	1	55	2consulting	2consulting	NUM
ijpds-7762	1	56	oral	oral	ADJ
ijpds-7762	1	57	pathologist	pathologist	NOUN
ijpds-7762	1	58	,	,	PUNCT
ijpds-7762	1	59	bengaluru	bengaluru	PROPN
ijpds-7762	1	60	,	,	PUNCT
ijpds-7762	1	61	karnataka	karnataka	PROPN
ijpds-7762	1	62	,	,	PUNCT
ijpds-7762	1	63	india	india	PROPN
ijpds-7762	1	64	abstract	abstract	PROPN
ijpds-7762	1	65	drug	drug	NOUN
ijpds-7762	1	66	development	development	NOUN
ijpds-7762	1	67	,	,	PUNCT
ijpds-7762	1	68	right	right	ADV
ijpds-7762	1	69	from	from	ADP
ijpds-7762	1	70	discovery	discovery	NOUN
ijpds-7762	1	71	,	,	PUNCT
ijpds-7762	1	72	designing	designing	NOUN
ijpds-7762	1	73	,	,	PUNCT
ijpds-7762	1	74	and	and	CCONJ
ijpds-7762	1	75	repurposing	repurpose	VERB
ijpds-7762	1	76	,	,	PUNCT
ijpds-7762	1	77	along	along	ADP
ijpds-7762	1	78	with	with	ADP
ijpds-7762	1	79	various	various	ADJ
ijpds-7762	1	80	phases	phase	NOUN
ijpds-7762	1	81	to	to	ADP
ijpds-7762	1	82	clinical	clinical	ADJ
ijpds-7762	1	83	trials	trial	NOUN
ijpds-7762	1	84	,	,	PUNCT
ijpds-7762	1	85	is	be	AUX
ijpds-7762	1	86	a	a	DET
ijpds-7762	1	87	complex	complex	ADJ
ijpds-7762	1	88	and	and	CCONJ
ijpds-7762	1	89	timeconsuming	timeconsuming	ADJ
ijpds-7762	1	90	process	process	NOUN
ijpds-7762	1	91	that	that	PRON
ijpds-7762	1	92	traditionally	traditionally	ADV
ijpds-7762	1	93	relies	rely	VERB
ijpds-7762	1	94	on	on	ADP
ijpds-7762	1	95	the	the	DET
ijpds-7762	1	96	experience	experience	NOUN
ijpds-7762	1	97	of	of	ADP
ijpds-7762	1	98	labor	labor	NOUN
ijpds-7762	1	99	forces	force	NOUN
ijpds-7762	1	100	,	,	PUNCT
ijpds-7762	1	101	along	along	ADP
ijpds-7762	1	102	with	with	ADP
ijpds-7762	1	103	incessant	incessant	ADJ
ijpds-7762	1	104	trial	trial	NOUN
ijpds-7762	1	105	-	-	PUNCT
ijpds-7762	1	106	and	and	CCONJ
ijpds-7762	1	107	-	-	PUNCT
ijpds-7762	1	108	error	error	NOUN
ijpds-7762	1	109	experimentation	experimentation	NOUN
ijpds-7762	1	110	.	.	PUNCT
ijpds-7762	2	1	the	the	DET
ijpds-7762	2	2	emergence	emergence	NOUN
ijpds-7762	2	3	of	of	ADP
ijpds-7762	2	4	various	various	ADJ
ijpds-7762	2	5	artificial	artificial	ADJ
ijpds-7762	2	6	intelligence	intelligence	NOUN
ijpds-7762	2	7	(	(	PUNCT
ijpds-7762	2	8	ai	ai	NOUN
ijpds-7762	2	9	)	)	PUNCT
ijpds-7762	2	10	tools	tool	NOUN
ijpds-7762	2	11	and	and	CCONJ
ijpds-7762	2	12	techniques	technique	NOUN
ijpds-7762	2	13	is	be	AUX
ijpds-7762	2	14	redefining	redefine	VERB
ijpds-7762	2	15	the	the	DET
ijpds-7762	2	16	pharmaceutical	pharmaceutical	ADJ
ijpds-7762	2	17	industry	industry	NOUN
ijpds-7762	2	18	.	.	PUNCT
ijpds-7762	3	1	the	the	DET
ijpds-7762	3	2	integration	integration	NOUN
ijpds-7762	3	3	of	of	ADP
ijpds-7762	3	4	aidriven	aidriven	ADJ
ijpds-7762	3	5	methodologies	methodology	NOUN
ijpds-7762	3	6	into	into	ADP
ijpds-7762	3	7	all	all	DET
ijpds-7762	3	8	stages	stage	NOUN
ijpds-7762	3	9	of	of	ADP
ijpds-7762	3	10	the	the	DET
ijpds-7762	3	11	drug	drug	NOUN
ijpds-7762	3	12	development	development	NOUN
ijpds-7762	3	13	pipeline	pipeline	NOUN
ijpds-7762	3	14	has	have	AUX
ijpds-7762	3	15	enhanced	enhance	VERB
ijpds-7762	3	16	the	the	DET
ijpds-7762	3	17	efficiency	efficiency	NOUN
ijpds-7762	3	18	and	and	CCONJ
ijpds-7762	3	19	effectiveness	effectiveness	NOUN
ijpds-7762	3	20	of	of	ADP
ijpds-7762	3	21	the	the	DET
ijpds-7762	3	22	process	process	NOUN
ijpds-7762	3	23	.	.	PUNCT
ijpds-7762	4	1	with	with	ADP
ijpds-7762	4	2	this	this	DET
ijpds-7762	4	3	review	review	NOUN
ijpds-7762	4	4	,	,	PUNCT
ijpds-7762	4	5	we	we	PRON
ijpds-7762	4	6	aim	aim	VERB
ijpds-7762	4	7	to	to	PART
ijpds-7762	4	8	provide	provide	VERB
ijpds-7762	4	9	insights	insight	NOUN
ijpds-7762	4	10	into	into	ADP
ijpds-7762	4	11	the	the	DET
ijpds-7762	4	12	application	application	NOUN
ijpds-7762	4	13	of	of	ADP
ijpds-7762	4	14	ai	ai	NOUN
ijpds-7762	4	15	at	at	ADP
ijpds-7762	4	16	various	various	ADJ
ijpds-7762	4	17	stages	stage	NOUN
ijpds-7762	4	18	mentioned	mention	VERB
ijpds-7762	4	19	,	,	PUNCT
ijpds-7762	4	20	with	with	ADP
ijpds-7762	4	21	an	an	DET
ijpds-7762	4	22	emphasis	emphasis	NOUN
ijpds-7762	4	23	on	on	ADP
ijpds-7762	4	24	the	the	DET
ijpds-7762	4	25	latest	late	ADJ
ijpds-7762	4	26	advancements	advancement	NOUN
ijpds-7762	4	27	.	.	PUNCT
ijpds-7762	5	1	the	the	DET
ijpds-7762	5	2	role	role	NOUN
ijpds-7762	5	3	of	of	ADP
ijpds-7762	5	4	ai	ai	VERB
ijpds-7762	5	5	in	in	ADP
ijpds-7762	5	6	speeding	speed	VERB
ijpds-7762	5	7	up	up	ADP
ijpds-7762	5	8	the	the	DET
ijpds-7762	5	9	process	process	NOUN
ijpds-7762	5	10	of	of	ADP
ijpds-7762	5	11	drug	drug	NOUN
ijpds-7762	5	12	development	development	NOUN
ijpds-7762	5	13	while	while	SCONJ
ijpds-7762	5	14	giving	give	VERB
ijpds-7762	5	15	distinct	distinct	ADJ
ijpds-7762	5	16	and	and	CCONJ
ijpds-7762	5	17	accurate	accurate	ADJ
ijpds-7762	5	18	outcomes	outcome	NOUN
ijpds-7762	5	19	is	be	AUX
ijpds-7762	5	20	highlighted	highlight	VERB
ijpds-7762	5	21	as	as	ADV
ijpds-7762	5	22	well	well	ADV
ijpds-7762	5	23	.	.	PUNCT
ijpds-7762	6	1	finally	finally	ADV
ijpds-7762	6	2	,	,	PUNCT
ijpds-7762	6	3	we	we	PRON
ijpds-7762	6	4	addressed	address	VERB
ijpds-7762	6	5	the	the	DET
ijpds-7762	6	6	current	current	ADJ
ijpds-7762	6	7	challenges	challenge	NOUN
ijpds-7762	6	8	in	in	ADP
ijpds-7762	6	9	employing	employ	VERB
ijpds-7762	6	10	ai	ai	VERB
ijpds-7762	6	11	along	along	ADV
ijpds-7762	6	12	with	with	ADP
ijpds-7762	6	13	future	future	ADJ
ijpds-7762	6	14	perspectives	perspective	NOUN
ijpds-7762	6	15	in	in	ADP
ijpds-7762	6	16	order	order	NOUN
ijpds-7762	6	17	to	to	PART
ijpds-7762	6	18	enhance	enhance	VERB
ijpds-7762	6	19	ai	ai	VERB
ijpds-7762	6	20	-	-	PUNCT
ijpds-7762	6	21	augmented	augment	VERB
ijpds-7762	6	22	drug	drug	NOUN
ijpds-7762	6	23	development	development	NOUN
ijpds-7762	6	24	,	,	PUNCT
ijpds-7762	6	25	ultimately	ultimately	ADV
ijpds-7762	6	26	offering	offer	VERB
ijpds-7762	6	27	significant	significant	ADJ
ijpds-7762	6	28	benefits	benefit	NOUN
ijpds-7762	6	29	to	to	ADP
ijpds-7762	6	30	patients	patient	NOUN
ijpds-7762	6	31	and	and	CCONJ
ijpds-7762	6	32	society	society	NOUN
ijpds-7762	6	33	.	.	PUNCT
ijpds-7762	7	1	key	key	ADJ
ijpds-7762	7	2	words	word	NOUN
ijpds-7762	7	3	:	:	PUNCT
ijpds-7762	7	4	artificial	artificial	ADJ
ijpds-7762	7	5	intelligence	intelligence	NOUN
ijpds-7762	7	6	,	,	PUNCT
ijpds-7762	7	7	drug	drug	NOUN
ijpds-7762	7	8	discovery	discovery	NOUN
ijpds-7762	7	9	,	,	PUNCT
ijpds-7762	7	10	clinical	clinical	ADJ
ijpds-7762	7	11	trial	trial	NOUN
ijpds-7762	7	12	design	design	NOUN
ijpds-7762	7	13	,	,	PUNCT
ijpds-7762	7	14	neural	neural	ADJ
ijpds-7762	7	15	networks	network	NOUN
ijpds-7762	7	16	,	,	PUNCT
ijpds-7762	7	17	drug	drug	NOUN
ijpds-7762	7	18	repurposing	repurpose	VERB
ijpds-7762	7	19	rtificial	rtificial	ADJ
ijpds-7762	7	20	intelligence	intelligence	NOUN
ijpds-7762	7	21	(	(	PUNCT
ijpds-7762	7	22	ai	ai	NOUN
ijpds-7762	7	23	)	)	PUNCT
ijpds-7762	7	24	involves	involve	VERB
ijpds-7762	7	25	the	the	DET
ijpds-7762	7	26	least	least	ADJ
ijpds-7762	7	27	amount	amount	NOUN
ijpds-7762	7	28	of	of	ADP
ijpds-7762	7	29	human	human	ADJ
ijpds-7762	7	30	intervention	intervention	NOUN
ijpds-7762	7	31	possible	possible	ADJ
ijpds-7762	7	32	when	when	SCONJ
ijpds-7762	7	33	utilizing	utilize	VERB
ijpds-7762	7	34	a	a	DET
ijpds-7762	7	35	computer	computer	NOUN
ijpds-7762	7	36	to	to	PART
ijpds-7762	7	37	imitate	imitate	VERB
ijpds-7762	7	38	intelligent	intelligent	ADJ
ijpds-7762	7	39	behaviour	behaviour	NOUN
ijpds-7762	7	40	[	[	X
ijpds-7762	7	41	1	1	NUM
ijpds-7762	7	42	]	]	PUNCT
ijpds-7762	7	43	.	.	PUNCT
ijpds-7762	8	1	ai	ai	PROPN
ijpds-7762	8	2	has	have	AUX
ijpds-7762	8	3	been	be	AUX
ijpds-7762	8	4	implemented	implement	VERB
ijpds-7762	8	5	in	in	ADP
ijpds-7762	8	6	the	the	DET
ijpds-7762	8	7	pharmaceutical	pharmaceutical	ADJ
ijpds-7762	8	8	industry	industry	NOUN
ijpds-7762	8	9	in	in	ADP
ijpds-7762	8	10	recent	recent	ADJ
ijpds-7762	8	11	years	year	NOUN
ijpds-7762	8	12	.	.	PUNCT
ijpds-7762	9	1	one	one	NUM
ijpds-7762	9	2	of	of	ADP
ijpds-7762	9	3	the	the	DET
ijpds-7762	9	4	important	important	ADJ
ijpds-7762	9	5	aspects	aspect	NOUN
ijpds-7762	9	6	in	in	ADP
ijpds-7762	9	7	medicinal	medicinal	ADJ
ijpds-7762	9	8	chemistry	chemistry	NOUN
ijpds-7762	9	9	,	,	PUNCT
ijpds-7762	9	10	drug	drug	NOUN
ijpds-7762	9	11	discovery	discovery	NOUN
ijpds-7762	9	12	that	that	PRON
ijpds-7762	9	13	involves	involve	VERB
ijpds-7762	9	14	identifying	identify	VERB
ijpds-7762	9	15	,	,	PUNCT
ijpds-7762	9	16	formulating	formulating	NOUN
ijpds-7762	9	17	,	,	PUNCT
ijpds-7762	9	18	and	and	CCONJ
ijpds-7762	9	19	developing	develop	VERB
ijpds-7762	9	20	new	new	ADJ
ijpds-7762	9	21	medications	medication	NOUN
ijpds-7762	9	22	,	,	PUNCT
ijpds-7762	9	23	is	be	AUX
ijpds-7762	9	24	an	an	DET
ijpds-7762	9	25	arduous	arduous	ADJ
ijpds-7762	9	26	,	,	PUNCT
ijpds-7762	9	27	techniquesensitive	techniquesensitive	ADJ
ijpds-7762	9	28	,	,	PUNCT
ijpds-7762	9	29	and	and	CCONJ
ijpds-7762	9	30	time	time	NOUN
ijpds-7762	9	31	-	-	PUNCT
ijpds-7762	9	32	consuming	consume	VERB
ijpds-7762	9	33	process	process	NOUN
ijpds-7762	9	34	with	with	ADP
ijpds-7762	9	35	long	long	ADV
ijpds-7762	9	36	-	-	PUNCT
ijpds-7762	9	37	established	establish	VERB
ijpds-7762	9	38	protocols	protocol	NOUN
ijpds-7762	9	39	that	that	PRON
ijpds-7762	9	40	require	require	VERB
ijpds-7762	9	41	exorbitant	exorbitant	ADJ
ijpds-7762	9	42	resources	resource	NOUN
ijpds-7762	9	43	with	with	ADP
ijpds-7762	9	44	several	several	ADJ
ijpds-7762	9	45	trial	trial	NOUN
ijpds-7762	9	46	and	and	CCONJ
ijpds-7762	9	47	error	error	NOUN
ijpds-7762	9	48	experimentations	experimentation	NOUN
ijpds-7762	9	49	needing	need	VERB
ijpds-7762	9	50	a	a	DET
ijpds-7762	9	51	good	good	ADJ
ijpds-7762	9	52	deal	deal	NOUN
ijpds-7762	9	53	of	of	ADP
ijpds-7762	9	54	time	time	NOUN
ijpds-7762	9	55	[	[	X
ijpds-7762	9	56	2	2	NUM
ijpds-7762	9	57	]	]	PUNCT
ijpds-7762	9	58	.	.	PUNCT
ijpds-7762	10	1	this	this	DET
ijpds-7762	10	2	complex	complex	ADJ
ijpds-7762	10	3	process	process	NOUN
ijpds-7762	10	4	,	,	PUNCT
ijpds-7762	10	5	further	far	ADV
ijpds-7762	10	6	requires	require	VERB
ijpds-7762	10	7	an	an	DET
ijpds-7762	10	8	average	average	NOUN
ijpds-7762	10	9	of	of	ADP
ijpds-7762	10	10	12	12	NUM
ijpds-7762	10	11	years	year	NOUN
ijpds-7762	10	12	and	and	CCONJ
ijpds-7762	10	13	a	a	DET
ijpds-7762	10	14	cost	cost	NOUN
ijpds-7762	10	15	of	of	ADP
ijpds-7762	10	16	$	$	SYM
ijpds-7762	10	17	2.6	2.6	NUM
ijpds-7762	10	18	billion	billion	NUM
ijpds-7762	10	19	to	to	PART
ijpds-7762	10	20	forge	forge	VERB
ijpds-7762	10	21	ahead	ahead	ADV
ijpds-7762	10	22	a	a	DET
ijpds-7762	10	23	single	single	ADJ
ijpds-7762	10	24	molecule	molecule	NOUN
ijpds-7762	10	25	from	from	ADP
ijpds-7762	10	26	inception	inception	NOUN
ijpds-7762	10	27	till	till	SCONJ
ijpds-7762	10	28	food	food	NOUN
ijpds-7762	10	29	and	and	CCONJ
ijpds-7762	10	30	drug	drug	PROPN
ijpds-7762	10	31	administration	administration	PROPN
ijpds-7762	10	32	(	(	PUNCT
ijpds-7762	10	33	fda	fda	PROPN
ijpds-7762	10	34	)	)	PUNCT
ijpds-7762	10	35	approval	approval	NOUN
ijpds-7762	10	36	.	.	PUNCT
ijpds-7762	11	1	in	in	ADP
ijpds-7762	11	2	spite	spite	NOUN
ijpds-7762	11	3	of	of	ADP
ijpds-7762	11	4	these	these	DET
ijpds-7762	11	5	strenuous	strenuous	ADJ
ijpds-7762	11	6	endeavours	endeavour	NOUN
ijpds-7762	11	7	,	,	PUNCT
ijpds-7762	11	8	the	the	DET
ijpds-7762	11	9	process	process	NOUN
ijpds-7762	11	10	is	be	AUX
ijpds-7762	11	11	marked	mark	VERB
ijpds-7762	11	12	by	by	ADP
ijpds-7762	11	13	unfavourable	unfavourable	ADJ
ijpds-7762	11	14	adverse	adverse	ADJ
ijpds-7762	11	15	effects	effect	NOUN
ijpds-7762	11	16	of	of	ADP
ijpds-7762	11	17	the	the	DET
ijpds-7762	11	18	drugs	drug	NOUN
ijpds-7762	11	19	,	,	PUNCT
ijpds-7762	11	20	high	high	ADJ
ijpds-7762	11	21	attrition	attrition	NOUN
ijpds-7762	11	22	rates	rate	NOUN
ijpds-7762	11	23	,	,	PUNCT
ijpds-7762	11	24	and	and	CCONJ
ijpds-7762	11	25	tenacious	tenacious	ADJ
ijpds-7762	11	26	challenges	challenge	NOUN
ijpds-7762	11	27	in	in	ADP
ijpds-7762	11	28	addressing	address	VERB
ijpds-7762	11	29	chronic	chronic	ADJ
ijpds-7762	11	30	diseases	disease	NOUN
ijpds-7762	11	31	,	,	PUNCT
ijpds-7762	11	32	including	include	VERB
ijpds-7762	11	33	cancers	cancer	NOUN
ijpds-7762	11	34	and	and	CCONJ
ijpds-7762	11	35	diabetes	diabetes	NOUN
ijpds-7762	11	36	mellitus	mellitus	NOUN
ijpds-7762	12	1	[	[	X
ijpds-7762	12	2	3	3	NUM
ijpds-7762	12	3	,	,	PUNCT
ijpds-7762	12	4	4	4	NUM
ijpds-7762	12	5	]	]	PUNCT
ijpds-7762	12	6	.	.	PUNCT
ijpds-7762	13	1	the	the	DET
ijpds-7762	13	2	emergence	emergence	NOUN
ijpds-7762	13	3	of	of	ADP
ijpds-7762	13	4	ai	ai	PROPN
ijpds-7762	13	5	marks	mark	NOUN
ijpds-7762	13	6	a	a	DET
ijpds-7762	13	7	revolutionary	revolutionary	ADJ
ijpds-7762	13	8	drift	drift	NOUN
ijpds-7762	13	9	in	in	ADP
ijpds-7762	13	10	drug	drug	NOUN
ijpds-7762	13	11	development	development	NOUN
ijpds-7762	13	12	,	,	PUNCT
ijpds-7762	13	13	with	with	ADP
ijpds-7762	13	14	the	the	DET
ijpds-7762	13	15	advent	advent	NOUN
ijpds-7762	13	16	of	of	ADP
ijpds-7762	13	17	computational	computational	ADJ
ijpds-7762	13	18	tools	tool	NOUN
ijpds-7762	13	19	designed	design	VERB
ijpds-7762	13	20	to	to	PART
ijpds-7762	13	21	supplement	supplement	VERB
ijpds-7762	13	22	human	human	ADJ
ijpds-7762	13	23	capabilities	capability	NOUN
ijpds-7762	13	24	and	and	CCONJ
ijpds-7762	13	25	intelligence	intelligence	NOUN
ijpds-7762	13	26	rather	rather	ADV
ijpds-7762	13	27	than	than	ADP
ijpds-7762	13	28	replace	replace	VERB
ijpds-7762	13	29	them	they	PRON
ijpds-7762	13	30	[	[	X
ijpds-7762	13	31	5	5	NUM
ijpds-7762	13	32	]	]	PUNCT
ijpds-7762	13	33	.	.	PUNCT
ijpds-7762	14	1	ai	ai	VERB
ijpds-7762	14	2	leverages	leverage	NOUN
ijpds-7762	14	3	suave	suave	ADJ
ijpds-7762	14	4	algorithms	algorithm	NOUN
ijpds-7762	14	5	for	for	ADP
ijpds-7762	14	6	autonomous	autonomous	ADJ
ijpds-7762	14	7	decision	decision	NOUN
ijpds-7762	14	8	-	-	PUNCT
ijpds-7762	14	9	making	making	NOUN
ijpds-7762	14	10	,	,	PUNCT
ijpds-7762	14	11	hence	hence	ADV
ijpds-7762	14	12	revolutionizing	revolutionize	VERB
ijpds-7762	14	13	the	the	DET
ijpds-7762	14	14	pharmaceutical	pharmaceutical	ADJ
ijpds-7762	14	15	industry	industry	NOUN
ijpds-7762	14	16	[	[	X
ijpds-7762	14	17	6	6	NUM
ijpds-7762	14	18	]	]	PUNCT
ijpds-7762	14	19	.	.	PUNCT
ijpds-7762	15	1	ai	ai	VERB
ijpds-7762	15	2	techniques	technique	NOUN
ijpds-7762	15	3	such	such	ADJ
ijpds-7762	15	4	as	as	ADP
ijpds-7762	15	5	machine	machine	NOUN
ijpds-7762	15	6	learning	learning	NOUN
ijpds-7762	15	7	(	(	PUNCT
ijpds-7762	15	8	ml	ml	NOUN
ijpds-7762	15	9	)	)	PUNCT
ijpds-7762	15	10	and	and	CCONJ
ijpds-7762	15	11	deep	deep	ADJ
ijpds-7762	15	12	learning	learning	NOUN
ijpds-7762	15	13	(	(	PUNCT
ijpds-7762	15	14	dl	dl	INTJ
ijpds-7762	15	15	)	)	PUNCT
ijpds-7762	15	16	offer	offer	VERB
ijpds-7762	15	17	the	the	DET
ijpds-7762	15	18	potential	potential	NOUN
ijpds-7762	15	19	to	to	PART
ijpds-7762	15	20	accelerate	accelerate	VERB
ijpds-7762	15	21	the	the	DET
ijpds-7762	15	22	above	above	ADV
ijpds-7762	15	23	-	-	PUNCT
ijpds-7762	15	24	mentioned	mention	VERB
ijpds-7762	15	25	processes	process	NOUN
ijpds-7762	15	26	by	by	ADP
ijpds-7762	15	27	enabling	enable	VERB
ijpds-7762	15	28	more	more	ADV
ijpds-7762	15	29	coherent	coherent	ADJ
ijpds-7762	15	30	,	,	PUNCT
ijpds-7762	15	31	efficient	efficient	ADJ
ijpds-7762	15	32	,	,	PUNCT
ijpds-7762	15	33	and	and	CCONJ
ijpds-7762	15	34	precise	precise	ADJ
ijpds-7762	15	35	analysis	analysis	NOUN
ijpds-7762	15	36	of	of	ADP
ijpds-7762	15	37	large	large	ADJ
ijpds-7762	15	38	amounts	amount	NOUN
ijpds-7762	15	39	of	of	ADP
ijpds-7762	15	40	data	datum	NOUN
ijpds-7762	15	41	[	[	X
ijpds-7762	15	42	7	7	NUM
ijpds-7762	15	43	]	]	PUNCT
ijpds-7762	15	44	.	.	PUNCT
ijpds-7762	16	1	ai	ai	PROPN
ijpds-7762	16	2	has	have	AUX
ijpds-7762	16	3	also	also	ADV
ijpds-7762	16	4	been	be	AUX
ijpds-7762	16	5	able	able	ADJ
ijpds-7762	16	6	to	to	PART
ijpds-7762	16	7	predict	predict	VERB
ijpds-7762	16	8	the	the	DET
ijpds-7762	16	9	toxicity	toxicity	NOUN
ijpds-7762	16	10	of	of	ADP
ijpds-7762	16	11	drugs	drug	NOUN
ijpds-7762	16	12	;	;	PUNCT
ijpds-7762	16	13	access	access	NOUN
ijpds-7762	16	14	this	this	DET
ijpds-7762	16	15	article	article	NOUN
ijpds-7762	16	16	online	online	ADV
ijpds-7762	16	17	received	receive	VERB
ijpds-7762	16	18	–	–	PUNCT
ijpds-7762	16	19	23rd	23rd	ADJ
ijpds-7762	16	20	july	july	NOUN
ijpds-7762	16	21	2025	2025	NUM
ijpds-7762	16	22	initial	initial	ADJ
ijpds-7762	16	23	review	review	NOUN
ijpds-7762	16	24	–	–	PUNCT
ijpds-7762	16	25	24th	24th	ADJ
ijpds-7762	16	26	july	july	PROPN
ijpds-7762	16	27	2025	2025	NUM
ijpds-7762	16	28	accepted	accept	VERB
ijpds-7762	16	29	–	–	PUNCT
ijpds-7762	16	30	25th	25th	NOUN
ijpds-7762	16	31	july	july	PROPN
ijpds-7762	16	32	2025	2025	NUM
ijpds-7762	16	33	quick	quick	ADJ
ijpds-7762	16	34	response	response	NOUN
ijpds-7762	16	35	code	code	NOUN
ijpds-7762	16	36	besides	besides	SCONJ
ijpds-7762	16	37	its	its	PRON
ijpds-7762	16	38	role	role	NOUN
ijpds-7762	16	39	in	in	ADP
ijpds-7762	16	40	drug	drug	NOUN
ijpds-7762	16	41	-	-	PUNCT
ijpds-7762	16	42	target	target	NOUN
ijpds-7762	16	43	interaction	interaction	NOUN
ijpds-7762	16	44	predictions	prediction	NOUN
ijpds-7762	16	45	,	,	PUNCT
ijpds-7762	16	46	clinical	clinical	ADJ
ijpds-7762	16	47	trial	trial	NOUN
ijpds-7762	16	48	design	design	NOUN
ijpds-7762	16	49	,	,	PUNCT
ijpds-7762	16	50	and	and	CCONJ
ijpds-7762	16	51	drug	drug	NOUN
ijpds-7762	16	52	repurposing	repurposing	NOUN
ijpds-7762	16	53	,	,	PUNCT
ijpds-7762	16	54	it	it	PRON
ijpds-7762	16	55	is	be	AUX
ijpds-7762	16	56	aiding	aid	VERB
ijpds-7762	16	57	in	in	ADP
ijpds-7762	16	58	the	the	DET
ijpds-7762	16	59	reformation	reformation	NOUN
ijpds-7762	16	60	of	of	ADP
ijpds-7762	16	61	drug	drug	NOUN
ijpds-7762	16	62	development	development	NOUN
ijpds-7762	16	63	approaches	approach	NOUN
ijpds-7762	16	64	[	[	X
ijpds-7762	16	65	8	8	NUM
ijpds-7762	16	66	,	,	PUNCT
ijpds-7762	16	67	9	9	NUM
ijpds-7762	16	68	]	]	PUNCT
ijpds-7762	16	69	.	.	PUNCT
ijpds-7762	17	1	this	this	DET
ijpds-7762	17	2	narrative	narrative	NOUN
ijpds-7762	17	3	review	review	NOUN
ijpds-7762	17	4	aims	aim	VERB
ijpds-7762	17	5	to	to	PART
ijpds-7762	17	6	unveil	unveil	VERB
ijpds-7762	17	7	the	the	DET
ijpds-7762	17	8	transformative	transformative	ADJ
ijpds-7762	17	9	impact	impact	NOUN
ijpds-7762	17	10	of	of	ADP
ijpds-7762	17	11	ai	ai	VERB
ijpds-7762	17	12	on	on	ADP
ijpds-7762	17	13	the	the	DET
ijpds-7762	17	14	whole	whole	ADJ
ijpds-7762	17	15	process	process	NOUN
ijpds-7762	17	16	of	of	ADP
ijpds-7762	17	17	drug	drug	NOUN
ijpds-7762	17	18	discovery	discovery	NOUN
ijpds-7762	17	19	till	till	SCONJ
ijpds-7762	17	20	the	the	DET
ijpds-7762	17	21	completion	completion	NOUN
ijpds-7762	17	22	of	of	ADP
ijpds-7762	17	23	development	development	NOUN
ijpds-7762	17	24	and	and	CCONJ
ijpds-7762	17	25	sheds	shed	VERB
ijpds-7762	17	26	light	light	NOUN
ijpds-7762	17	27	on	on	ADP
ijpds-7762	17	28	the	the	DET
ijpds-7762	17	29	role	role	NOUN
ijpds-7762	17	30	of	of	ADP
ijpds-7762	17	31	ai	ai	VERB
ijpds-7762	17	32	in	in	ADP
ijpds-7762	17	33	drug	drug	NOUN
ijpds-7762	17	34	repurposing	repurpose	VERB
ijpds-7762	17	35	as	as	ADV
ijpds-7762	17	36	well	well	ADV
ijpds-7762	17	37	.	.	PUNCT
ijpds-7762	18	1	the	the	DET
ijpds-7762	18	2	paper	paper	NOUN
ijpds-7762	18	3	also	also	ADV
ijpds-7762	18	4	emphasizes	emphasize	VERB
ijpds-7762	18	5	the	the	DET
ijpds-7762	18	6	importance	importance	NOUN
ijpds-7762	18	7	of	of	ADP
ijpds-7762	18	8	ai	ai	NOUN
ijpds-7762	18	9	in	in	ADP
ijpds-7762	18	10	accelerating	accelerate	VERB
ijpds-7762	18	11	the	the	DET
ijpds-7762	18	12	development	development	NOUN
ijpds-7762	18	13	of	of	ADP
ijpds-7762	18	14	novel	novel	ADJ
ijpds-7762	18	15	therapeutics	therapeutic	NOUN
ijpds-7762	18	16	while	while	SCONJ
ijpds-7762	18	17	juxtaposing	juxtapose	VERB
ijpds-7762	18	18	it	it	PRON
ijpds-7762	18	19	with	with	ADP
ijpds-7762	18	20	traditional	traditional	ADJ
ijpds-7762	18	21	methodologies	methodology	NOUN
ijpds-7762	18	22	.	.	PUNCT
ijpds-7762	19	1	furthermore	furthermore	ADV
ijpds-7762	19	2	,	,	PUNCT
ijpds-7762	19	3	we	we	PRON
ijpds-7762	19	4	also	also	ADV
ijpds-7762	19	5	discuss	discuss	VERB
ijpds-7762	19	6	the	the	DET
ijpds-7762	19	7	ongoing	ongoing	ADJ
ijpds-7762	19	8	challenges	challenge	NOUN
ijpds-7762	19	9	with	with	ADP
ijpds-7762	19	10	respect	respect	NOUN
ijpds-7762	19	11	to	to	ADP
ijpds-7762	19	12	the	the	DET
ijpds-7762	19	13	usage	usage	NOUN
ijpds-7762	19	14	of	of	ADP
ijpds-7762	19	15	ai	ai	NOUN
ijpds-7762	19	16	,	,	PUNCT
ijpds-7762	19	17	along	along	ADP
ijpds-7762	19	18	with	with	ADP
ijpds-7762	19	19	the	the	DET
ijpds-7762	19	20	future	future	NOUN
ijpds-7762	19	21	of	of	ADP
ijpds-7762	19	22	ai	ai	NOUN
ijpds-7762	19	23	in	in	ADP
ijpds-7762	19	24	the	the	DET
ijpds-7762	19	25	pharmaceutical	pharmaceutical	NOUN
ijpds-7762	19	26	industry	industry	NOUN
ijpds-7762	19	27	and	and	CCONJ
ijpds-7762	19	28	the	the	DET
ijpds-7762	19	29	ways	way	NOUN
ijpds-7762	19	30	it	it	PRON
ijpds-7762	19	31	can	can	AUX
ijpds-7762	19	32	significantly	significantly	ADV
ijpds-7762	19	33	restructure	restructure	VERB
ijpds-7762	19	34	the	the	DET
ijpds-7762	19	35	global	global	ADJ
ijpds-7762	19	36	healthcare	healthcare	PROPN
ijpds-7762	19	37	system	system	NOUN
ijpds-7762	19	38	.	.	PUNCT
ijpds-7762	20	1	revolution	revolution	NOUN
ijpds-7762	20	2	of	of	ADP
ijpds-7762	20	3	ai	ai	VERB
ijpds-7762	20	4	the	the	DET
ijpds-7762	20	5	dartmouth	dartmouth	PROPN
ijpds-7762	20	6	workshop	workshop	NOUN
ijpds-7762	20	7	conducted	conduct	VERB
ijpds-7762	20	8	in	in	ADP
ijpds-7762	20	9	1956	1956	NUM
ijpds-7762	20	10	is	be	AUX
ijpds-7762	20	11	considered	consider	VERB
ijpds-7762	20	12	the	the	DET
ijpds-7762	20	13	foundational	foundational	ADJ
ijpds-7762	20	14	event	event	NOUN
ijpds-7762	20	15	for	for	ADP
ijpds-7762	20	16	the	the	DET
ijpds-7762	20	17	advent	advent	NOUN
ijpds-7762	20	18	of	of	ADP
ijpds-7762	20	19	ai	ai	NOUN
ijpds-7762	20	20	.	.	PUNCT
ijpds-7762	21	1	it	it	PRON
ijpds-7762	21	2	is	be	AUX
ijpds-7762	21	3	described	describe	VERB
ijpds-7762	21	4	as	as	ADP
ijpds-7762	21	5	intelligence	intelligence	NOUN
ijpds-7762	21	6	displayed	display	VERB
ijpds-7762	21	7	by	by	ADP
ijpds-7762	21	8	man	man	NOUN
ijpds-7762	21	9	-	-	PUNCT
ijpds-7762	21	10	made	make	VERB
ijpds-7762	21	11	machines	machine	NOUN
ijpds-7762	21	12	,	,	PUNCT
ijpds-7762	21	13	dedicated	dedicate	VERB
ijpds-7762	21	14	to	to	ADP
ijpds-7762	21	15	developing	develop	VERB
ijpds-7762	21	16	theories	theory	NOUN
ijpds-7762	21	17	,	,	PUNCT
ijpds-7762	21	18	technologies	technology	NOUN
ijpds-7762	21	19	,	,	PUNCT
ijpds-7762	21	20	applications	application	NOUN
ijpds-7762	21	21	,	,	PUNCT
ijpds-7762	21	22	and	and	CCONJ
ijpds-7762	21	23	methods	method	NOUN
ijpds-7762	21	24	aimed	aim	VERB
ijpds-7762	21	25	at	at	ADP
ijpds-7762	21	26	replicating	replicate	VERB
ijpds-7762	21	27	,	,	PUNCT
ijpds-7762	21	28	enhancing	enhancing	NOUN
ijpds-7762	21	29	,	,	PUNCT
ijpds-7762	21	30	and	and	CCONJ
ijpds-7762	21	31	extending	extend	VERB
ijpds-7762	21	32	human	human	ADJ
ijpds-7762	21	33	intelligence	intelligence	NOUN
ijpds-7762	21	34	[	[	X
ijpds-7762	21	35	10	10	NUM
ijpds-7762	21	36	]	]	PUNCT
ijpds-7762	21	37	.	.	PUNCT
ijpds-7762	22	1	over	over	ADP
ijpds-7762	22	2	the	the	DET
ijpds-7762	22	3	past	past	ADJ
ijpds-7762	22	4	70	70	NUM
ijpds-7762	22	5	years	year	NOUN
ijpds-7762	22	6	,	,	PUNCT
ijpds-7762	22	7	ai	ai	AUX
ijpds-7762	22	8	has	have	AUX
ijpds-7762	22	9	evolved	evolve	VERB
ijpds-7762	22	10	from	from	ADP
ijpds-7762	22	11	a	a	DET
ijpds-7762	22	12	theoretical	theoretical	ADJ
ijpds-7762	22	13	notion	notion	NOUN
ijpds-7762	22	14	into	into	ADP
ijpds-7762	22	15	a	a	DET
ijpds-7762	22	16	powerful	powerful	ADJ
ijpds-7762	22	17	industrial	industrial	ADJ
ijpds-7762	22	18	adaptation	adaptation	NOUN
ijpds-7762	22	19	,	,	PUNCT
ijpds-7762	22	20	revolutionizing	revolutionize	VERB
ijpds-7762	22	21	industries	industry	NOUN
ijpds-7762	22	22	such	such	ADJ
ijpds-7762	22	23	as	as	ADP
ijpds-7762	22	24	manufacturing	manufacturing	NOUN
ijpds-7762	22	25	,	,	PUNCT
ijpds-7762	22	26	agriculture	agriculture	NOUN
ijpds-7762	22	27	,	,	PUNCT
ijpds-7762	22	28	finance	finance	NOUN
ijpds-7762	22	29	,	,	PUNCT
ijpds-7762	22	30	and	and	CCONJ
ijpds-7762	22	31	healthcare	healthcare	NOUN
ijpds-7762	22	32	[	[	X
ijpds-7762	22	33	11	11	NUM
ijpds-7762	22	34	-	-	SYM
ijpds-7762	22	35	13	13	NUM
ijpds-7762	22	36	]	]	PUNCT
ijpds-7762	22	37	.	.	PUNCT
ijpds-7762	23	1	ai	ai	VERB
ijpds-7762	23	2	includes	include	VERB
ijpds-7762	23	3	various	various	ADJ
ijpds-7762	23	4	subtypes	subtype	NOUN
ijpds-7762	23	5	,	,	PUNCT
ijpds-7762	23	6	some	some	PRON
ijpds-7762	23	7	of	of	ADP
ijpds-7762	23	8	which	which	PRON
ijpds-7762	23	9	are	be	AUX
ijpds-7762	23	10	described	describe	VERB
ijpds-7762	23	11	as	as	ADP
ijpds-7762	23	12	follows	follow	VERB
ijpds-7762	23	13	:	:	PUNCT
ijpds-7762	23	14	machine	machine	NOUN
ijpds-7762	23	15	learning	learning	NOUN
ijpds-7762	23	16	(	(	PUNCT
ijpds-7762	23	17	ml	ml	NOUN
ijpds-7762	23	18	)	)	PUNCT
ijpds-7762	23	19	,	,	PUNCT
ijpds-7762	23	20	natural	natural	ADJ
ijpds-7762	23	21	language	language	NOUN
ijpds-7762	23	22	processing	processing	NOUN
ijpds-7762	23	23	(	(	PUNCT
ijpds-7762	23	24	nlp	nlp	NOUN
ijpds-7762	23	25	)	)	PUNCT
ijpds-7762	23	26	,	,	PUNCT
ijpds-7762	23	27	computer	computer	NOUN
ijpds-7762	23	28	vision	vision	NOUN
ijpds-7762	23	29	(	(	PUNCT
ijpds-7762	23	30	cv	cv	PROPN
ijpds-7762	23	31	)	)	PUNCT
ijpds-7762	23	32	,	,	PUNCT
ijpds-7762	23	33	and	and	CCONJ
ijpds-7762	23	34	fuzzy	fuzzy	ADJ
ijpds-7762	23	35	logic	logic	NOUN
ijpds-7762	23	36	_	_	PUNCT
ijpds-7762	24	1	_	_	PUNCT
ijpds-7762	25	1	_	_	PUNCT
ijpds-7762	26	1	_	_	PUNCT
ijpds-7762	27	1	_	_	PUNCT
ijpds-7762	28	1	_	_	PUNCT
ijpds-7762	29	1	_	_	PUNCT
ijpds-7762	30	1	_	_	PUNCT
ijpds-7762	31	1	_	_	PUNCT
ijpds-7762	32	1	_	_	PUNCT
ijpds-7762	33	1	_	_	PUNCT
ijpds-7762	34	1	_	_	PUNCT
ijpds-7762	35	1	_	_	PUNCT
ijpds-7762	36	1	_	_	PUNCT
ijpds-7762	37	1	_	_	PUNCT
ijpds-7762	38	1	_	_	PUNCT
ijpds-7762	39	1	_	_	PUNCT
ijpds-7762	40	1	_	_	PUNCT
ijpds-7762	41	1	_	_	PUNCT
ijpds-7762	42	1	_	_	PUNCT
ijpds-7762	43	1	_	_	PUNCT
ijpds-7762	44	1	_	_	PUNCT
ijpds-7762	45	1	_	_	PUNCT
ijpds-7762	46	1	_	_	PUNCT
ijpds-7762	47	1	_	_	PUNCT
ijpds-7762	48	1	_	_	PUNCT
ijpds-7762	49	1	_	_	PUNCT
ijpds-7762	50	1	_	_	PUNCT
ijpds-7762	51	1	_	_	PUNCT
ijpds-7762	52	1	_	_	PUNCT
ijpds-7762	53	1	_	_	PUNCT
ijpds-7762	54	1	_	_	PUNCT
ijpds-7762	55	1	_	_	PUNCT
ijpds-7762	56	1	_	_	PUNCT
ijpds-7762	57	1	_	_	PUNCT
ijpds-7762	58	1	_	_	PUNCT
ijpds-7762	59	1	_	_	PUNCT
ijpds-7762	60	1	_	_	PUNCT
ijpds-7762	61	1	_	_	PUNCT
ijpds-7762	62	1	_	_	PUNCT
ijpds-7762	63	1	_	_	PUNCT
ijpds-7762	64	1	_	_	PUNCT
ijpds-7762	65	1	_	_	PUNCT
ijpds-7762	66	1	_	_	PUNCT
ijpds-7762	67	1	_	_	PUNCT
ijpds-7762	68	1	_	_	PUNCT
ijpds-7762	69	1	_	_	PUNCT
ijpds-7762	70	1	_	_	PUNCT
ijpds-7762	71	1	_	_	PUNCT
ijpds-7762	72	1	_	_	PUNCT
ijpds-7762	72	2	correspondence	correspondence	NOUN
ijpds-7762	72	3	to	to	ADP
ijpds-7762	72	4	:	:	PUNCT
ijpds-7762	72	5	dr	dr	PROPN
ijpds-7762	72	6	.	.	PROPN
ijpds-7762	72	7	rashmi	rashmi	PROPN
ijpds-7762	72	8	agrawal	agrawal	PROPN
ijpds-7762	72	9	.	.	PUNCT
ijpds-7762	73	1	devmata	devmata	PROPN
ijpds-7762	73	2	hospital	hospital	NOUN
ijpds-7762	73	3	,	,	PUNCT
ijpds-7762	73	4	bhopal	bhopal	PROPN
ijpds-7762	73	5	,	,	PUNCT
ijpds-7762	73	6	madhya	madhya	PROPN
ijpds-7762	73	7	pradesh	pradesh	PROPN
ijpds-7762	73	8	,	,	PUNCT
ijpds-7762	73	9	india	india	PROPN
ijpds-7762	73	10	.	.	PUNCT
ijpds-7762	73	11	email	email	NOUN
ijpds-7762	73	12	:	:	PUNCT
ijpds-7762	73	13	atharvapub@gmail.com	atharvapub@gmail.com	X
ijpds-7762	74	1	a	a	DET
ijpds-7762	74	2	mailto:atharvapub@gmail.com	mailto:atharvapub@gmail.com	PROPN
ijpds-7762	74	3	agrawal	agrawal	PROPN
ijpds-7762	74	4	and	and	CCONJ
ijpds-7762	74	5	kulkarni	kulkarni	PROPN
ijpds-7762	74	6	ai	ai	VERB
ijpds-7762	74	7	applications	application	NOUN
ijpds-7762	74	8	in	in	ADP
ijpds-7762	74	9	drug	drug	NOUN
ijpds-7762	74	10	discovery	discovery	NOUN
ijpds-7762	74	11	and	and	CCONJ
ijpds-7762	74	12	development	development	NOUN
ijpds-7762	74	13	online	online	PROPN
ijpds-7762	74	14	first	first	PROPN
ijpds-7762	74	15	indian	indian	PROPN
ijpds-7762	74	16	j	j	PROPN
ijpds-7762	74	17	pharm	pharm	PROPN
ijpds-7762	74	18	drug	drug	PROPN
ijpds-7762	74	19	studies	study	NOUN
ijpds-7762	74	20	|	|	ADV
ijpds-7762	74	21	2	2	NUM
ijpds-7762	74	22	(	(	PUNCT
ijpds-7762	74	23	fl	fl	NOUN
ijpds-7762	74	24	)	)	PUNCT
ijpds-7762	74	25	.	.	PUNCT
ijpds-7762	75	1	ml	ml	PROPN
ijpds-7762	75	2	works	work	VERB
ijpds-7762	75	3	on	on	ADP
ijpds-7762	75	4	algorithms	algorithm	NOUN
ijpds-7762	75	5	trained	train	VERB
ijpds-7762	75	6	for	for	ADP
ijpds-7762	75	7	decision	decision	NOUN
ijpds-7762	75	8	-	-	PUNCT
ijpds-7762	75	9	making	making	NOUN
ijpds-7762	75	10	that	that	PRON
ijpds-7762	75	11	learn	learn	VERB
ijpds-7762	75	12	from	from	ADP
ijpds-7762	75	13	the	the	DET
ijpds-7762	75	14	already	already	ADV
ijpds-7762	75	15	analyzed	analyze	VERB
ijpds-7762	75	16	data	datum	NOUN
ijpds-7762	75	17	.	.	PUNCT
ijpds-7762	76	1	ml	ml	PROPN
ijpds-7762	76	2	is	be	AUX
ijpds-7762	76	3	further	far	ADV
ijpds-7762	76	4	classified	classify	VERB
ijpds-7762	76	5	into	into	ADP
ijpds-7762	76	6	supervised	supervised	ADJ
ijpds-7762	76	7	learning	learning	NOUN
ijpds-7762	76	8	and	and	CCONJ
ijpds-7762	76	9	unsupervised	unsupervised	ADJ
ijpds-7762	76	10	learning	learning	NOUN
ijpds-7762	76	11	.	.	PUNCT
ijpds-7762	77	1	in	in	ADP
ijpds-7762	77	2	supervised	supervised	ADJ
ijpds-7762	77	3	learning	learning	NOUN
ijpds-7762	77	4	,	,	PUNCT
ijpds-7762	77	5	pre	pre	ADJ
ijpds-7762	77	6	-	-	ADJ
ijpds-7762	77	7	catalogued/	catalogued/	PUNCT
ijpds-7762	77	8	labelled	labelled	ADJ
ijpds-7762	77	9	data	datum	NOUN
ijpds-7762	77	10	is	be	AUX
ijpds-7762	77	11	used	use	VERB
ijpds-7762	77	12	as	as	ADP
ijpds-7762	77	13	input	input	NOUN
ijpds-7762	77	14	,	,	PUNCT
ijpds-7762	77	15	whereas	whereas	SCONJ
ijpds-7762	77	16	in	in	ADP
ijpds-7762	77	17	the	the	DET
ijpds-7762	77	18	latter	latter	ADJ
ijpds-7762	77	19	,	,	PUNCT
ijpds-7762	77	20	training	training	NOUN
ijpds-7762	77	21	data	datum	NOUN
ijpds-7762	77	22	is	be	AUX
ijpds-7762	77	23	not	not	PART
ijpds-7762	77	24	catalogued	catalogue	VERB
ijpds-7762	77	25	/	/	PUNCT
ijpds-7762	77	26	labelled	label	VERB
ijpds-7762	77	27	,	,	PUNCT
ijpds-7762	77	28	and	and	CCONJ
ijpds-7762	77	29	the	the	DET
ijpds-7762	77	30	system	system	NOUN
ijpds-7762	77	31	must	must	AUX
ijpds-7762	77	32	perceive	perceive	VERB
ijpds-7762	77	33	and	and	CCONJ
ijpds-7762	77	34	label	label	VERB
ijpds-7762	77	35	the	the	DET
ijpds-7762	77	36	said	say	VERB
ijpds-7762	77	37	data	datum	NOUN
ijpds-7762	77	38	.	.	PUNCT
ijpds-7762	78	1	a	a	DET
ijpds-7762	78	2	third	third	ADJ
ijpds-7762	78	3	sub	sub	NOUN
ijpds-7762	78	4	-	-	ADJ
ijpds-7762	78	5	category	category	NOUN
ijpds-7762	78	6	exists	exist	VERB
ijpds-7762	78	7	,	,	PUNCT
ijpds-7762	78	8	known	know	VERB
ijpds-7762	78	9	as	as	ADP
ijpds-7762	78	10	semisupervised	semisupervised	ADJ
ijpds-7762	78	11	learning	learning	NOUN
ijpds-7762	78	12	,	,	PUNCT
ijpds-7762	78	13	a	a	DET
ijpds-7762	78	14	combination	combination	NOUN
ijpds-7762	78	15	of	of	ADP
ijpds-7762	78	16	the	the	DET
ijpds-7762	78	17	two	two	NUM
ijpds-7762	78	18	previously	previously	ADV
ijpds-7762	78	19	explained	explain	VERB
ijpds-7762	78	20	types	type	NOUN
ijpds-7762	78	21	[	[	X
ijpds-7762	78	22	14	14	NUM
ijpds-7762	78	23	]	]	PUNCT
ijpds-7762	78	24	.	.	PUNCT
ijpds-7762	79	1	deep	deep	ADJ
ijpds-7762	79	2	learning	learning	NOUN
ijpds-7762	79	3	(	(	PUNCT
ijpds-7762	79	4	dl	dl	INTJ
ijpds-7762	79	5	)	)	PUNCT
ijpds-7762	79	6	is	be	AUX
ijpds-7762	79	7	a	a	DET
ijpds-7762	79	8	subgroup	subgroup	NOUN
ijpds-7762	79	9	of	of	ADP
ijpds-7762	79	10	ml	ml	NOUN
ijpds-7762	79	11	based	base	VERB
ijpds-7762	79	12	on	on	ADP
ijpds-7762	79	13	systems	system	NOUN
ijpds-7762	79	14	that	that	PRON
ijpds-7762	79	15	use	use	VERB
ijpds-7762	79	16	artificial	artificial	ADJ
ijpds-7762	79	17	neural	neural	ADJ
ijpds-7762	79	18	networks	network	NOUN
ijpds-7762	79	19	(	(	PUNCT
ijpds-7762	79	20	ann	ann	PROPN
ijpds-7762	79	21	)	)	PUNCT
ijpds-7762	79	22	,	,	PUNCT
ijpds-7762	79	23	which	which	PRON
ijpds-7762	79	24	imitate	imitate	VERB
ijpds-7762	79	25	the	the	DET
ijpds-7762	79	26	human	human	ADJ
ijpds-7762	79	27	brain	brain	NOUN
ijpds-7762	79	28	,	,	PUNCT
ijpds-7762	79	29	and	and	CCONJ
ijpds-7762	79	30	act	act	VERB
ijpds-7762	79	31	by	by	ADP
ijpds-7762	79	32	interpreting	interpret	VERB
ijpds-7762	79	33	and	and	CCONJ
ijpds-7762	79	34	drawing	draw	VERB
ijpds-7762	79	35	conclusions	conclusion	NOUN
ijpds-7762	79	36	from	from	ADP
ijpds-7762	79	37	the	the	DET
ijpds-7762	79	38	given	give	VERB
ijpds-7762	79	39	data	datum	NOUN
ijpds-7762	79	40	.	.	PUNCT
ijpds-7762	80	1	whereas	whereas	ADV
ijpds-7762	80	2	,	,	PUNCT
ijpds-7762	80	3	nlp	nlp	NOUN
ijpds-7762	80	4	is	be	AUX
ijpds-7762	80	5	a	a	DET
ijpds-7762	80	6	branch	branch	NOUN
ijpds-7762	80	7	of	of	ADP
ijpds-7762	80	8	ai	ai	NOUN
ijpds-7762	80	9	that	that	PRON
ijpds-7762	80	10	recognizes	recognize	VERB
ijpds-7762	80	11	natural	natural	ADJ
ijpds-7762	80	12	language	language	NOUN
ijpds-7762	80	13	and	and	CCONJ
ijpds-7762	80	14	builds	build	VERB
ijpds-7762	80	15	communication	communication	NOUN
ijpds-7762	80	16	between	between	ADP
ijpds-7762	80	17	machines	machine	NOUN
ijpds-7762	80	18	and	and	CCONJ
ijpds-7762	80	19	humans	human	NOUN
ijpds-7762	80	20	.	.	PUNCT
ijpds-7762	81	1	cv	cv	PROPN
ijpds-7762	81	2	is	be	AUX
ijpds-7762	81	3	a	a	DET
ijpds-7762	81	4	subtype	subtype	NOUN
ijpds-7762	81	5	of	of	ADP
ijpds-7762	81	6	ai	ai	NOUN
ijpds-7762	81	7	that	that	PRON
ijpds-7762	81	8	allows	allow	VERB
ijpds-7762	81	9	computers	computer	NOUN
ijpds-7762	81	10	to	to	PART
ijpds-7762	81	11	discern	discern	VERB
ijpds-7762	81	12	an	an	DET
ijpds-7762	81	13	image	image	NOUN
ijpds-7762	81	14	and	and	CCONJ
ijpds-7762	81	15	distinguish	distinguish	VERB
ijpds-7762	81	16	the	the	DET
ijpds-7762	81	17	individual	individual	ADJ
ijpds-7762	81	18	elements	element	NOUN
ijpds-7762	81	19	of	of	ADP
ijpds-7762	81	20	that	that	DET
ijpds-7762	81	21	particular	particular	ADJ
ijpds-7762	81	22	image	image	NOUN
ijpds-7762	81	23	by	by	ADP
ijpds-7762	81	24	assigning	assign	VERB
ijpds-7762	81	25	them	they	PRON
ijpds-7762	81	26	a	a	DET
ijpds-7762	81	27	meaning	meaning	NOUN
ijpds-7762	81	28	.	.	PUNCT
ijpds-7762	82	1	on	on	ADP
ijpds-7762	82	2	the	the	DET
ijpds-7762	82	3	other	other	ADJ
ijpds-7762	82	4	hand	hand	NOUN
ijpds-7762	82	5	,	,	PUNCT
ijpds-7762	82	6	fl	fl	PROPN
ijpds-7762	82	7	uses	use	VERB
ijpds-7762	82	8	nonbinary	nonbinary	ADJ
ijpds-7762	82	9	values	value	NOUN
ijpds-7762	82	10	to	to	PART
ijpds-7762	82	11	solve	solve	VERB
ijpds-7762	82	12	issues	issue	NOUN
ijpds-7762	82	13	that	that	PRON
ijpds-7762	82	14	normally	normally	ADV
ijpds-7762	82	15	require	require	VERB
ijpds-7762	82	16	tackling	tackle	VERB
ijpds-7762	82	17	with	with	ADP
ijpds-7762	82	18	more	more	ADJ
ijpds-7762	82	19	values	value	NOUN
ijpds-7762	82	20	,	,	PUNCT
ijpds-7762	82	21	hence	hence	ADV
ijpds-7762	82	22	deciphers	decipher	VERB
ijpds-7762	82	23	the	the	DET
ijpds-7762	82	24	problems	problem	NOUN
ijpds-7762	82	25	that	that	SCONJ
ijpds-7762	82	26	classical	classical	ADJ
ijpds-7762	82	27	logic	logic	NOUN
ijpds-7762	82	28	can	can	AUX
ijpds-7762	82	29	not	not	PART
ijpds-7762	82	30	solve	solve	VERB
ijpds-7762	82	31	[	[	X
ijpds-7762	82	32	15	15	NUM
ijpds-7762	82	33	,	,	PUNCT
ijpds-7762	82	34	16	16	NUM
ijpds-7762	82	35	]	]	PUNCT
ijpds-7762	82	36	.	.	PUNCT
ijpds-7762	83	1	figure	figure	NOUN
ijpds-7762	83	2	1	1	NUM
ijpds-7762	83	3	:	:	PUNCT
ijpds-7762	83	4	classification	classification	NOUN
ijpds-7762	83	5	of	of	ADP
ijpds-7762	83	6	anns	anns	NOUN
ijpds-7762	83	7	[	[	X
ijpds-7762	83	8	16	16	NUM
ijpds-7762	83	9	,	,	PUNCT
ijpds-7762	83	10	17	17	NUM
ijpds-7762	83	11	]	]	PUNCT
ijpds-7762	83	12	an	an	DET
ijpds-7762	83	13	ml	ml	X
ijpds-7762	83	14	algorithm	algorithm	NOUN
ijpds-7762	83	15	for	for	ADP
ijpds-7762	83	16	any	any	DET
ijpds-7762	83	17	task	task	NOUN
ijpds-7762	83	18	begins	begin	VERB
ijpds-7762	83	19	with	with	ADP
ijpds-7762	83	20	task	task	NOUN
ijpds-7762	83	21	definition	definition	NOUN
ijpds-7762	83	22	and	and	CCONJ
ijpds-7762	83	23	ends	end	VERB
ijpds-7762	83	24	with	with	ADP
ijpds-7762	83	25	model	model	NOUN
ijpds-7762	83	26	application	application	NOUN
ijpds-7762	83	27	.	.	PUNCT
ijpds-7762	84	1	different	different	ADJ
ijpds-7762	84	2	steps	step	NOUN
ijpds-7762	84	3	with	with	ADP
ijpds-7762	84	4	detailed	detailed	ADJ
ijpds-7762	84	5	explanations	explanation	NOUN
ijpds-7762	84	6	are	be	AUX
ijpds-7762	84	7	described	describe	VERB
ijpds-7762	84	8	in	in	ADP
ijpds-7762	84	9	table	table	NOUN
ijpds-7762	84	10	1	1	NUM
ijpds-7762	84	11	.	.	PUNCT
ijpds-7762	84	12	table	table	NOUN
ijpds-7762	84	13	1	1	NUM
ijpds-7762	84	14	:	:	PUNCT
ijpds-7762	84	15	steps	step	NOUN
ijpds-7762	84	16	in	in	ADP
ijpds-7762	84	17	machine	machine	NOUN
ijpds-7762	84	18	learning	learn	VERB
ijpds-7762	85	1	[	[	X
ijpds-7762	85	2	16	16	NUM
ijpds-7762	85	3	,	,	PUNCT
ijpds-7762	85	4	17	17	NUM
ijpds-7762	85	5	]	]	PUNCT
ijpds-7762	85	6	s.	s.	PROPN
ijpds-7762	85	7	no	no	DET
ijpds-7762	85	8	step	step	NOUN
ijpds-7762	85	9	description	description	NOUN
ijpds-7762	85	10	1	1	NUM
ijpds-7762	85	11	pre	pre	ADJ
ijpds-7762	85	12	-	-	ADJ
ijpds-7762	85	13	processing	processing	ADJ
ijpds-7762	85	14			NOUN
ijpds-7762	85	15	ensures	ensure	VERB
ijpds-7762	85	16	that	that	SCONJ
ijpds-7762	85	17	the	the	DET
ijpds-7762	85	18	algorithm	algorithm	NOUN
ijpds-7762	85	19	easily	easily	ADV
ijpds-7762	85	20	interprets	interpret	VERB
ijpds-7762	85	21	the	the	DET
ijpds-7762	85	22	datasets	dataset	NOUN
ijpds-7762	85	23			NOUN
ijpds-7762	85	24	includes	include	VERB
ijpds-7762	85	25	data	datum	NOUN
ijpds-7762	85	26	loading	loading	NOUN
ijpds-7762	85	27	,	,	PUNCT
ijpds-7762	85	28	normalization	normalization	NOUN
ijpds-7762	85	29	,	,	PUNCT
ijpds-7762	85	30	aggregation	aggregation	NOUN
ijpds-7762	85	31	,	,	PUNCT
ijpds-7762	85	32	and	and	CCONJ
ijpds-7762	85	33	standardization	standardization	NOUN
ijpds-7762	85	34	of	of	ADP
ijpds-7762	85	35	the	the	DET
ijpds-7762	85	36	dataset	dataset	ADJ
ijpds-7762	85	37	2	2	NUM
ijpds-7762	85	38	exploratory	exploratory	ADJ
ijpds-7762	85	39	data	datum	NOUN
ijpds-7762	85	40	analysis	analysis	NOUN
ijpds-7762	85	41	(	(	PUNCT
ijpds-7762	85	42	eda	eda	PROPN
ijpds-7762	85	43	)	)	PUNCT
ijpds-7762	85	44			NOUN
ijpds-7762	85	45	tests	test	VERB
ijpds-7762	85	46	several	several	ADJ
ijpds-7762	85	47	hypotheses	hypothesis	NOUN
ijpds-7762	85	48	and	and	CCONJ
ijpds-7762	85	49	yields	yield	NOUN
ijpds-7762	85	50	a	a	DET
ijpds-7762	85	51	better	well	ADJ
ijpds-7762	85	52	understanding	understanding	NOUN
ijpds-7762	85	53	of	of	ADP
ijpds-7762	85	54	dataset	dataset	ADJ
ijpds-7762	85	55	variables	variable	NOUN
ijpds-7762	85	56	and	and	CCONJ
ijpds-7762	85	57	their	their	PRON
ijpds-7762	85	58	interrelationships	interrelationship	NOUN
ijpds-7762	85	59	.	.	PUNCT
ijpds-7762	86	1			X
ijpds-7762	86	2	check	check	VERB
ijpds-7762	86	3	for	for	ADP
ijpds-7762	86	4	errors	error	NOUN
ijpds-7762	86	5	and	and	CCONJ
ijpds-7762	86	6	missing	miss	VERB
ijpds-7762	86	7	values	value	NOUN
ijpds-7762	86	8			PRON
ijpds-7762	86	9	helps	help	VERB
ijpds-7762	86	10	determine	determine	VERB
ijpds-7762	86	11	if	if	SCONJ
ijpds-7762	86	12	the	the	DET
ijpds-7762	86	13	statistical	statistical	ADJ
ijpds-7762	86	14	techniques	technique	NOUN
ijpds-7762	86	15	that	that	PRON
ijpds-7762	86	16	are	be	AUX
ijpds-7762	86	17	used	use	VERB
ijpds-7762	86	18	for	for	ADP
ijpds-7762	86	19	the	the	DET
ijpds-7762	86	20	data	datum	NOUN
ijpds-7762	86	21	analysis	analysis	NOUN
ijpds-7762	86	22	are	be	AUX
ijpds-7762	86	23	appropriate	appropriate	ADJ
ijpds-7762	86	24	.	.	PUNCT
ijpds-7762	87	1	3	3	NUM
ijpds-7762	87	2	model	model	NOUN
ijpds-7762	87	3	selection	selection	NOUN
ijpds-7762	87	4			NOUN
ijpds-7762	87	5	creation	creation	NOUN
ijpds-7762	87	6	of	of	ADP
ijpds-7762	87	7	a	a	DET
ijpds-7762	87	8	predictive	predictive	ADJ
ijpds-7762	87	9	model	model	NOUN
ijpds-7762	87	10			NOUN
ijpds-7762	87	11	algorithms	algorithm	NOUN
ijpds-7762	87	12	are	be	AUX
ijpds-7762	87	13	often	often	ADV
ijpds-7762	87	14	grouped	group	VERB
ijpds-7762	87	15	according	accord	VERB
ijpds-7762	87	16	to	to	ADP
ijpds-7762	87	17	the	the	DET
ijpds-7762	87	18	ml	ml	PROPN
ijpds-7762	87	19	techniques	technique	NOUN
ijpds-7762	87	20	used	use	VERB
ijpds-7762	87	21	such	such	ADJ
ijpds-7762	87	22	as	as	ADP
ijpds-7762	87	23	supervised	supervised	ADJ
ijpds-7762	87	24	or	or	CCONJ
ijpds-7762	87	25	unsupervised	unsupervised	ADJ
ijpds-7762	87	26	etc	etc	X
ijpds-7762	87	27	.	.	X
ijpds-7762	88	1			NOUN
ijpds-7762	88	2	few	few	ADJ
ijpds-7762	88	3	ml	ml	NOUN
ijpds-7762	88	4	algorithms	algorithm	NOUN
ijpds-7762	88	5	used	use	VERB
ijpds-7762	88	6	in	in	ADP
ijpds-7762	88	7	medical	medical	ADJ
ijpds-7762	88	8	research	research	NOUN
ijpds-7762	88	9	are	be	AUX
ijpds-7762	88	10	support	support	NOUN
ijpds-7762	88	11	vector	vector	NOUN
ijpds-7762	88	12	machine	machine	NOUN
ijpds-7762	88	13	(	(	PUNCT
ijpds-7762	88	14	svm	svm	PROPN
ijpds-7762	88	15	)	)	PUNCT
ijpds-7762	88	16	,	,	PUNCT
ijpds-7762	88	17	multinomial	multinomial	ADJ
ijpds-7762	88	18	logistic	logistic	ADJ
ijpds-7762	88	19	regression	regression	NOUN
ijpds-7762	88	20	(	(	PUNCT
ijpds-7762	88	21	mlr	mlr	NOUN
ijpds-7762	88	22	)	)	PUNCT
ijpds-7762	88	23	,	,	PUNCT
ijpds-7762	88	24	bayesian	bayesian	NOUN
ijpds-7762	88	25	networks	network	NOUN
ijpds-7762	88	26	(	(	PUNCT
ijpds-7762	88	27	bn	bn	NOUN
ijpds-7762	88	28	)	)	PUNCT
ijpds-7762	88	29	,	,	PUNCT
ijpds-7762	88	30	and	and	CCONJ
ijpds-7762	88	31	decision	decision	NOUN
ijpds-7762	88	32	tree	tree	NOUN
ijpds-7762	88	33	(	(	PUNCT
ijpds-7762	88	34	dt	dt	NOUN
ijpds-7762	88	35	)	)	PUNCT
ijpds-7762	88	36	.	.	PUNCT
ijpds-7762	89	1			X
ijpds-7762	89	2	few	few	ADJ
ijpds-7762	89	3	dl	dl	PROPN
ijpds-7762	89	4	algorithms	algorithm	NOUN
ijpds-7762	89	5	used	use	VERB
ijpds-7762	89	6	in	in	ADP
ijpds-7762	89	7	medical	medical	ADJ
ijpds-7762	89	8	research	research	NOUN
ijpds-7762	89	9	are	be	AUX
ijpds-7762	89	10	all	all	DET
ijpds-7762	89	11	the	the	DET
ijpds-7762	89	12	sub	sub	NOUN
ijpds-7762	89	13	-	-	NOUN
ijpds-7762	89	14	types	type	NOUN
ijpds-7762	89	15	of	of	ADP
ijpds-7762	89	16	anns	ann	NOUN
ijpds-7762	89	17	,	,	PUNCT
ijpds-7762	89	18	long	long	ADJ
ijpds-7762	89	19	short	short	ADJ
ijpds-7762	89	20	-	-	PUNCT
ijpds-7762	89	21	term	term	NOUN
ijpds-7762	89	22	memory	memory	NOUN
ijpds-7762	89	23	(	(	PUNCT
ijpds-7762	89	24	lstm	lstm	NOUN
ijpds-7762	89	25	)	)	PUNCT
ijpds-7762	89	26	,	,	PUNCT
ijpds-7762	89	27	and	and	CCONJ
ijpds-7762	89	28	mixed	mixed	ADJ
ijpds-7762	89	29	networks	network	NOUN
ijpds-7762	89	30	.	.	PUNCT
ijpds-7762	90	1	4	4	NUM
ijpds-7762	90	2	model	model	NOUN
ijpds-7762	90	3	processing	processing	NOUN
ijpds-7762	90	4	and	and	CCONJ
ijpds-7762	90	5	evaluation	evaluation	NOUN
ijpds-7762	90	6			NOUN
ijpds-7762	90	7	datasets	dataset	NOUN
ijpds-7762	90	8	are	be	AUX
ijpds-7762	90	9	divided	divide	VERB
ijpds-7762	90	10	into	into	ADP
ijpds-7762	90	11	test	test	NOUN
ijpds-7762	90	12	and	and	CCONJ
ijpds-7762	90	13	train	train	NOUN
ijpds-7762	90	14	sets	set	NOUN
ijpds-7762	90	15	,	,	PUNCT
ijpds-7762	90	16	and	and	CCONJ
ijpds-7762	90	17	further	further	ADJ
ijpds-7762	90	18	crossvalidation	crossvalidation	NOUN
ijpds-7762	90	19	is	be	AUX
ijpds-7762	90	20	done	do	VERB
ijpds-7762	90	21	.	.	PUNCT
ijpds-7762	91	1			X
ijpds-7762	92	1	if	if	SCONJ
ijpds-7762	92	2	the	the	DET
ijpds-7762	92	3	model	model	NOUN
ijpds-7762	92	4	shows	show	VERB
ijpds-7762	92	5	discrepancies	discrepancy	NOUN
ijpds-7762	92	6	,	,	PUNCT
ijpds-7762	92	7	it	it	PRON
ijpds-7762	92	8	can	can	AUX
ijpds-7762	92	9	be	be	AUX
ijpds-7762	92	10	rebuilt	rebuild	VERB
ijpds-7762	92	11	using	use	VERB
ijpds-7762	92	12	improvement	improvement	NOUN
ijpds-7762	92	13	strategies	strategy	NOUN
ijpds-7762	92	14	,	,	PUNCT
ijpds-7762	92	15	which	which	PRON
ijpds-7762	92	16	is	be	AUX
ijpds-7762	92	17	known	know	VERB
ijpds-7762	92	18	as	as	ADP
ijpds-7762	92	19	‘	'	PUNCT
ijpds-7762	92	20	tuning	tuning	NOUN
ijpds-7762	92	21	’	'	PUNCT
ijpds-7762	92	22			NOUN
ijpds-7762	92	23	model	model	NOUN
ijpds-7762	92	24	evaluation	evaluation	NOUN
ijpds-7762	92	25	is	be	AUX
ijpds-7762	92	26	done	do	VERB
ijpds-7762	92	27	with	with	ADP
ijpds-7762	92	28	anns	ann	NOUN
ijpds-7762	92	29	.	.	PUNCT
ijpds-7762	93	1	data	datum	NOUN
ijpds-7762	93	2	,	,	PUNCT
ijpds-7762	93	3	computation	computation	NOUN
ijpds-7762	93	4	,	,	PUNCT
ijpds-7762	93	5	and	and	CCONJ
ijpds-7762	93	6	algorithms	algorithm	NOUN
ijpds-7762	93	7	,	,	PUNCT
ijpds-7762	93	8	the	the	DET
ijpds-7762	93	9	essential	essential	ADJ
ijpds-7762	93	10	components	component	NOUN
ijpds-7762	93	11	of	of	ADP
ijpds-7762	93	12	ai	ai	NOUN
ijpds-7762	93	13	,	,	PUNCT
ijpds-7762	93	14	serve	serve	VERB
ijpds-7762	93	15	as	as	ADP
ijpds-7762	93	16	the	the	DET
ijpds-7762	93	17	basis	basis	NOUN
ijpds-7762	93	18	of	of	ADP
ijpds-7762	93	19	the	the	DET
ijpds-7762	93	20	ai	ai	ADJ
ijpds-7762	93	21	-	-	PUNCT
ijpds-7762	93	22	driven	drive	VERB
ijpds-7762	93	23	pharmaceutical	pharmaceutical	NOUN
ijpds-7762	93	24	research	research	NOUN
ijpds-7762	93	25	[	[	X
ijpds-7762	93	26	18	18	NUM
ijpds-7762	93	27	]	]	PUNCT
ijpds-7762	93	28	.	.	PUNCT
ijpds-7762	94	1	sources	source	NOUN
ijpds-7762	94	2	of	of	ADP
ijpds-7762	94	3	data	datum	NOUN
ijpds-7762	94	4	in	in	ADP
ijpds-7762	94	5	the	the	DET
ijpds-7762	94	6	pharmaceutical	pharmaceutical	ADJ
ijpds-7762	94	7	industry	industry	NOUN
ijpds-7762	94	8	include	include	VERB
ijpds-7762	94	9	public	public	ADJ
ijpds-7762	94	10	and	and	CCONJ
ijpds-7762	94	11	commercial	commercial	ADJ
ijpds-7762	94	12	datasets	dataset	NOUN
ijpds-7762	94	13	,	,	PUNCT
ijpds-7762	94	14	and	and	CCONJ
ijpds-7762	94	15	research	research	NOUN
ijpds-7762	94	16	datasets	dataset	NOUN
ijpds-7762	94	17	generated	generate	VERB
ijpds-7762	94	18	through	through	ADP
ijpds-7762	94	19	data	datum	NOUN
ijpds-7762	94	20	mining	mining	NOUN
ijpds-7762	94	21	.	.	PUNCT
ijpds-7762	95	1	the	the	DET
ijpds-7762	95	2	evolution	evolution	NOUN
ijpds-7762	95	3	of	of	ADP
ijpds-7762	95	4	computational	computational	ADJ
ijpds-7762	95	5	power	power	NOUN
ijpds-7762	95	6	and	and	CCONJ
ijpds-7762	95	7	the	the	DET
ijpds-7762	95	8	advent	advent	NOUN
ijpds-7762	95	9	of	of	ADP
ijpds-7762	95	10	various	various	ADJ
ijpds-7762	95	11	algorithms	algorithm	NOUN
ijpds-7762	95	12	have	have	AUX
ijpds-7762	95	13	provided	provide	VERB
ijpds-7762	95	14	critical	critical	ADJ
ijpds-7762	95	15	support	support	NOUN
ijpds-7762	95	16	for	for	ADP
ijpds-7762	95	17	ai	ai	PRON
ijpds-7762	95	18	pharmaceutical	pharmaceutical	ADJ
ijpds-7762	95	19	companies	company	NOUN
ijpds-7762	95	20	in	in	ADP
ijpds-7762	95	21	carrying	carry	VERB
ijpds-7762	95	22	out	out	ADP
ijpds-7762	95	23	research	research	NOUN
ijpds-7762	95	24	using	use	VERB
ijpds-7762	95	25	the	the	DET
ijpds-7762	95	26	extremely	extremely	ADV
ijpds-7762	95	27	potent	potent	ADJ
ijpds-7762	95	28	tool	tool	NOUN
ijpds-7762	95	29	,	,	PUNCT
ijpds-7762	95	30	ai	ai	VERB
ijpds-7762	95	31	[	[	X
ijpds-7762	95	32	19	19	NUM
ijpds-7762	95	33	]	]	PUNCT
ijpds-7762	95	34	.	.	PUNCT
ijpds-7762	96	1	challenges	challenge	NOUN
ijpds-7762	96	2	faced	face	VERB
ijpds-7762	96	3	with	with	ADP
ijpds-7762	96	4	traditional	traditional	ADJ
ijpds-7762	96	5	drug	drug	NOUN
ijpds-7762	96	6	discovery	discovery	NOUN
ijpds-7762	96	7	and	and	CCONJ
ijpds-7762	96	8	development	development	NOUN
ijpds-7762	96	9	methods	method	NOUN
ijpds-7762	96	10	traditional	traditional	ADJ
ijpds-7762	96	11	drug	drug	NOUN
ijpds-7762	96	12	discovery	discovery	NOUN
ijpds-7762	96	13	,	,	PUNCT
ijpds-7762	96	14	as	as	SCONJ
ijpds-7762	96	15	described	describe	VERB
ijpds-7762	96	16	before	before	ADV
ijpds-7762	96	17	,	,	PUNCT
ijpds-7762	96	18	is	be	AUX
ijpds-7762	96	19	a	a	DET
ijpds-7762	96	20	complex	complex	ADJ
ijpds-7762	96	21	,	,	PUNCT
ijpds-7762	96	22	time	time	NOUN
ijpds-7762	96	23	-	-	PUNCT
ijpds-7762	96	24	consuming	consume	VERB
ijpds-7762	96	25	,	,	PUNCT
ijpds-7762	96	26	laborious	laborious	ADJ
ijpds-7762	96	27	,	,	PUNCT
ijpds-7762	96	28	and	and	CCONJ
ijpds-7762	96	29	costly	costly	ADJ
ijpds-7762	96	30	undertaking	undertaking	NOUN
ijpds-7762	96	31	.	.	PUNCT
ijpds-7762	97	1	to	to	PART
ijpds-7762	97	2	bring	bring	VERB
ijpds-7762	97	3	a	a	DET
ijpds-7762	97	4	single	single	ADJ
ijpds-7762	97	5	drug	drug	NOUN
ijpds-7762	97	6	to	to	ADP
ijpds-7762	97	7	the	the	DET
ijpds-7762	97	8	market	market	NOUN
ijpds-7762	97	9	,	,	PUNCT
ijpds-7762	97	10	it	it	PRON
ijpds-7762	97	11	typically	typically	ADV
ijpds-7762	97	12	takes	take	VERB
ijpds-7762	97	13	over	over	ADP
ijpds-7762	97	14	a	a	DET
ijpds-7762	97	15	decade	decade	NOUN
ijpds-7762	97	16	and	and	CCONJ
ijpds-7762	97	17	an	an	DET
ijpds-7762	97	18	average	average	ADJ
ijpds-7762	97	19	cost	cost	NOUN
ijpds-7762	97	20	exceeding	exceed	VERB
ijpds-7762	97	21	$	$	SYM
ijpds-7762	97	22	2	2	NUM
ijpds-7762	97	23	billion	billion	NUM
ijpds-7762	97	24	.	.	PUNCT
ijpds-7762	98	1	each	each	DET
ijpds-7762	98	2	and	and	CCONJ
ijpds-7762	98	3	every	every	PRON
ijpds-7762	98	4	stage	stage	NOUN
ijpds-7762	98	5	,	,	PUNCT
ijpds-7762	98	6	starting	start	VERB
ijpds-7762	98	7	from	from	ADP
ijpds-7762	98	8	target	target	NOUN
ijpds-7762	98	9	identification	identification	NOUN
ijpds-7762	98	10	and	and	CCONJ
ijpds-7762	98	11	validation	validation	NOUN
ijpds-7762	98	12	till	till	SCONJ
ijpds-7762	98	13	preclinical	preclinical	ADJ
ijpds-7762	98	14	testing	testing	NOUN
ijpds-7762	98	15	and	and	CCONJ
ijpds-7762	98	16	clinical	clinical	ADJ
ijpds-7762	98	17	trials	trial	NOUN
ijpds-7762	98	18	,	,	PUNCT
ijpds-7762	98	19	requires	require	VERB
ijpds-7762	98	20	immense	immense	ADJ
ijpds-7762	98	21	trial	trial	NOUN
ijpds-7762	98	22	-	-	PUNCT
ijpds-7762	98	23	and	and	CCONJ
ijpds-7762	98	24	-	-	PUNCT
ijpds-7762	98	25	error	error	NOUN
ijpds-7762	98	26	experimentations	experimentation	NOUN
ijpds-7762	98	27	with	with	ADP
ijpds-7762	98	28	huge	huge	ADJ
ijpds-7762	98	29	irreversible	irreversible	ADJ
ijpds-7762	98	30	expenses	expense	NOUN
ijpds-7762	98	31	along	along	ADP
ijpds-7762	98	32	the	the	DET
ijpds-7762	98	33	way	way	NOUN
ijpds-7762	98	34	[	[	X
ijpds-7762	98	35	20	20	NUM
ijpds-7762	98	36	]	]	PUNCT
ijpds-7762	98	37	.	.	PUNCT
ijpds-7762	99	1	furthermore	furthermore	ADV
ijpds-7762	99	2	,	,	PUNCT
ijpds-7762	99	3	attrition	attrition	NOUN
ijpds-7762	99	4	rates	rate	NOUN
ijpds-7762	99	5	of	of	ADP
ijpds-7762	99	6	the	the	DET
ijpds-7762	99	7	drug	drug	NOUN
ijpds-7762	99	8	candidates	candidate	NOUN
ijpds-7762	99	9	are	be	AUX
ijpds-7762	99	10	very	very	ADV
ijpds-7762	99	11	high	high	ADJ
ijpds-7762	99	12	,	,	PUNCT
ijpds-7762	99	13	with	with	ADP
ijpds-7762	99	14	almost	almost	ADV
ijpds-7762	99	15	90	90	NUM
ijpds-7762	99	16	%	%	NOUN
ijpds-7762	99	17	of	of	ADP
ijpds-7762	99	18	them	they	PRON
ijpds-7762	99	19	failing	fail	VERB
ijpds-7762	99	20	owing	owe	VERB
ijpds-7762	99	21	to	to	ADP
ijpds-7762	99	22	insufficient	insufficient	ADJ
ijpds-7762	99	23	efficacy	efficacy	NOUN
ijpds-7762	99	24	and/or	and/or	CCONJ
ijpds-7762	99	25	safety	safety	NOUN
ijpds-7762	99	26	concerns	concern	NOUN
ijpds-7762	99	27	during	during	ADP
ijpds-7762	99	28	clinical	clinical	ADJ
ijpds-7762	99	29	trials	trial	NOUN
ijpds-7762	99	30	.	.	PUNCT
ijpds-7762	100	1	additionally	additionally	ADV
ijpds-7762	100	2	,	,	PUNCT
ijpds-7762	100	3	financial	financial	ADJ
ijpds-7762	100	4	losses	loss	NOUN
ijpds-7762	100	5	multiply	multiply	VERB
ijpds-7762	100	6	when	when	SCONJ
ijpds-7762	100	7	toxicity	toxicity	NOUN
ijpds-7762	100	8	is	be	AUX
ijpds-7762	100	9	detected	detect	VERB
ijpds-7762	100	10	after	after	ADP
ijpds-7762	100	11	-	-	PUNCT
ijpds-7762	100	12	market	market	NOUN
ijpds-7762	100	13	release	release	NOUN
ijpds-7762	100	14	of	of	ADP
ijpds-7762	100	15	the	the	DET
ijpds-7762	100	16	drugs	drug	NOUN
ijpds-7762	100	17	[	[	X
ijpds-7762	100	18	21	21	NUM
ijpds-7762	100	19	]	]	PUNCT
ijpds-7762	100	20	.	.	PUNCT
ijpds-7762	101	1	hence	hence	ADV
ijpds-7762	101	2	,	,	PUNCT
ijpds-7762	101	3	evaluation	evaluation	NOUN
ijpds-7762	101	4	of	of	ADP
ijpds-7762	101	5	toxicity	toxicity	NOUN
ijpds-7762	101	6	and	and	CCONJ
ijpds-7762	101	7	safety	safety	NOUN
ijpds-7762	101	8	is	be	AUX
ijpds-7762	101	9	of	of	ADP
ijpds-7762	101	10	paramount	paramount	ADJ
ijpds-7762	101	11	importance	importance	NOUN
ijpds-7762	101	12	during	during	ADP
ijpds-7762	101	13	drug	drug	NOUN
ijpds-7762	101	14	development	development	NOUN
ijpds-7762	101	15	,	,	PUNCT
ijpds-7762	101	16	which	which	PRON
ijpds-7762	101	17	can	can	AUX
ijpds-7762	101	18	be	be	AUX
ijpds-7762	101	19	achieved	achieve	VERB
ijpds-7762	101	20	by	by	ADP
ijpds-7762	101	21	a	a	DET
ijpds-7762	101	22	better	well	ADJ
ijpds-7762	101	23	understanding	understanding	NOUN
ijpds-7762	101	24	of	of	ADP
ijpds-7762	101	25	the	the	DET
ijpds-7762	101	26	protein	protein	NOUN
ijpds-7762	101	27	–	–	PUNCT
ijpds-7762	101	28	ligand	ligand	NOUN
ijpds-7762	101	29	interactions	interaction	NOUN
ijpds-7762	101	30	and	and	CCONJ
ijpds-7762	101	31	predictability	predictability	NOUN
ijpds-7762	101	32	of	of	ADP
ijpds-7762	101	33	toxicity	toxicity	NOUN
ijpds-7762	101	34	.	.	PUNCT
ijpds-7762	102	1	the	the	DET
ijpds-7762	102	2	development	development	NOUN
ijpds-7762	102	3	of	of	ADP
ijpds-7762	102	4	computational	computational	ADJ
ijpds-7762	102	5	methods	method	NOUN
ijpds-7762	102	6	and	and	CCONJ
ijpds-7762	102	7	ai	ai	PROPN
ijpds-7762	102	8	has	have	AUX
ijpds-7762	102	9	emerged	emerge	VERB
ijpds-7762	102	10	as	as	ADP
ijpds-7762	102	11	a	a	DET
ijpds-7762	102	12	promising	promising	ADJ
ijpds-7762	102	13	approach	approach	NOUN
ijpds-7762	102	14	to	to	PART
ijpds-7762	102	15	tackle	tackle	VERB
ijpds-7762	102	16	the	the	DET
ijpds-7762	102	17	above	above	ADV
ijpds-7762	102	18	-	-	PUNCT
ijpds-7762	102	19	mentioned	mention	VERB
ijpds-7762	102	20	obstacles	obstacle	NOUN
ijpds-7762	102	21	while	while	SCONJ
ijpds-7762	102	22	developing	develop	VERB
ijpds-7762	102	23	a	a	DET
ijpds-7762	102	24	drug	drug	NOUN
ijpds-7762	102	25	.	.	PUNCT
ijpds-7762	103	1	the	the	DET
ijpds-7762	103	2	further	further	ADJ
ijpds-7762	103	3	sections	section	NOUN
ijpds-7762	103	4	delve	delve	VERB
ijpds-7762	103	5	into	into	ADP
ijpds-7762	103	6	the	the	DET
ijpds-7762	103	7	applications	application	NOUN
ijpds-7762	103	8	of	of	ADP
ijpds-7762	103	9	ai	ai	VERB
ijpds-7762	103	10	in	in	ADP
ijpds-7762	103	11	all	all	DET
ijpds-7762	103	12	the	the	DET
ijpds-7762	103	13	steps	step	NOUN
ijpds-7762	103	14	of	of	ADP
ijpds-7762	103	15	drug	drug	NOUN
ijpds-7762	103	16	development	development	NOUN
ijpds-7762	103	17	[	[	X
ijpds-7762	103	18	21	21	NUM
ijpds-7762	103	19	]	]	PUNCT
ijpds-7762	103	20	.	.	PUNCT
ijpds-7762	104	1	role	role	NOUN
ijpds-7762	104	2	of	of	ADP
ijpds-7762	104	3	ai	ai	VERB
ijpds-7762	104	4	in	in	ADP
ijpds-7762	104	5	drug	drug	NOUN
ijpds-7762	104	6	discovery	discovery	NOUN
ijpds-7762	104	7	there	there	PRON
ijpds-7762	104	8	exist	exist	VERB
ijpds-7762	104	9	more	more	ADJ
ijpds-7762	104	10	than	than	ADP
ijpds-7762	104	11	1060	1060	NUM
ijpds-7762	104	12	molecules	molecule	NOUN
ijpds-7762	104	13	that	that	PRON
ijpds-7762	104	14	help	help	VERB
ijpds-7762	104	15	in	in	ADP
ijpds-7762	104	16	the	the	DET
ijpds-7762	104	17	development	development	NOUN
ijpds-7762	104	18	of	of	ADP
ijpds-7762	104	19	novel	novel	ADJ
ijpds-7762	104	20	drugs	drug	NOUN
ijpds-7762	104	21	[	[	X
ijpds-7762	104	22	22	22	NUM
ijpds-7762	104	23	]	]	PUNCT
ijpds-7762	104	24	.	.	PUNCT
ijpds-7762	105	1	al	al	PROPN
ijpds-7762	105	2	has	have	VERB
ijpds-7762	105	3	the	the	DET
ijpds-7762	105	4	ability	ability	NOUN
ijpds-7762	105	5	to	to	PART
ijpds-7762	105	6	collect	collect	VERB
ijpds-7762	105	7	https://pubmed.ncbi.nlm.nih.gov/38758610	https://pubmed.ncbi.nlm.nih.gov/38758610	PRON
ijpds-7762	105	8	https://pubmed.ncbi.nlm.nih.gov/38758610	https://pubmed.ncbi.nlm.nih.gov/38758610	NOUN
ijpds-7762	105	9	agrawal	agrawal	NOUN
ijpds-7762	105	10	and	and	CCONJ
ijpds-7762	105	11	kulkarni	kulkarni	PROPN
ijpds-7762	105	12	ai	ai	VERB
ijpds-7762	105	13	applications	application	NOUN
ijpds-7762	105	14	in	in	ADP
ijpds-7762	105	15	drug	drug	NOUN
ijpds-7762	105	16	discovery	discovery	NOUN
ijpds-7762	105	17	and	and	CCONJ
ijpds-7762	105	18	development	development	NOUN
ijpds-7762	105	19	online	online	PROPN
ijpds-7762	105	20	first	first	PROPN
ijpds-7762	105	21	indian	indian	PROPN
ijpds-7762	105	22	j	j	PROPN
ijpds-7762	105	23	pharm	pharm	PROPN
ijpds-7762	105	24	drug	drug	PROPN
ijpds-7762	105	25	studies	study	NOUN
ijpds-7762	105	26	|	|	ADV
ijpds-7762	105	27	3	3	NUM
ijpds-7762	105	28	positional	positional	ADJ
ijpds-7762	105	29	information	information	NOUN
ijpds-7762	105	30	about	about	ADP
ijpds-7762	105	31	molecules	molecule	NOUN
ijpds-7762	105	32	within	within	ADP
ijpds-7762	105	33	the	the	DET
ijpds-7762	105	34	space	space	NOUN
ijpds-7762	105	35	to	to	PART
ijpds-7762	105	36	search	search	VERB
ijpds-7762	105	37	for	for	ADP
ijpds-7762	105	38	bioactive	bioactive	ADJ
ijpds-7762	105	39	compounds	compound	NOUN
ijpds-7762	105	40	and	and	CCONJ
ijpds-7762	105	41	select	select	VERB
ijpds-7762	105	42	appropriate	appropriate	ADJ
ijpds-7762	105	43	molecules	molecule	NOUN
ijpds-7762	105	44	via	via	ADP
ijpds-7762	105	45	virtual	virtual	ADJ
ijpds-7762	105	46	screening	screening	NOUN
ijpds-7762	105	47	(	(	PUNCT
ijpds-7762	105	48	vs	vs	NOUN
ijpds-7762	105	49	)	)	PUNCT
ijpds-7762	105	50	.	.	PUNCT
ijpds-7762	106	1	a	a	DET
ijpds-7762	106	2	few	few	ADJ
ijpds-7762	106	3	chemical	chemical	NOUN
ijpds-7762	106	4	spaces	space	NOUN
ijpds-7762	106	5	that	that	PRON
ijpds-7762	106	6	have	have	VERB
ijpds-7762	106	7	open	open	ADJ
ijpds-7762	106	8	access	access	NOUN
ijpds-7762	106	9	are	be	AUX
ijpds-7762	106	10	chembank	chembank	ADJ
ijpds-7762	106	11	,	,	PUNCT
ijpds-7762	106	12	pubchem	pubchem	NOUN
ijpds-7762	106	13	,	,	PUNCT
ijpds-7762	106	14	chemdb	chemdb	NOUN
ijpds-7762	106	15	,	,	PUNCT
ijpds-7762	106	16	and	and	CCONJ
ijpds-7762	106	17	drugbank	drugbank	VERB
ijpds-7762	106	18	[	[	X
ijpds-7762	106	19	17	17	NUM
ijpds-7762	106	20	]	]	PUNCT
ijpds-7762	106	21	.	.	PUNCT
ijpds-7762	107	1	quantitative	quantitative	ADJ
ijpds-7762	107	2	structure	structure	NOUN
ijpds-7762	107	3	-	-	PUNCT
ijpds-7762	107	4	activity	activity	NOUN
ijpds-7762	107	5	relationship	relationship	NOUN
ijpds-7762	107	6	(	(	PUNCT
ijpds-7762	107	7	qsar)-based	qsar)-base	VERB
ijpds-7762	107	8	computational	computational	ADJ
ijpds-7762	107	9	models	model	NOUN
ijpds-7762	107	10	are	be	AUX
ijpds-7762	107	11	capable	capable	ADJ
ijpds-7762	107	12	of	of	ADP
ijpds-7762	107	13	quickly	quickly	ADV
ijpds-7762	107	14	predicting	predict	VERB
ijpds-7762	107	15	large	large	ADJ
ijpds-7762	107	16	numbers	number	NOUN
ijpds-7762	107	17	of	of	ADP
ijpds-7762	107	18	physicochemical	physicochemical	ADJ
ijpds-7762	107	19	parameters	parameter	NOUN
ijpds-7762	107	20	of	of	ADP
ijpds-7762	107	21	the	the	DET
ijpds-7762	107	22	drug	drug	NOUN
ijpds-7762	107	23	candidates	candidate	NOUN
ijpds-7762	107	24	.	.	PUNCT
ijpds-7762	108	1	ai	ai	VERB
ijpds-7762	108	2	-	-	PUNCT
ijpds-7762	108	3	based	base	VERB
ijpds-7762	108	4	qsar	qsar	NOUN
ijpds-7762	108	5	models	model	NOUN
ijpds-7762	108	6	,	,	PUNCT
ijpds-7762	108	7	such	such	ADJ
ijpds-7762	108	8	as	as	ADP
ijpds-7762	108	9	support	support	NOUN
ijpds-7762	108	10	vector	vector	NOUN
ijpds-7762	108	11	machines	machine	NOUN
ijpds-7762	108	12	(	(	PUNCT
ijpds-7762	108	13	svms	svms	NOUN
ijpds-7762	108	14	)	)	PUNCT
ijpds-7762	108	15	,	,	PUNCT
ijpds-7762	108	16	linear	linear	VERB
ijpds-7762	108	17	discriminant	discriminant	ADJ
ijpds-7762	108	18	analysis	analysis	NOUN
ijpds-7762	108	19	(	(	PUNCT
ijpds-7762	108	20	lda	lda	PROPN
ijpds-7762	108	21	)	)	PUNCT
ijpds-7762	108	22	,	,	PUNCT
ijpds-7762	108	23	random	random	ADJ
ijpds-7762	108	24	forest	forest	NOUN
ijpds-7762	108	25	(	(	PUNCT
ijpds-7762	108	26	rf	rf	NOUN
ijpds-7762	108	27	)	)	PUNCT
ijpds-7762	108	28	,	,	PUNCT
ijpds-7762	108	29	and	and	CCONJ
ijpds-7762	108	30	decision	decision	NOUN
ijpds-7762	108	31	trees	tree	NOUN
ijpds-7762	108	32	,	,	PUNCT
ijpds-7762	108	33	are	be	AUX
ijpds-7762	108	34	being	be	AUX
ijpds-7762	108	35	applied	apply	VERB
ijpds-7762	108	36	to	to	PART
ijpds-7762	108	37	speed	speed	VERB
ijpds-7762	108	38	up	up	ADP
ijpds-7762	108	39	qsar	qsar	NOUN
ijpds-7762	108	40	analysis	analysis	NOUN
ijpds-7762	108	41	[	[	X
ijpds-7762	108	42	23	23	NUM
ijpds-7762	108	43	]	]	PUNCT
ijpds-7762	108	44	.	.	PUNCT
ijpds-7762	109	1	deep	deep	ADJ
ijpds-7762	109	2	docking	docking	NOUN
ijpds-7762	109	3	(	(	PUNCT
ijpds-7762	109	4	dd	dd	NOUN
ijpds-7762	109	5	)	)	PUNCT
ijpds-7762	109	6	,	,	PUNCT
ijpds-7762	109	7	an	an	DET
ijpds-7762	109	8	open	open	ADJ
ijpds-7762	109	9	-	-	PUNCT
ijpds-7762	109	10	source	source	NOUN
ijpds-7762	109	11	protocol	protocol	NOUN
ijpds-7762	109	12	for	for	ADP
ijpds-7762	109	13	aienabled	aienable	VERB
ijpds-7762	109	14	vs	vs	ADP
ijpds-7762	109	15	,	,	PUNCT
ijpds-7762	109	16	was	be	AUX
ijpds-7762	109	17	developed	develop	VERB
ijpds-7762	109	18	by	by	ADP
ijpds-7762	109	19	gentile	gentile	NOUN
ijpds-7762	109	20	and	and	CCONJ
ijpds-7762	109	21	colleagues	colleague	NOUN
ijpds-7762	109	22	.	.	PUNCT
ijpds-7762	110	1	it	it	PRON
ijpds-7762	110	2	is	be	AUX
ijpds-7762	110	3	supposed	suppose	VERB
ijpds-7762	110	4	to	to	PART
ijpds-7762	110	5	be	be	AUX
ijpds-7762	110	6	one	one	NUM
ijpds-7762	110	7	of	of	ADP
ijpds-7762	110	8	the	the	DET
ijpds-7762	110	9	fastest	fast	ADJ
ijpds-7762	110	10	ai	ai	ADJ
ijpds-7762	110	11	-	-	PUNCT
ijpds-7762	110	12	enabled	enable	VERB
ijpds-7762	110	13	docking	docking	NOUN
ijpds-7762	110	14	platforms	platform	NOUN
ijpds-7762	110	15	being	be	AUX
ijpds-7762	110	16	tested	test	VERB
ijpds-7762	110	17	on	on	ADP
ijpds-7762	110	18	one	one	NUM
ijpds-7762	110	19	billion	billion	NUM
ijpds-7762	110	20	-	-	PUNCT
ijpds-7762	110	21	plus	plus	CCONJ
ijpds-7762	110	22	molecular	molecular	ADJ
ijpds-7762	110	23	libraries	library	NOUN
ijpds-7762	110	24	[	[	X
ijpds-7762	110	25	24	24	NUM
ijpds-7762	110	26	]	]	PUNCT
ijpds-7762	110	27	.	.	PUNCT
ijpds-7762	111	1	the	the	DET
ijpds-7762	111	2	input	input	NOUN
ijpds-7762	111	3	data	datum	NOUN
ijpds-7762	111	4	in	in	ADP
ijpds-7762	111	5	dd	dd	NOUN
ijpds-7762	111	6	consists	consist	NOUN
ijpds-7762	111	7	of	of	ADP
ijpds-7762	111	8	a	a	DET
ijpds-7762	111	9	particular	particular	ADJ
ijpds-7762	111	10	molecule	molecule	NOUN
ijpds-7762	111	11	’s	’s	PART
ijpds-7762	111	12	simplified	simplify	VERB
ijpds-7762	111	13	molecular	molecular	ADJ
ijpds-7762	111	14	input	input	NOUN
ijpds-7762	111	15	line	line	NOUN
ijpds-7762	111	16	entry	entry	NOUN
ijpds-7762	111	17	system	system	NOUN
ijpds-7762	111	18	(	(	PUNCT
ijpds-7762	111	19	smiles	smile	NOUN
ijpds-7762	111	20	)	)	PUNCT
ijpds-7762	111	21	and	and	CCONJ
ijpds-7762	111	22	the	the	DET
ijpds-7762	111	23	target	target	NOUN
ijpds-7762	111	24	’s	’s	PART
ijpds-7762	111	25	structure	structure	NOUN
ijpds-7762	111	26	.	.	PUNCT
ijpds-7762	112	1	dd	dd	NOUN
ijpds-7762	112	2	executes	execute	VERB
ijpds-7762	112	3	molecular	molecular	ADJ
ijpds-7762	112	4	docking	docking	NOUN
ijpds-7762	112	5	for	for	ADP
ijpds-7762	112	6	a	a	DET
ijpds-7762	112	7	small	small	ADJ
ijpds-7762	112	8	subset	subset	NOUN
ijpds-7762	112	9	of	of	ADP
ijpds-7762	112	10	a	a	DET
ijpds-7762	112	11	large	large	ADJ
ijpds-7762	112	12	library	library	NOUN
ijpds-7762	112	13	to	to	PART
ijpds-7762	112	14	deduce	deduce	VERB
ijpds-7762	112	15	the	the	DET
ijpds-7762	112	16	ranking	ranking	NOUN
ijpds-7762	112	17	of	of	ADP
ijpds-7762	112	18	the	the	DET
ijpds-7762	112	19	unprocessed	unprocessed	ADJ
ijpds-7762	112	20	datasets	dataset	NOUN
ijpds-7762	112	21	,	,	PUNCT
ijpds-7762	112	22	followed	follow	VERB
ijpds-7762	112	23	by	by	ADP
ijpds-7762	112	24	ligand	ligand	NOUN
ijpds-7762	112	25	-	-	PUNCT
ijpds-7762	112	26	based	base	VERB
ijpds-7762	112	27	prediction	prediction	NOUN
ijpds-7762	112	28	for	for	ADP
ijpds-7762	112	29	the	the	DET
ijpds-7762	112	30	rest	rest	NOUN
ijpds-7762	112	31	of	of	ADP
ijpds-7762	112	32	the	the	DET
ijpds-7762	112	33	library	library	NOUN
ijpds-7762	112	34	.	.	PUNCT
ijpds-7762	113	1	in	in	ADP
ijpds-7762	113	2	this	this	DET
ijpds-7762	113	3	way	way	NOUN
ijpds-7762	113	4	,	,	PUNCT
ijpds-7762	113	5	dd	dd	VERB
ijpds-7762	113	6	scraps	scrap	NOUN
ijpds-7762	113	7	off	off	ADP
ijpds-7762	113	8	undockable	undockable	ADJ
ijpds-7762	113	9	molecular	molecular	ADJ
ijpds-7762	113	10	structures	structure	NOUN
ijpds-7762	113	11	without	without	ADP
ijpds-7762	113	12	wasting	waste	VERB
ijpds-7762	113	13	computational	computational	ADJ
ijpds-7762	113	14	resources	resource	NOUN
ijpds-7762	113	15	[	[	X
ijpds-7762	113	16	25	25	NUM
ijpds-7762	113	17	]	]	PUNCT
ijpds-7762	113	18	.	.	PUNCT
ijpds-7762	114	1	further	far	ADV
ijpds-7762	114	2	,	,	PUNCT
ijpds-7762	114	3	diverse	diverse	ADJ
ijpds-7762	114	4	ml	ml	NOUN
ijpds-7762	114	5	techniques	technique	NOUN
ijpds-7762	114	6	,	,	PUNCT
ijpds-7762	114	7	including	include	VERB
ijpds-7762	114	8	naïve	naïve	ADJ
ijpds-7762	114	9	bayesian	bayesian	NOUN
ijpds-7762	114	10	algorithm	algorithm	NOUN
ijpds-7762	114	11	(	(	PUNCT
ijpds-7762	114	12	nb	nb	PROPN
ijpds-7762	114	13	)	)	PUNCT
ijpds-7762	114	14	,	,	PUNCT
ijpds-7762	114	15	k	k	X
ijpds-7762	114	16	-	-	PUNCT
ijpds-7762	114	17	nearest	near	ADJ
ijpds-7762	114	18	neighbor	neighbor	NOUN
ijpds-7762	114	19	algorithm	algorithm	NOUN
ijpds-7762	114	20	(	(	PUNCT
ijpds-7762	114	21	knns	knns	PROPN
ijpds-7762	114	22	)	)	PUNCT
ijpds-7762	114	23	,	,	PUNCT
ijpds-7762	114	24	support	support	NOUN
ijpds-7762	114	25	vector	vector	NOUN
ijpds-7762	114	26	machine	machine	NOUN
ijpds-7762	114	27	(	(	PUNCT
ijpds-7762	114	28	svms	svms	NOUN
ijpds-7762	114	29	)	)	PUNCT
ijpds-7762	114	30	,	,	PUNCT
ijpds-7762	114	31	and	and	CCONJ
ijpds-7762	114	32	anns	ann	NOUN
ijpds-7762	114	33	,	,	PUNCT
ijpds-7762	114	34	can	can	AUX
ijpds-7762	114	35	also	also	ADV
ijpds-7762	114	36	be	be	AUX
ijpds-7762	114	37	used	use	VERB
ijpds-7762	114	38	for	for	ADP
ijpds-7762	114	39	vs.	vs.	X
ijpds-7762	114	40	although	although	SCONJ
ijpds-7762	114	41	anns	anns	NOUN
ijpds-7762	114	42	and	and	CCONJ
ijpds-7762	114	43	svms	svms	NOUN
ijpds-7762	114	44	are	be	AUX
ijpds-7762	114	45	commonly	commonly	ADV
ijpds-7762	114	46	considered	consider	VERB
ijpds-7762	114	47	as	as	ADP
ijpds-7762	114	48	the	the	DET
ijpds-7762	114	49	most	most	ADV
ijpds-7762	114	50	accurate	accurate	ADJ
ijpds-7762	114	51	,	,	PUNCT
ijpds-7762	114	52	nb	nb	PROPN
ijpds-7762	114	53	is	be	AUX
ijpds-7762	114	54	excellent	excellent	ADJ
ijpds-7762	114	55	in	in	ADP
ijpds-7762	114	56	identifying	identify	VERB
ijpds-7762	114	57	favourable	favourable	ADJ
ijpds-7762	114	58	scaffold	scaffold	NOUN
ijpds-7762	114	59	fragments	fragment	NOUN
ijpds-7762	114	60	,	,	PUNCT
ijpds-7762	114	61	while	while	SCONJ
ijpds-7762	114	62	knn	knn	PROPN
ijpds-7762	114	63	is	be	AUX
ijpds-7762	114	64	easy	easy	ADJ
ijpds-7762	114	65	to	to	PART
ijpds-7762	114	66	implement	implement	VERB
ijpds-7762	114	67	and	and	CCONJ
ijpds-7762	114	68	utilizes	utilize	VERB
ijpds-7762	114	69	multi	multi	ADJ
ijpds-7762	114	70	-	-	ADJ
ijpds-7762	114	71	task	task	ADJ
ijpds-7762	114	72	learning	learning	NOUN
ijpds-7762	114	73	(	(	PUNCT
ijpds-7762	114	74	mtl	mtl	PROPN
ijpds-7762	114	75	)	)	PUNCT
ijpds-7762	114	76	{	{	PUNCT
ijpds-7762	114	77	mtl	mtl	PROPN
ijpds-7762	114	78	training	training	NOUN
ijpds-7762	114	79	,	,	PUNCT
ijpds-7762	114	80	a	a	DET
ijpds-7762	114	81	sub	sub	NOUN
ijpds-7762	114	82	-	-	NOUN
ijpds-7762	114	83	field	field	NOUN
ijpds-7762	114	84	of	of	ADP
ijpds-7762	114	85	ml	ml	NOUN
ijpds-7762	114	86	,	,	PUNCT
ijpds-7762	114	87	involves	involve	VERB
ijpds-7762	114	88	training	train	VERB
ijpds-7762	114	89	a	a	DET
ijpds-7762	114	90	model	model	NOUN
ijpds-7762	114	91	to	to	PART
ijpds-7762	114	92	perform	perform	VERB
ijpds-7762	114	93	multiple	multiple	ADJ
ijpds-7762	114	94	tasks	task	NOUN
ijpds-7762	114	95	at	at	ADP
ijpds-7762	114	96	the	the	DET
ijpds-7762	114	97	same	same	ADJ
ijpds-7762	114	98	time	time	NOUN
ijpds-7762	114	99	}	}	PUNCT
ijpds-7762	114	100	.	.	PUNCT
ijpds-7762	115	1	amalgamating	amalgamate	VERB
ijpds-7762	115	2	various	various	ADJ
ijpds-7762	115	3	ml	ml	NOUN
ijpds-7762	115	4	algorithms	algorithms	NOUN
ijpds-7762	115	5	is	be	AUX
ijpds-7762	115	6	preferred	prefer	VERB
ijpds-7762	115	7	as	as	SCONJ
ijpds-7762	115	8	it	it	PRON
ijpds-7762	115	9	can	can	AUX
ijpds-7762	115	10	enhance	enhance	VERB
ijpds-7762	115	11	performance	performance	NOUN
ijpds-7762	115	12	[	[	X
ijpds-7762	115	13	26	26	NUM
ijpds-7762	115	14	]	]	PUNCT
ijpds-7762	115	15	.	.	PUNCT
ijpds-7762	116	1	dl	dl	PROPN
ijpds-7762	116	2	algorithms	algorithm	NOUN
ijpds-7762	116	3	are	be	AUX
ijpds-7762	116	4	proven	prove	VERB
ijpds-7762	116	5	to	to	PART
ijpds-7762	116	6	show	show	VERB
ijpds-7762	116	7	increased	increase	VERB
ijpds-7762	116	8	predictability	predictability	NOUN
ijpds-7762	116	9	compared	compare	VERB
ijpds-7762	116	10	to	to	ADP
ijpds-7762	116	11	traditional	traditional	ADJ
ijpds-7762	116	12	ml	ml	NOUN
ijpds-7762	116	13	models	model	NOUN
ijpds-7762	116	14	,	,	PUNCT
ijpds-7762	116	15	especially	especially	ADV
ijpds-7762	116	16	in	in	ADP
ijpds-7762	116	17	distribution	distribution	NOUN
ijpds-7762	116	18	,	,	PUNCT
ijpds-7762	116	19	metabolism	metabolism	NOUN
ijpds-7762	116	20	,	,	PUNCT
ijpds-7762	116	21	excretion	excretion	NOUN
ijpds-7762	116	22	,	,	PUNCT
ijpds-7762	116	23	and	and	CCONJ
ijpds-7762	116	24	toxicity	toxicity	NOUN
ijpds-7762	116	25	(	(	PUNCT
ijpds-7762	116	26	admet	admet	PROPN
ijpds-7762	116	27	)	)	PUNCT
ijpds-7762	116	28	data	datum	NOUN
ijpds-7762	116	29	sets	set	VERB
ijpds-7762	116	30	[	[	X
ijpds-7762	116	31	27	27	NUM
ijpds-7762	116	32	]	]	PUNCT
ijpds-7762	116	33	.	.	PUNCT
ijpds-7762	117	1	the	the	DET
ijpds-7762	117	2	recent	recent	ADJ
ijpds-7762	117	3	rise	rise	NOUN
ijpds-7762	117	4	of	of	ADP
ijpds-7762	117	5	graph	graph	NOUN
ijpds-7762	117	6	neural	neural	ADJ
ijpds-7762	117	7	networks	network	NOUN
ijpds-7762	117	8	(	(	PUNCT
ijpds-7762	117	9	gnns	gnns	NOUN
ijpds-7762	117	10	)	)	PUNCT
ijpds-7762	117	11	has	have	AUX
ijpds-7762	117	12	set	set	VERB
ijpds-7762	117	13	in	in	ADP
ijpds-7762	117	14	motion	motion	NOUN
ijpds-7762	117	15	a	a	DET
ijpds-7762	117	16	new	new	ADJ
ijpds-7762	117	17	paradigm	paradigm	NOUN
ijpds-7762	117	18	in	in	ADP
ijpds-7762	117	19	admet	admet	PROPN
ijpds-7762	117	20	model	model	NOUN
ijpds-7762	117	21	designing	designing	PROPN
ijpds-7762	117	22	.	.	PUNCT
ijpds-7762	118	1	gnns	gnns	PROPN
ijpds-7762	118	2	offer	offer	VERB
ijpds-7762	118	3	an	an	DET
ijpds-7762	118	4	informative	informative	ADJ
ijpds-7762	118	5	and	and	CCONJ
ijpds-7762	118	6	compact	compact	ADJ
ijpds-7762	118	7	representation	representation	NOUN
ijpds-7762	118	8	of	of	ADP
ijpds-7762	118	9	datasets	dataset	NOUN
ijpds-7762	118	10	[	[	X
ijpds-7762	118	11	28	28	NUM
ijpds-7762	118	12	]	]	PUNCT
ijpds-7762	118	13	.	.	PUNCT
ijpds-7762	119	1	the	the	DET
ijpds-7762	119	2	efficacy	efficacy	NOUN
ijpds-7762	119	3	of	of	ADP
ijpds-7762	119	4	gnn	gnn	PROPN
ijpds-7762	119	5	algorithms	algorithm	NOUN
ijpds-7762	119	6	in	in	ADP
ijpds-7762	119	7	predicting	predict	VERB
ijpds-7762	119	8	physiochemical	physiochemical	ADJ
ijpds-7762	119	9	properties	property	NOUN
ijpds-7762	119	10	of	of	ADP
ijpds-7762	119	11	drugs	drug	NOUN
ijpds-7762	119	12	has	have	AUX
ijpds-7762	119	13	been	be	AUX
ijpds-7762	119	14	validated	validate	VERB
ijpds-7762	119	15	by	by	ADP
ijpds-7762	119	16	frameworks	framework	NOUN
ijpds-7762	119	17	such	such	ADJ
ijpds-7762	119	18	as	as	ADP
ijpds-7762	119	19	chemi	chemi	NOUN
ijpds-7762	119	20	-	-	PUNCT
ijpds-7762	119	21	net	net	NOUN
ijpds-7762	119	22	and	and	CCONJ
ijpds-7762	119	23	molecule	molecule	NOUN
ijpds-7762	119	24	-	-	PUNCT
ijpds-7762	119	25	net	net	NOUN
ijpds-7762	119	26	,	,	PUNCT
ijpds-7762	119	27	which	which	PRON
ijpds-7762	119	28	have	have	VERB
ijpds-7762	119	29	superior	superior	ADJ
ijpds-7762	119	30	potential	potential	NOUN
ijpds-7762	119	31	when	when	SCONJ
ijpds-7762	119	32	compared	compare	VERB
ijpds-7762	119	33	to	to	ADP
ijpds-7762	119	34	ml	ml	NOUN
ijpds-7762	119	35	models	model	NOUN
ijpds-7762	119	36	[	[	X
ijpds-7762	119	37	29	29	NUM
ijpds-7762	119	38	]	]	PUNCT
ijpds-7762	119	39	.	.	PUNCT
ijpds-7762	120	1	role	role	NOUN
ijpds-7762	120	2	of	of	ADP
ijpds-7762	120	3	al	al	PROPN
ijpds-7762	120	4	in	in	ADP
ijpds-7762	120	5	drug	drug	NOUN
ijpds-7762	120	6	designing	design	VERB
ijpds-7762	120	7	the	the	DET
ijpds-7762	120	8	most	most	ADV
ijpds-7762	120	9	important	important	ADJ
ijpds-7762	120	10	aspect	aspect	NOUN
ijpds-7762	120	11	of	of	ADP
ijpds-7762	120	12	drug	drug	NOUN
ijpds-7762	120	13	designing	designing	NOUN
ijpds-7762	120	14	is	be	AUX
ijpds-7762	120	15	to	to	PART
ijpds-7762	120	16	predict	predict	VERB
ijpds-7762	120	17	the	the	DET
ijpds-7762	120	18	structure	structure	NOUN
ijpds-7762	120	19	of	of	ADP
ijpds-7762	120	20	the	the	DET
ijpds-7762	120	21	target	target	NOUN
ijpds-7762	120	22	protein	protein	NOUN
ijpds-7762	120	23	in	in	ADP
ijpds-7762	120	24	order	order	NOUN
ijpds-7762	120	25	to	to	PART
ijpds-7762	120	26	design	design	VERB
ijpds-7762	120	27	the	the	DET
ijpds-7762	120	28	drug	drug	NOUN
ijpds-7762	120	29	molecule	molecule	NOUN
ijpds-7762	120	30	.	.	PUNCT
ijpds-7762	121	1	ai	ai	VERB
ijpds-7762	121	2	tools	tool	NOUN
ijpds-7762	121	3	can	can	AUX
ijpds-7762	121	4	assist	assist	VERB
ijpds-7762	121	5	by	by	ADP
ijpds-7762	121	6	predicting	predict	VERB
ijpds-7762	121	7	the	the	DET
ijpds-7762	121	8	3	3	NUM
ijpds-7762	121	9	dimensional	dimensional	ADJ
ijpds-7762	121	10	(	(	PUNCT
ijpds-7762	121	11	3d	3d	NOUN
ijpds-7762	121	12	)	)	PUNCT
ijpds-7762	121	13	protein	protein	NOUN
ijpds-7762	121	14	structure	structure	NOUN
ijpds-7762	121	15	,	,	PUNCT
ijpds-7762	121	16	thus	thus	ADV
ijpds-7762	121	17	helping	help	VERB
ijpds-7762	121	18	to	to	PART
ijpds-7762	121	19	predict	predict	VERB
ijpds-7762	121	20	the	the	DET
ijpds-7762	121	21	effect	effect	NOUN
ijpds-7762	121	22	of	of	ADP
ijpds-7762	121	23	a	a	DET
ijpds-7762	121	24	drug	drug	NOUN
ijpds-7762	121	25	molecule	molecule	NOUN
ijpds-7762	121	26	on	on	ADP
ijpds-7762	121	27	the	the	DET
ijpds-7762	121	28	target	target	NOUN
ijpds-7762	121	29	prior	prior	ADV
ijpds-7762	121	30	to	to	ADP
ijpds-7762	121	31	its	its	PRON
ijpds-7762	121	32	synthesis	synthesis	NOUN
ijpds-7762	121	33	or	or	CCONJ
ijpds-7762	121	34	production	production	NOUN
ijpds-7762	122	1	[	[	X
ijpds-7762	122	2	30	30	NUM
ijpds-7762	122	3	]	]	PUNCT
ijpds-7762	122	4	.	.	PUNCT
ijpds-7762	123	1	alphafold	alphafold	ADJ
ijpds-7762	123	2	is	be	AUX
ijpds-7762	123	3	an	an	DET
ijpds-7762	123	4	ai	ai	NOUN
ijpds-7762	123	5	tool	tool	NOUN
ijpds-7762	123	6	based	base	VERB
ijpds-7762	123	7	on	on	ADP
ijpds-7762	123	8	dnns	dnn	NOUN
ijpds-7762	123	9	,	,	PUNCT
ijpds-7762	123	10	used	use	VERB
ijpds-7762	123	11	to	to	PART
ijpds-7762	123	12	scrutinize	scrutinize	VERB
ijpds-7762	123	13	the	the	DET
ijpds-7762	123	14	distance	distance	NOUN
ijpds-7762	123	15	between	between	ADP
ijpds-7762	123	16	the	the	DET
ijpds-7762	123	17	adjacent	adjacent	ADJ
ijpds-7762	123	18	amino	amino	NOUN
ijpds-7762	123	19	acids	acid	NOUN
ijpds-7762	123	20	and	and	CCONJ
ijpds-7762	123	21	the	the	DET
ijpds-7762	123	22	correlating	correlate	VERB
ijpds-7762	123	23	angles	angle	NOUN
ijpds-7762	123	24	of	of	ADP
ijpds-7762	123	25	the	the	DET
ijpds-7762	123	26	peptide	peptide	ADJ
ijpds-7762	123	27	bonds	bond	NOUN
ijpds-7762	123	28	to	to	PART
ijpds-7762	123	29	predict	predict	VERB
ijpds-7762	123	30	the	the	DET
ijpds-7762	123	31	3d	3d	PROPN
ijpds-7762	123	32	target	target	NOUN
ijpds-7762	123	33	protein	protein	NOUN
ijpds-7762	123	34	structure	structure	NOUN
ijpds-7762	123	35	[	[	X
ijpds-7762	123	36	17	17	NUM
ijpds-7762	123	37	]	]	PUNCT
ijpds-7762	123	38	.	.	PUNCT
ijpds-7762	124	1	the	the	DET
ijpds-7762	124	2	development	development	NOUN
ijpds-7762	124	3	of	of	ADP
ijpds-7762	124	4	alphafold	alphafold	ADJ
ijpds-7762	124	5	is	be	AUX
ijpds-7762	124	6	expected	expect	VERB
ijpds-7762	124	7	to	to	PART
ijpds-7762	124	8	revolutionize	revolutionize	VERB
ijpds-7762	124	9	personalized	personalized	ADJ
ijpds-7762	124	10	medicine	medicine	NOUN
ijpds-7762	124	11	and	and	CCONJ
ijpds-7762	124	12	drug	drug	NOUN
ijpds-7762	124	13	discovery	discovery	NOUN
ijpds-7762	124	14	.	.	PUNCT
ijpds-7762	125	1	it	it	PRON
ijpds-7762	125	2	represents	represent	VERB
ijpds-7762	125	3	a	a	DET
ijpds-7762	125	4	significant	significant	ADJ
ijpds-7762	125	5	step	step	NOUN
ijpds-7762	125	6	forward	forward	ADV
ijpds-7762	125	7	in	in	ADP
ijpds-7762	125	8	the	the	DET
ijpds-7762	125	9	use	use	NOUN
ijpds-7762	125	10	of	of	ADP
ijpds-7762	125	11	ai	ai	NOUN
ijpds-7762	125	12	in	in	ADP
ijpds-7762	125	13	structural	structural	ADJ
ijpds-7762	125	14	biology	biology	NOUN
ijpds-7762	125	15	.	.	PUNCT
ijpds-7762	126	1	ai	ai	VERB
ijpds-7762	126	2	platforms	platform	NOUN
ijpds-7762	126	3	such	such	ADJ
ijpds-7762	126	4	as	as	ADP
ijpds-7762	126	5	self	self	NOUN
ijpds-7762	126	6	-	-	PUNCT
ijpds-7762	126	7	organizing	organize	VERB
ijpds-7762	126	8	map	map	NOUN
ijpds-7762	126	9	(	(	PUNCT
ijpds-7762	126	10	som	som	NOUN
ijpds-7762	126	11	)	)	PUNCT
ijpds-7762	126	12	are	be	AUX
ijpds-7762	126	13	leveraged	leverage	VERB
ijpds-7762	126	14	to	to	PART
ijpds-7762	126	15	link	link	VERB
ijpds-7762	126	16	several	several	ADJ
ijpds-7762	126	17	compounds	compound	NOUN
ijpds-7762	126	18	to	to	ADP
ijpds-7762	126	19	numerous	numerous	ADJ
ijpds-7762	126	20	targets	target	NOUN
ijpds-7762	126	21	along	along	ADP
ijpds-7762	126	22	with	with	ADP
ijpds-7762	126	23	bayesian	bayesian	NOUN
ijpds-7762	126	24	classifiers	classifier	NOUN
ijpds-7762	126	25	and	and	CCONJ
ijpds-7762	126	26	similarity	similarity	NOUN
ijpds-7762	126	27	ensemble	ensemble	ADJ
ijpds-7762	126	28	approach	approach	NOUN
ijpds-7762	126	29	(	(	PUNCT
ijpds-7762	126	30	sea	sea	NOUN
ijpds-7762	126	31	)	)	PUNCT
ijpds-7762	126	32	algorithms	algorithm	NOUN
ijpds-7762	126	33	,	,	PUNCT
ijpds-7762	126	34	which	which	PRON
ijpds-7762	126	35	can	can	AUX
ijpds-7762	126	36	be	be	AUX
ijpds-7762	126	37	used	use	VERB
ijpds-7762	126	38	for	for	ADP
ijpds-7762	126	39	integration	integration	NOUN
ijpds-7762	126	40	between	between	ADP
ijpds-7762	126	41	the	the	DET
ijpds-7762	126	42	pharmacological	pharmacological	ADJ
ijpds-7762	126	43	profiles	profile	NOUN
ijpds-7762	126	44	of	of	ADP
ijpds-7762	126	45	drug	drug	NOUN
ijpds-7762	126	46	molecules	molecule	NOUN
ijpds-7762	126	47	and	and	CCONJ
ijpds-7762	126	48	their	their	PRON
ijpds-7762	126	49	possible	possible	ADJ
ijpds-7762	126	50	targets	target	NOUN
ijpds-7762	126	51	[	[	X
ijpds-7762	126	52	31	31	NUM
ijpds-7762	126	53	]	]	PUNCT
ijpds-7762	126	54	.	.	PUNCT
ijpds-7762	127	1	newer	new	ADJ
ijpds-7762	127	2	methods	method	NOUN
ijpds-7762	127	3	based	base	VERB
ijpds-7762	127	4	on	on	ADP
ijpds-7762	127	5	nlp	nlp	NOUN
ijpds-7762	127	6	are	be	AUX
ijpds-7762	127	7	implemented	implement	VERB
ijpds-7762	127	8	,	,	PUNCT
ijpds-7762	127	9	which	which	PRON
ijpds-7762	127	10	use	use	VERB
ijpds-7762	127	11	the	the	DET
ijpds-7762	127	12	amino	amino	NOUN
ijpds-7762	127	13	acid	acid	NOUN
ijpds-7762	127	14	sequences	sequence	NOUN
ijpds-7762	127	15	from	from	ADP
ijpds-7762	127	16	sequence	sequence	NOUN
ijpds-7762	127	17	databases	database	NOUN
ijpds-7762	127	18	to	to	PART
ijpds-7762	127	19	learn	learn	VERB
ijpds-7762	127	20	and	and	CCONJ
ijpds-7762	127	21	predict	predict	VERB
ijpds-7762	127	22	structural	structural	ADJ
ijpds-7762	127	23	and	and	CCONJ
ijpds-7762	127	24	functional	functional	ADJ
ijpds-7762	127	25	patterns	pattern	NOUN
ijpds-7762	127	26	.	.	PUNCT
ijpds-7762	128	1	evolutionary	evolutionary	ADJ
ijpds-7762	128	2	scale	scale	NOUN
ijpds-7762	128	3	modeling	modeling	NOUN
ijpds-7762	128	4	-	-	PUNCT
ijpds-7762	128	5	based	base	VERB
ijpds-7762	128	6	software	software	NOUN
ijpds-7762	128	7	esmfold	esmfold	NOUN
ijpds-7762	128	8	was	be	AUX
ijpds-7762	128	9	developed	develop	VERB
ijpds-7762	128	10	by	by	ADP
ijpds-7762	128	11	lin	lin	PROPN
ijpds-7762	128	12	et	et	PROPN
ijpds-7762	128	13	al	al	PROPN
ijpds-7762	128	14	.	.	PROPN
ijpds-7762	129	1	in	in	ADP
ijpds-7762	129	2	2022	2022	NUM
ijpds-7762	129	3	,	,	PUNCT
ijpds-7762	129	4	which	which	PRON
ijpds-7762	129	5	utilizes	utilize	VERB
ijpds-7762	129	6	a	a	DET
ijpds-7762	129	7	masked	masked	ADJ
ijpds-7762	129	8	transformer	transformer	NOUN
ijpds-7762	129	9	protein	protein	NOUN
ijpds-7762	129	10	language	language	NOUN
ijpds-7762	129	11	model	model	NOUN
ijpds-7762	129	12	with	with	ADP
ijpds-7762	129	13	a	a	DET
ijpds-7762	129	14	deep	deep	ADJ
ijpds-7762	129	15	understanding	understanding	NOUN
ijpds-7762	129	16	of	of	ADP
ijpds-7762	129	17	biological	biological	ADJ
ijpds-7762	129	18	properties	property	NOUN
ijpds-7762	129	19	,	,	PUNCT
ijpds-7762	129	20	trained	train	VERB
ijpds-7762	129	21	with	with	ADP
ijpds-7762	129	22	over	over	ADP
ijpds-7762	129	23	15	15	NUM
ijpds-7762	129	24	billion	billion	NUM
ijpds-7762	129	25	parameters	parameter	NOUN
ijpds-7762	129	26	[	[	X
ijpds-7762	129	27	32	32	NUM
ijpds-7762	129	28	]	]	PUNCT
ijpds-7762	129	29	.	.	PUNCT
ijpds-7762	130	1	apart	apart	ADV
ijpds-7762	130	2	from	from	ADP
ijpds-7762	130	3	ml	ml	ADP
ijpds-7762	130	4	algorithms	algorithm	NOUN
ijpds-7762	130	5	,	,	PUNCT
ijpds-7762	130	6	dl	dl	PROPN
ijpds-7762	130	7	models	model	NOUN
ijpds-7762	130	8	,	,	PUNCT
ijpds-7762	130	9	such	such	ADJ
ijpds-7762	130	10	as	as	ADP
ijpds-7762	130	11	platform	platform	NOUN
ijpds-7762	130	12	for	for	ADP
ijpds-7762	130	13	analytics	analytic	NOUN
ijpds-7762	130	14	and	and	CCONJ
ijpds-7762	130	15	distributed	distribute	VERB
ijpds-7762	130	16	machine	machine	NOUN
ijpds-7762	130	17	learning	learning	NOUN
ijpds-7762	130	18	for	for	ADP
ijpds-7762	130	19	enterprises	enterprise	NOUN
ijpds-7762	130	20	(	(	PUNCT
ijpds-7762	130	21	padme	padme	NOUN
ijpds-7762	130	22	)	)	PUNCT
ijpds-7762	130	23	and	and	CCONJ
ijpds-7762	130	24	deepaffinity	deepaffinity	NOUN
ijpds-7762	130	25	,	,	PUNCT
ijpds-7762	130	26	have	have	VERB
ijpds-7762	130	27	the	the	DET
ijpds-7762	130	28	ability	ability	NOUN
ijpds-7762	130	29	to	to	PART
ijpds-7762	130	30	predict	predict	VERB
ijpds-7762	130	31	drugtarget	drugtarget	NOUN
ijpds-7762	130	32	interactions	interaction	NOUN
ijpds-7762	130	33	by	by	ADP
ijpds-7762	130	34	integrating	integrate	VERB
ijpds-7762	130	35	drug	drug	NOUN
ijpds-7762	130	36	and	and	CCONJ
ijpds-7762	130	37	target	target	NOUN
ijpds-7762	130	38	features	feature	NOUN
ijpds-7762	130	39	.	.	PUNCT
ijpds-7762	131	1	padme	padme	PROPN
ijpds-7762	131	2	helps	helps	AUX
ijpds-7762	131	3	forecast	forecast	VERB
ijpds-7762	131	4	the	the	DET
ijpds-7762	131	5	strength	strength	NOUN
ijpds-7762	131	6	between	between	ADP
ijpds-7762	131	7	drugs	drug	NOUN
ijpds-7762	131	8	and	and	CCONJ
ijpds-7762	131	9	target	target	NOUN
ijpds-7762	131	10	proteins	protein	NOUN
ijpds-7762	131	11	,	,	PUNCT
ijpds-7762	131	12	leading	lead	VERB
ijpds-7762	131	13	to	to	ADP
ijpds-7762	131	14	accurate	accurate	ADJ
ijpds-7762	131	15	predictions	prediction	NOUN
ijpds-7762	131	16	of	of	ADP
ijpds-7762	131	17	therapeutic	therapeutic	ADJ
ijpds-7762	131	18	efficacy	efficacy	NOUN
ijpds-7762	131	19	and	and	CCONJ
ijpds-7762	131	20	mechanism	mechanism	NOUN
ijpds-7762	131	21	of	of	ADP
ijpds-7762	131	22	action	action	NOUN
ijpds-7762	131	23	.	.	PUNCT
ijpds-7762	132	1	deepaffinity	deepaffinity	NOUN
ijpds-7762	132	2	combines	combine	VERB
ijpds-7762	132	3	rnn	rnn	PROPN
ijpds-7762	132	4	and	and	CCONJ
ijpds-7762	132	5	cnn	cnn	PROPN
ijpds-7762	132	6	with	with	ADP
ijpds-7762	132	7	labeled	label	VERB
ijpds-7762	132	8	and	and	CCONJ
ijpds-7762	132	9	unlabeled	unlabeled	ADJ
ijpds-7762	132	10	data	datum	NOUN
ijpds-7762	132	11	,	,	PUNCT
ijpds-7762	132	12	providing	provide	VERB
ijpds-7762	132	13	a	a	DET
ijpds-7762	132	14	subtle	subtle	ADJ
ijpds-7762	132	15	understanding	understanding	NOUN
ijpds-7762	132	16	of	of	ADP
ijpds-7762	132	17	drug	drug	NOUN
ijpds-7762	132	18	-	-	PUNCT
ijpds-7762	132	19	protein	protein	NOUN
ijpds-7762	132	20	interactions	interaction	NOUN
ijpds-7762	132	21	[	[	X
ijpds-7762	132	22	33	33	NUM
ijpds-7762	132	23	,	,	PUNCT
ijpds-7762	132	24	34	34	NUM
ijpds-7762	132	25	]	]	PUNCT
ijpds-7762	132	26	.	.	PUNCT
ijpds-7762	133	1	apart	apart	ADV
ijpds-7762	133	2	from	from	ADP
ijpds-7762	133	3	target	target	NOUN
ijpds-7762	133	4	protein	protein	NOUN
ijpds-7762	133	5	prediction	prediction	NOUN
ijpds-7762	133	6	,	,	PUNCT
ijpds-7762	133	7	the	the	DET
ijpds-7762	133	8	prediction	prediction	NOUN
ijpds-7762	133	9	of	of	ADP
ijpds-7762	133	10	drug	drug	NOUN
ijpds-7762	133	11	–	–	PUNCT
ijpds-7762	133	12	target	target	NOUN
ijpds-7762	133	13	binding	bind	VERB
ijpds-7762	133	14	affinity	affinity	NOUN
ijpds-7762	133	15	(	(	PUNCT
ijpds-7762	133	16	dtba	dtba	NOUN
ijpds-7762	133	17	)	)	PUNCT
ijpds-7762	133	18	is	be	AUX
ijpds-7762	133	19	critical	critical	ADJ
ijpds-7762	133	20	for	for	ADP
ijpds-7762	133	21	evaluating	evaluate	VERB
ijpds-7762	133	22	the	the	DET
ijpds-7762	133	23	efficacy	efficacy	NOUN
ijpds-7762	133	24	of	of	ADP
ijpds-7762	133	25	drug	drug	NOUN
ijpds-7762	133	26	molecules	molecule	NOUN
ijpds-7762	133	27	.	.	PUNCT
ijpds-7762	134	1	ai	ai	VERB
ijpds-7762	134	2	tools	tool	NOUN
ijpds-7762	134	3	such	such	ADJ
ijpds-7762	134	4	as	as	ADP
ijpds-7762	134	5	chemmapper	chemmapper	NOUN
ijpds-7762	134	6	and	and	CCONJ
ijpds-7762	134	7	sea	sea	NOUN
ijpds-7762	134	8	,	,	PUNCT
ijpds-7762	134	9	along	along	ADP
ijpds-7762	134	10	with	with	ADP
ijpds-7762	134	11	ml	ml	NOUN
ijpds-7762	134	12	and	and	CCONJ
ijpds-7762	134	13	dl	dl	X
ijpds-7762	134	14	techniques	technique	NOUN
ijpds-7762	134	15	such	such	ADJ
ijpds-7762	134	16	as	as	ADP
ijpds-7762	134	17	simboost	simboost	NOUN
ijpds-7762	134	18	,	,	PUNCT
ijpds-7762	134	19	deepdta	deepdta	NOUN
ijpds-7762	134	20	,	,	PUNCT
ijpds-7762	134	21	and	and	CCONJ
ijpds-7762	134	22	padme	padme	NOUN
ijpds-7762	134	23	,	,	PUNCT
ijpds-7762	134	24	have	have	AUX
ijpds-7762	134	25	been	be	AUX
ijpds-7762	134	26	employed	employ	VERB
ijpds-7762	134	27	to	to	PART
ijpds-7762	134	28	accurately	accurately	ADV
ijpds-7762	134	29	predict	predict	VERB
ijpds-7762	134	30	dtba	dtba	NOUN
ijpds-7762	134	31	[	[	X
ijpds-7762	134	32	34	34	NUM
ijpds-7762	134	33	]	]	PUNCT
ijpds-7762	134	34	.	.	PUNCT
ijpds-7762	135	1	these	these	PRON
ijpds-7762	135	2	ai	ai	VERB
ijpds-7762	135	3	approaches	approach	NOUN
ijpds-7762	135	4	have	have	AUX
ijpds-7762	135	5	provided	provide	VERB
ijpds-7762	135	6	an	an	DET
ijpds-7762	135	7	upgrade	upgrade	NOUN
ijpds-7762	135	8	to	to	ADP
ijpds-7762	135	9	the	the	DET
ijpds-7762	135	10	traditional	traditional	ADJ
ijpds-7762	135	11	methods	method	NOUN
ijpds-7762	135	12	by	by	ADP
ijpds-7762	135	13	deploying	deploy	VERB
ijpds-7762	135	14	computational	computational	ADJ
ijpds-7762	135	15	models	model	NOUN
ijpds-7762	135	16	for	for	ADP
ijpds-7762	135	17	predicting	predict	VERB
ijpds-7762	135	18	interactions	interaction	NOUN
ijpds-7762	135	19	between	between	ADP
ijpds-7762	135	20	drugs	drug	NOUN
ijpds-7762	135	21	and	and	CCONJ
ijpds-7762	135	22	protein	protein	NOUN
ijpds-7762	135	23	targets	target	NOUN
ijpds-7762	135	24	.	.	PUNCT
ijpds-7762	136	1	in	in	ADP
ijpds-7762	136	2	recent	recent	ADJ
ijpds-7762	136	3	times	time	NOUN
ijpds-7762	136	4	,	,	PUNCT
ijpds-7762	136	5	dl	dl	PROPN
ijpds-7762	136	6	methods	method	NOUN
ijpds-7762	136	7	have	have	AUX
ijpds-7762	136	8	been	be	AUX
ijpds-7762	136	9	used	use	VERB
ijpds-7762	136	10	in	in	ADP
ijpds-7762	136	11	de	de	X
ijpds-7762	136	12	novo	novo	NOUN
ijpds-7762	136	13	drug	drug	NOUN
ijpds-7762	136	14	designing	design	VERB
ijpds-7762	136	15	[	[	X
ijpds-7762	136	16	35	35	NUM
ijpds-7762	136	17	]	]	PUNCT
ijpds-7762	136	18	.	.	PUNCT
ijpds-7762	137	1	in	in	ADP
ijpds-7762	137	2	2018	2018	NUM
ijpds-7762	137	3	,	,	PUNCT
ijpds-7762	137	4	popova	popova	NOUN
ijpds-7762	137	5	et	et	PROPN
ijpds-7762	137	6	al	al	PROPN
ijpds-7762	137	7	.	.	PROPN
ijpds-7762	137	8	developed	develop	VERB
ijpds-7762	137	9	a	a	DET
ijpds-7762	137	10	reinforcement	reinforcement	NOUN
ijpds-7762	137	11	learning	learning	NOUN
ijpds-7762	137	12	(	(	PUNCT
ijpds-7762	137	13	rl	rl	NOUN
ijpds-7762	137	14	)	)	PUNCT
ijpds-7762	137	15	algorithm	algorithm	NOUN
ijpds-7762	137	16	for	for	ADP
ijpds-7762	137	17	de	de	X
ijpds-7762	137	18	novo	novo	PROPN
ijpds-7762	137	19	drug	drug	NOUN
ijpds-7762	137	20	synthesis	synthesis	NOUN
ijpds-7762	137	21	,	,	PUNCT
ijpds-7762	137	22	which	which	PRON
ijpds-7762	137	23	involves	involve	VERB
ijpds-7762	137	24	employing	employ	VERB
ijpds-7762	137	25	generative	generative	ADJ
ijpds-7762	137	26	and	and	CCONJ
ijpds-7762	137	27	predictive	predictive	ADJ
ijpds-7762	137	28	dnns	dnn	NOUN
ijpds-7762	137	29	to	to	PART
ijpds-7762	137	30	develop	develop	VERB
ijpds-7762	137	31	new	new	ADJ
ijpds-7762	137	32	drug	drug	NOUN
ijpds-7762	137	33	molecules	molecule	NOUN
ijpds-7762	137	34	.	.	PUNCT
ijpds-7762	138	1	the	the	DET
ijpds-7762	138	2	generative	generative	ADJ
ijpds-7762	138	3	models	model	NOUN
ijpds-7762	138	4	are	be	AUX
ijpds-7762	138	5	used	use	VERB
ijpds-7762	138	6	to	to	PART
ijpds-7762	138	7	produce	produce	VERB
ijpds-7762	138	8	more	more	ADV
ijpds-7762	138	9	unique	unique	ADJ
ijpds-7762	138	10	molecules	molecule	NOUN
ijpds-7762	138	11	,	,	PUNCT
ijpds-7762	138	12	whereas	whereas	SCONJ
ijpds-7762	138	13	the	the	DET
ijpds-7762	138	14	predictive	predictive	ADJ
ijpds-7762	138	15	models	model	NOUN
ijpds-7762	138	16	foretell	foretell	VERB
ijpds-7762	138	17	the	the	DET
ijpds-7762	138	18	properties	property	NOUN
ijpds-7762	138	19	of	of	ADP
ijpds-7762	138	20	the	the	DET
ijpds-7762	138	21	developed	develop	VERB
ijpds-7762	138	22	compound	compound	NOUN
ijpds-7762	139	1	[	[	X
ijpds-7762	139	2	36	36	NUM
ijpds-7762	139	3	]	]	PUNCT
ijpds-7762	139	4	.	.	PUNCT
ijpds-7762	140	1	the	the	DET
ijpds-7762	140	2	involvement	involvement	NOUN
ijpds-7762	140	3	of	of	ADP
ijpds-7762	140	4	ai	ai	VERB
ijpds-7762	140	5	in	in	ADP
ijpds-7762	140	6	the	the	DET
ijpds-7762	140	7	de	de	PROPN
ijpds-7762	140	8	novo	novo	PROPN
ijpds-7762	140	9	drug	drug	NOUN
ijpds-7762	140	10	design	design	NOUN
ijpds-7762	140	11	is	be	AUX
ijpds-7762	140	12	beneficial	beneficial	ADJ
ijpds-7762	140	13	to	to	ADP
ijpds-7762	140	14	the	the	DET
ijpds-7762	140	15	pharmaceutical	pharmaceutical	ADJ
ijpds-7762	140	16	sector	sector	NOUN
ijpds-7762	140	17	as	as	SCONJ
ijpds-7762	140	18	it	it	PRON
ijpds-7762	140	19	provides	provide	VERB
ijpds-7762	140	20	optimization	optimization	NOUN
ijpds-7762	140	21	of	of	ADP
ijpds-7762	140	22	the	the	DET
ijpds-7762	140	23	already	already	ADV
ijpds-7762	140	24	-	-	PUNCT
ijpds-7762	140	25	learned	learn	VERB
ijpds-7762	140	26	data	datum	NOUN
ijpds-7762	140	27	while	while	SCONJ
ijpds-7762	140	28	suggesting	suggest	VERB
ijpds-7762	140	29	possible	possible	ADJ
ijpds-7762	140	30	synthesis	synthesis	NOUN
ijpds-7762	140	31	routes	route	NOUN
ijpds-7762	140	32	for	for	ADP
ijpds-7762	140	33	drug	drug	NOUN
ijpds-7762	140	34	molecules	molecule	NOUN
ijpds-7762	140	35	,	,	PUNCT
ijpds-7762	140	36	leading	lead	VERB
ijpds-7762	140	37	to	to	ADP
ijpds-7762	140	38	prompt	prompt	ADJ
ijpds-7762	140	39	lead	lead	NOUN
ijpds-7762	140	40	design	design	NOUN
ijpds-7762	140	41	and	and	CCONJ
ijpds-7762	140	42	development	development	NOUN
ijpds-7762	140	43	[	[	X
ijpds-7762	140	44	37	37	NUM
ijpds-7762	140	45	,	,	PUNCT
ijpds-7762	140	46	38	38	NUM
ijpds-7762	140	47	]	]	PUNCT
ijpds-7762	140	48	.	.	PUNCT
ijpds-7762	141	1	role	role	NOUN
ijpds-7762	141	2	of	of	ADP
ijpds-7762	141	3	al	al	PROPN
ijpds-7762	141	4	in	in	ADP
ijpds-7762	141	5	clinical	clinical	ADJ
ijpds-7762	141	6	trials	trial	NOUN
ijpds-7762	141	7	clinical	clinical	ADJ
ijpds-7762	141	8	trials	trial	NOUN
ijpds-7762	141	9	are	be	AUX
ijpds-7762	141	10	necessary	necessary	ADJ
ijpds-7762	141	11	to	to	PART
ijpds-7762	141	12	prove	prove	VERB
ijpds-7762	141	13	the	the	DET
ijpds-7762	141	14	safety	safety	NOUN
ijpds-7762	141	15	and	and	CCONJ
ijpds-7762	141	16	efficacy	efficacy	NOUN
ijpds-7762	141	17	of	of	ADP
ijpds-7762	141	18	a	a	DET
ijpds-7762	141	19	drug	drug	NOUN
ijpds-7762	141	20	for	for	ADP
ijpds-7762	141	21	a	a	DET
ijpds-7762	141	22	particular	particular	ADJ
ijpds-7762	141	23	disease	disease	NOUN
ijpds-7762	141	24	condition	condition	NOUN
ijpds-7762	141	25	and	and	CCONJ
ijpds-7762	141	26	require	require	VERB
ijpds-7762	141	27	anywhere	anywhere	ADV
ijpds-7762	141	28	from	from	ADP
ijpds-7762	141	29	6–7	6–7	NUM
ijpds-7762	141	30	years	year	NOUN
ijpds-7762	141	31	with	with	ADP
ijpds-7762	141	32	substantial	substantial	ADJ
ijpds-7762	141	33	financial	financial	ADJ
ijpds-7762	141	34	investments	investment	NOUN
ijpds-7762	141	35	[	[	X
ijpds-7762	141	36	17	17	NUM
ijpds-7762	141	37	]	]	PUNCT
ijpds-7762	141	38	.	.	PUNCT
ijpds-7762	142	1	clinical	clinical	ADJ
ijpds-7762	142	2	trial	trial	NOUN
ijpds-7762	142	3	failure	failure	NOUN
ijpds-7762	142	4	rates	rate	NOUN
ijpds-7762	142	5	,	,	PUNCT
ijpds-7762	142	6	especially	especially	ADV
ijpds-7762	142	7	in	in	ADP
ijpds-7762	142	8	oncology	oncology	NOUN
ijpds-7762	142	9	and	and	CCONJ
ijpds-7762	142	10	other	other	ADJ
ijpds-7762	142	11	diseases	disease	NOUN
ijpds-7762	142	12	,	,	PUNCT
ijpds-7762	142	13	can	can	AUX
ijpds-7762	142	14	reach	reach	VERB
ijpds-7762	142	15	as	as	ADV
ijpds-7762	142	16	high	high	ADJ
ijpds-7762	142	17	as	as	ADP
ijpds-7762	142	18	95	95	NUM
ijpds-7762	142	19	%	%	NOUN
ijpds-7762	142	20	which	which	PRON
ijpds-7762	142	21	further	far	ADV
ijpds-7762	142	22	contributes	contribute	VERB
ijpds-7762	142	23	to	to	ADP
ijpds-7762	142	24	financial	financial	ADJ
ijpds-7762	142	25	strain	strain	NOUN
ijpds-7762	142	26	.	.	PUNCT
ijpds-7762	143	1	applying	apply	VERB
ijpds-7762	143	2	ai	ai	NOUN
ijpds-7762	143	3	in	in	ADP
ijpds-7762	143	4	various	various	ADJ
ijpds-7762	143	5	steps	step	NOUN
ijpds-7762	143	6	of	of	ADP
ijpds-7762	143	7	clinical	clinical	ADJ
ijpds-7762	143	8	trials	trial	NOUN
ijpds-7762	143	9	helps	help	VERB
ijpds-7762	143	10	to	to	PART
ijpds-7762	143	11	improve	improve	VERB
ijpds-7762	143	12	patient	patient	ADJ
ijpds-7762	143	13	stratification	stratification	NOUN
ijpds-7762	143	14	,	,	PUNCT
ijpds-7762	143	15	intensify	intensify	VERB
ijpds-7762	143	16	recruitment	recruitment	NOUN
ijpds-7762	143	17	efficiency	efficiency	NOUN
ijpds-7762	143	18	,	,	PUNCT
ijpds-7762	143	19	and	and	CCONJ
ijpds-7762	143	20	in	in	ADP
ijpds-7762	143	21	the	the	DET
ijpds-7762	143	22	long	long	ADJ
ijpds-7762	143	23	run	run	NOUN
ijpds-7762	143	24	increase	increase	VERB
ijpds-7762	143	25	the	the	DET
ijpds-7762	143	26	likelihood	likelihood	NOUN
ijpds-7762	143	27	of	of	ADP
ijpds-7762	143	28	trial	trial	NOUN
ijpds-7762	143	29	success	success	NOUN
ijpds-7762	143	30	[	[	X
ijpds-7762	143	31	18	18	NUM
ijpds-7762	143	32	]	]	PUNCT
ijpds-7762	143	33	.	.	PUNCT
ijpds-7762	144	1	in	in	ADP
ijpds-7762	144	2	silico	silico	NOUN
ijpds-7762	144	3	clinical	clinical	ADJ
ijpds-7762	144	4	trials	trial	NOUN
ijpds-7762	144	5	(	(	PUNCT
ijpds-7762	144	6	isct	isct	NOUN
ijpds-7762	144	7	)	)	PUNCT
ijpds-7762	144	8	are	be	AUX
ijpds-7762	144	9	anticipated	anticipate	VERB
ijpds-7762	144	10	to	to	ADP
ijpds-7762	144	11	agrawal	agrawal	PROPN
ijpds-7762	144	12	and	and	CCONJ
ijpds-7762	144	13	kulkarni	kulkarni	PROPN
ijpds-7762	144	14	ai	ai	VERB
ijpds-7762	144	15	applications	application	NOUN
ijpds-7762	144	16	in	in	ADP
ijpds-7762	144	17	drug	drug	NOUN
ijpds-7762	144	18	discovery	discovery	NOUN
ijpds-7762	144	19	and	and	CCONJ
ijpds-7762	144	20	development	development	NOUN
ijpds-7762	144	21	online	online	PROPN
ijpds-7762	144	22	first	first	PROPN
ijpds-7762	144	23	indian	indian	PROPN
ijpds-7762	144	24	j	j	PROPN
ijpds-7762	144	25	pharm	pharm	PROPN
ijpds-7762	144	26	drug	drug	PROPN
ijpds-7762	144	27	studies	study	NOUN
ijpds-7762	144	28	|	|	ADV
ijpds-7762	144	29	4	4	NUM
ijpds-7762	144	30	significantly	significantly	ADV
ijpds-7762	144	31	reduce	reduce	VERB
ijpds-7762	144	32	the	the	DET
ijpds-7762	144	33	costs	cost	NOUN
ijpds-7762	144	34	of	of	ADP
ijpds-7762	144	35	clinical	clinical	ADJ
ijpds-7762	144	36	trials	trial	NOUN
ijpds-7762	144	37	while	while	SCONJ
ijpds-7762	144	38	enhancing	enhance	VERB
ijpds-7762	144	39	overall	overall	ADJ
ijpds-7762	144	40	success	success	NOUN
ijpds-7762	144	41	rates	rate	NOUN
ijpds-7762	144	42	[	[	X
ijpds-7762	144	43	39	39	NUM
ijpds-7762	144	44	]	]	PUNCT
ijpds-7762	144	45	.	.	PUNCT
ijpds-7762	145	1	isct	isct	PROPN
ijpds-7762	145	2	integrates	integrate	VERB
ijpds-7762	145	3	physiological	physiological	ADJ
ijpds-7762	145	4	and	and	CCONJ
ijpds-7762	145	5	pathological	pathological	ADJ
ijpds-7762	145	6	data	datum	NOUN
ijpds-7762	145	7	to	to	PART
ijpds-7762	145	8	generate	generate	VERB
ijpds-7762	145	9	patient	patient	NOUN
ijpds-7762	145	10	-	-	PUNCT
ijpds-7762	145	11	specific	specific	ADJ
ijpds-7762	145	12	predictions	prediction	NOUN
ijpds-7762	145	13	that	that	PRON
ijpds-7762	145	14	provide	provide	VERB
ijpds-7762	145	15	decisions	decision	NOUN
ijpds-7762	145	16	regarding	regard	VERB
ijpds-7762	145	17	diagnosis	diagnosis	NOUN
ijpds-7762	145	18	,	,	PUNCT
ijpds-7762	145	19	dose	dose	NOUN
ijpds-7762	145	20	selection	selection	NOUN
ijpds-7762	145	21	,	,	PUNCT
ijpds-7762	145	22	prognosis	prognosis	NOUN
ijpds-7762	145	23	,	,	PUNCT
ijpds-7762	145	24	and	and	CCONJ
ijpds-7762	145	25	the	the	DET
ijpds-7762	145	26	identification	identification	NOUN
ijpds-7762	145	27	of	of	ADP
ijpds-7762	145	28	suitable	suitable	ADJ
ijpds-7762	145	29	patient	patient	ADJ
ijpds-7762	145	30	groups	group	NOUN
ijpds-7762	145	31	[	[	X
ijpds-7762	145	32	40	40	NUM
ijpds-7762	145	33	]	]	PUNCT
ijpds-7762	145	34	.	.	PUNCT
ijpds-7762	146	1	a	a	DET
ijpds-7762	146	2	newer	new	ADJ
ijpds-7762	146	3	concept	concept	NOUN
ijpds-7762	146	4	,	,	PUNCT
ijpds-7762	146	5	virtual	virtual	ADJ
ijpds-7762	146	6	physiological	physiological	ADJ
ijpds-7762	146	7	human	human	NOUN
ijpds-7762	146	8	(	(	PUNCT
ijpds-7762	146	9	vph	vph	NOUN
ijpds-7762	146	10	)	)	PUNCT
ijpds-7762	146	11	,	,	PUNCT
ijpds-7762	146	12	configures	configure	VERB
ijpds-7762	146	13	virtual	virtual	ADJ
ijpds-7762	146	14	patient	patient	ADJ
ijpds-7762	146	15	groups	group	NOUN
ijpds-7762	146	16	to	to	PART
ijpds-7762	146	17	test	test	VERB
ijpds-7762	146	18	the	the	DET
ijpds-7762	146	19	safety	safety	NOUN
ijpds-7762	146	20	and	and	CCONJ
ijpds-7762	146	21	efficacy	efficacy	NOUN
ijpds-7762	146	22	of	of	ADP
ijpds-7762	146	23	new	new	ADJ
ijpds-7762	146	24	drugs	drug	NOUN
ijpds-7762	146	25	and	and	CCONJ
ijpds-7762	146	26	medical	medical	ADJ
ijpds-7762	146	27	devices	device	NOUN
ijpds-7762	146	28	.	.	PUNCT
ijpds-7762	147	1	vph	vph	NOUN
ijpds-7762	147	2	acts	act	VERB
ijpds-7762	147	3	as	as	ADP
ijpds-7762	147	4	an	an	DET
ijpds-7762	147	5	adjuvant	adjuvant	NOUN
ijpds-7762	147	6	to	to	ADP
ijpds-7762	147	7	the	the	DET
ijpds-7762	147	8	traditional	traditional	ADJ
ijpds-7762	147	9	clinical	clinical	ADJ
ijpds-7762	147	10	trials	trial	NOUN
ijpds-7762	147	11	by	by	ADP
ijpds-7762	147	12	reducing	reduce	VERB
ijpds-7762	147	13	the	the	DET
ijpds-7762	147	14	number	number	NOUN
ijpds-7762	147	15	of	of	ADP
ijpds-7762	147	16	patients	patient	NOUN
ijpds-7762	147	17	needed	need	VERB
ijpds-7762	147	18	for	for	ADP
ijpds-7762	147	19	the	the	DET
ijpds-7762	147	20	trials	trial	NOUN
ijpds-7762	147	21	and	and	CCONJ
ijpds-7762	147	22	enhancing	enhance	VERB
ijpds-7762	147	23	the	the	DET
ijpds-7762	147	24	statistical	statistical	ADJ
ijpds-7762	147	25	power	power	NOUN
ijpds-7762	147	26	of	of	ADP
ijpds-7762	147	27	the	the	DET
ijpds-7762	147	28	results	result	NOUN
ijpds-7762	147	29	[	[	X
ijpds-7762	147	30	41	41	NUM
ijpds-7762	147	31	]	]	PUNCT
ijpds-7762	147	32	.	.	PUNCT
ijpds-7762	148	1	additionally	additionally	ADV
ijpds-7762	148	2	,	,	PUNCT
ijpds-7762	148	3	ai	ai	AUX
ijpds-7762	148	4	contributes	contribute	VERB
ijpds-7762	148	5	to	to	ADP
ijpds-7762	148	6	clinical	clinical	ADJ
ijpds-7762	148	7	trial	trial	NOUN
ijpds-7762	148	8	success	success	NOUN
ijpds-7762	148	9	by	by	ADP
ijpds-7762	148	10	linking	link	VERB
ijpds-7762	148	11	patient	patient	ADJ
ijpds-7762	148	12	genetic	genetic	ADJ
ijpds-7762	148	13	data	datum	NOUN
ijpds-7762	148	14	and	and	CCONJ
ijpds-7762	148	15	electronic	electronic	ADJ
ijpds-7762	148	16	health	health	NOUN
ijpds-7762	148	17	records	record	NOUN
ijpds-7762	148	18	,	,	PUNCT
ijpds-7762	148	19	along	along	ADP
ijpds-7762	148	20	with	with	ADP
ijpds-7762	148	21	cumulating	cumulating	ADJ
ijpds-7762	148	22	clinical	clinical	ADJ
ijpds-7762	148	23	trial	trial	NOUN
ijpds-7762	148	24	databases	database	NOUN
ijpds-7762	148	25	to	to	PART
ijpds-7762	148	26	predict	predict	VERB
ijpds-7762	148	27	drug	drug	NOUN
ijpds-7762	148	28	toxicity	toxicity	NOUN
ijpds-7762	148	29	,	,	PUNCT
ijpds-7762	148	30	and	and	CCONJ
ijpds-7762	148	31	assisting	assist	VERB
ijpds-7762	148	32	with	with	ADP
ijpds-7762	148	33	patient	patient	ADJ
ijpds-7762	148	34	trial	trial	NOUN
ijpds-7762	148	35	matching	matching	NOUN
ijpds-7762	148	36	and	and	CCONJ
ijpds-7762	148	37	recruitment	recruitment	NOUN
ijpds-7762	148	38	,	,	PUNCT
ijpds-7762	148	39	plus	plus	CCONJ
ijpds-7762	148	40	monitoring	monitor	VERB
ijpds-7762	148	41	patient	patient	ADJ
ijpds-7762	148	42	adherence	adherence	NOUN
ijpds-7762	148	43	during	during	ADP
ijpds-7762	148	44	trials	trial	NOUN
ijpds-7762	148	45	[	[	X
ijpds-7762	148	46	18	18	NUM
ijpds-7762	148	47	,	,	PUNCT
ijpds-7762	148	48	42	42	NUM
ijpds-7762	148	49	]	]	PUNCT
ijpds-7762	148	50	.	.	PUNCT
ijpds-7762	149	1	one	one	NUM
ijpds-7762	149	2	of	of	ADP
ijpds-7762	149	3	the	the	DET
ijpds-7762	149	4	major	major	ADJ
ijpds-7762	149	5	causes	cause	NOUN
ijpds-7762	149	6	of	of	ADP
ijpds-7762	149	7	failure	failure	NOUN
ijpds-7762	149	8	of	of	ADP
ijpds-7762	149	9	clinical	clinical	ADJ
ijpds-7762	149	10	trials	trial	NOUN
ijpds-7762	149	11	is	be	AUX
ijpds-7762	149	12	toxicity	toxicity	NOUN
ijpds-7762	149	13	.	.	PUNCT
ijpds-7762	150	1	in	in	ADP
ijpds-7762	150	2	light	light	NOUN
ijpds-7762	150	3	of	of	ADP
ijpds-7762	150	4	this	this	PRON
ijpds-7762	150	5	,	,	PUNCT
ijpds-7762	150	6	proctor	proctor	NOUN
ijpds-7762	150	7	,	,	PUNCT
ijpds-7762	150	8	a	a	DET
ijpds-7762	150	9	toxicity	toxicity	NOUN
ijpds-7762	150	10	prediction	prediction	NOUN
ijpds-7762	150	11	model	model	NOUN
ijpds-7762	150	12	,	,	PUNCT
ijpds-7762	150	13	was	be	AUX
ijpds-7762	150	14	designed	design	VERB
ijpds-7762	150	15	by	by	ADP
ijpds-7762	150	16	gayvert	gayvert	NOUN
ijpds-7762	150	17	,	,	PUNCT
ijpds-7762	150	18	et	et	PROPN
ijpds-7762	150	19	al	al	PROPN
ijpds-7762	150	20	.	.	PUNCT
ijpds-7762	151	1	that	that	PRON
ijpds-7762	151	2	helps	help	VERB
ijpds-7762	151	3	to	to	PART
ijpds-7762	151	4	distinguish	distinguish	VERB
ijpds-7762	151	5	between	between	ADP
ijpds-7762	151	6	fda	fda	PROPN
ijpds-7762	151	7	-	-	PUNCT
ijpds-7762	151	8	approved	approve	VERB
ijpds-7762	151	9	drugs	drug	NOUN
ijpds-7762	151	10	and	and	CCONJ
ijpds-7762	151	11	drugs	drug	NOUN
ijpds-7762	151	12	that	that	PRON
ijpds-7762	151	13	failed	fail	VERB
ijpds-7762	151	14	during	during	ADP
ijpds-7762	151	15	clinical	clinical	ADJ
ijpds-7762	151	16	trials	trial	NOUN
ijpds-7762	151	17	due	due	ADP
ijpds-7762	151	18	to	to	ADP
ijpds-7762	151	19	toxicity	toxicity	NOUN
ijpds-7762	151	20	.	.	PUNCT
ijpds-7762	152	1	this	this	PRON
ijpds-7762	152	2	enables	enable	VERB
ijpds-7762	152	3	the	the	DET
ijpds-7762	152	4	design	design	NOUN
ijpds-7762	152	5	of	of	ADP
ijpds-7762	152	6	therapeutic	therapeutic	ADJ
ijpds-7762	152	7	agents	agent	NOUN
ijpds-7762	152	8	with	with	ADP
ijpds-7762	152	9	less	less	ADJ
ijpds-7762	152	10	toxicity	toxicity	NOUN
ijpds-7762	152	11	[	[	X
ijpds-7762	152	12	43	43	NUM
ijpds-7762	152	13	]	]	PUNCT
ijpds-7762	152	14	.	.	PUNCT
ijpds-7762	153	1	targetox	targetox	NOUN
ijpds-7762	153	2	is	be	AUX
ijpds-7762	153	3	another	another	DET
ijpds-7762	153	4	toxicity	toxicity	NOUN
ijpds-7762	153	5	prediction	prediction	NOUN
ijpds-7762	153	6	model	model	NOUN
ijpds-7762	153	7	that	that	PRON
ijpds-7762	153	8	produces	produce	VERB
ijpds-7762	153	9	and	and	CCONJ
ijpds-7762	153	10	unites	unite	VERB
ijpds-7762	153	11	pharmacological	pharmacological	ADJ
ijpds-7762	153	12	and	and	CCONJ
ijpds-7762	153	13	functional	functional	ADJ
ijpds-7762	153	14	properties	property	NOUN
ijpds-7762	153	15	in	in	ADP
ijpds-7762	153	16	an	an	DET
ijpds-7762	153	17	ml	ml	NOUN
ijpds-7762	153	18	classifier	classifier	NOUN
ijpds-7762	153	19	to	to	PART
ijpds-7762	153	20	predict	predict	VERB
ijpds-7762	153	21	drug	drug	NOUN
ijpds-7762	153	22	toxicity	toxicity	NOUN
ijpds-7762	153	23	[	[	X
ijpds-7762	153	24	44	44	NUM
ijpds-7762	153	25	]	]	PUNCT
ijpds-7762	153	26	.	.	PUNCT
ijpds-7762	154	1	in	in	ADP
ijpds-7762	154	2	order	order	NOUN
ijpds-7762	154	3	to	to	PART
ijpds-7762	154	4	increase	increase	VERB
ijpds-7762	154	5	patient	patient	ADJ
ijpds-7762	154	6	adherence	adherence	NOUN
ijpds-7762	154	7	in	in	ADP
ijpds-7762	154	8	clinical	clinical	ADJ
ijpds-7762	154	9	trials	trial	NOUN
ijpds-7762	154	10	,	,	PUNCT
ijpds-7762	154	11	ai	ai	ADJ
ijpds-7762	154	12	-	-	PUNCT
ijpds-7762	154	13	powered	power	VERB
ijpds-7762	154	14	facial	facial	ADJ
ijpds-7762	154	15	recognition	recognition	NOUN
ijpds-7762	154	16	algorithms	algorithm	NOUN
ijpds-7762	154	17	are	be	AUX
ijpds-7762	154	18	implemented	implement	VERB
ijpds-7762	154	19	,	,	PUNCT
ijpds-7762	154	20	in	in	ADP
ijpds-7762	154	21	which	which	PRON
ijpds-7762	154	22	patients	patient	NOUN
ijpds-7762	154	23	need	need	VERB
ijpds-7762	154	24	to	to	PART
ijpds-7762	154	25	record	record	VERB
ijpds-7762	154	26	a	a	DET
ijpds-7762	154	27	video	video	NOUN
ijpds-7762	154	28	of	of	ADP
ijpds-7762	154	29	themselves	themselves	PRON
ijpds-7762	154	30	swallowing	swallow	VERB
ijpds-7762	154	31	the	the	DET
ijpds-7762	154	32	pills	pill	NOUN
ijpds-7762	154	33	.	.	PUNCT
ijpds-7762	155	1	the	the	DET
ijpds-7762	155	2	ai	ai	PROPN
ijpds-7762	155	3	system	system	NOUN
ijpds-7762	155	4	then	then	ADV
ijpds-7762	155	5	confirms	confirm	VERB
ijpds-7762	155	6	that	that	SCONJ
ijpds-7762	155	7	the	the	DET
ijpds-7762	155	8	correct	correct	ADJ
ijpds-7762	155	9	person	person	NOUN
ijpds-7762	155	10	has	have	AUX
ijpds-7762	155	11	taken	take	VERB
ijpds-7762	155	12	the	the	DET
ijpds-7762	155	13	prescribed	prescribed	ADJ
ijpds-7762	155	14	medication	medication	NOUN
ijpds-7762	155	15	[	[	X
ijpds-7762	155	16	45	45	NUM
ijpds-7762	155	17	]	]	PUNCT
ijpds-7762	155	18	.	.	PUNCT
ijpds-7762	156	1	in	in	ADP
ijpds-7762	156	2	a	a	DET
ijpds-7762	156	3	trial	trial	NOUN
ijpds-7762	156	4	of	of	ADP
ijpds-7762	156	5	patients	patient	NOUN
ijpds-7762	156	6	with	with	ADP
ijpds-7762	156	7	schizophrenia	schizophrenia	NOUN
ijpds-7762	156	8	,	,	PUNCT
ijpds-7762	156	9	adherence	adherence	NOUN
ijpds-7762	156	10	increased	increase	VERB
ijpds-7762	156	11	from	from	ADP
ijpds-7762	156	12	50	50	NUM
ijpds-7762	156	13	%	%	NOUN
ijpds-7762	156	14	to	to	PART
ijpds-7762	156	15	90	90	NUM
ijpds-7762	156	16	%	%	NOUN
ijpds-7762	156	17	within	within	ADP
ijpds-7762	156	18	a	a	DET
ijpds-7762	156	19	span	span	NOUN
ijpds-7762	156	20	of	of	ADP
ijpds-7762	156	21	six	six	NUM
ijpds-7762	156	22	months	month	NOUN
ijpds-7762	156	23	,	,	PUNCT
ijpds-7762	156	24	exhibiting	exhibit	VERB
ijpds-7762	156	25	the	the	DET
ijpds-7762	156	26	success	success	NOUN
ijpds-7762	156	27	of	of	ADP
ijpds-7762	156	28	ai	ai	ADJ
ijpds-7762	156	29	-	-	PUNCT
ijpds-7762	156	30	driven	drive	VERB
ijpds-7762	156	31	monitoring	monitoring	NOUN
ijpds-7762	156	32	approaches	approach	VERB
ijpds-7762	156	33	[	[	X
ijpds-7762	156	34	46	46	NUM
ijpds-7762	156	35	]	]	PUNCT
ijpds-7762	156	36	.	.	PUNCT
ijpds-7762	157	1	a	a	DET
ijpds-7762	157	2	systematic	systematic	ADJ
ijpds-7762	157	3	review	review	NOUN
ijpds-7762	157	4	in	in	ADP
ijpds-7762	157	5	2024	2024	NUM
ijpds-7762	157	6	deduced	deduce	VERB
ijpds-7762	157	7	that	that	SCONJ
ijpds-7762	157	8	ai	ai	NOUN
ijpds-7762	157	9	-	-	PUNCT
ijpds-7762	157	10	derived	derive	VERB
ijpds-7762	157	11	drugs	drug	NOUN
ijpds-7762	157	12	can	can	AUX
ijpds-7762	157	13	have	have	VERB
ijpds-7762	157	14	a	a	DET
ijpds-7762	157	15	success	success	NOUN
ijpds-7762	157	16	rate	rate	NOUN
ijpds-7762	157	17	of	of	ADP
ijpds-7762	157	18	80	80	NUM
ijpds-7762	157	19	–	–	SYM
ijpds-7762	157	20	90	90	NUM
ijpds-7762	157	21	%	%	NOUN
ijpds-7762	157	22	in	in	ADP
ijpds-7762	157	23	phase	phase	NOUN
ijpds-7762	157	24	i	i	PRON
ijpds-7762	157	25	trials	trial	NOUN
ijpds-7762	157	26	,	,	PUNCT
ijpds-7762	157	27	around	around	ADV
ijpds-7762	157	28	40	40	NUM
ijpds-7762	157	29	%	%	NOUN
ijpds-7762	157	30	in	in	ADP
ijpds-7762	157	31	phase	phase	NOUN
ijpds-7762	157	32	ii	ii	PROPN
ijpds-7762	157	33	trials	trial	NOUN
ijpds-7762	157	34	,	,	PUNCT
ijpds-7762	157	35	which	which	PRON
ijpds-7762	157	36	have	have	AUX
ijpds-7762	157	37	shown	show	VERB
ijpds-7762	157	38	to	to	PART
ijpds-7762	157	39	have	have	VERB
ijpds-7762	157	40	substantially	substantially	ADV
ijpds-7762	157	41	higher	high	ADJ
ijpds-7762	157	42	success	success	NOUN
ijpds-7762	157	43	rates	rate	NOUN
ijpds-7762	157	44	than	than	ADP
ijpds-7762	157	45	traditionally	traditionally	ADV
ijpds-7762	157	46	derived	derive	VERB
ijpds-7762	157	47	drugs	drug	NOUN
ijpds-7762	157	48	[	[	X
ijpds-7762	157	49	47	47	NUM
ijpds-7762	157	50	]	]	PUNCT
ijpds-7762	157	51	.	.	PUNCT
ijpds-7762	158	1	in	in	ADP
ijpds-7762	158	2	the	the	DET
ijpds-7762	158	3	forthcoming	forthcoming	ADJ
ijpds-7762	158	4	years	year	NOUN
ijpds-7762	158	5	,	,	PUNCT
ijpds-7762	158	6	as	as	SCONJ
ijpds-7762	158	7	more	more	ADV
ijpds-7762	158	8	clinical	clinical	ADJ
ijpds-7762	158	9	results	result	NOUN
ijpds-7762	158	10	for	for	ADP
ijpds-7762	158	11	ai	ai	ADV
ijpds-7762	158	12	-	-	PUNCT
ijpds-7762	158	13	discovered	discover	VERB
ijpds-7762	158	14	drug	drug	NOUN
ijpds-7762	158	15	molecules	molecule	NOUN
ijpds-7762	158	16	become	become	VERB
ijpds-7762	158	17	available	available	ADJ
ijpds-7762	158	18	,	,	PUNCT
ijpds-7762	158	19	it	it	PRON
ijpds-7762	158	20	will	will	AUX
ijpds-7762	158	21	be	be	AUX
ijpds-7762	158	22	exhilarating	exhilarate	VERB
ijpds-7762	158	23	to	to	PART
ijpds-7762	158	24	see	see	VERB
ijpds-7762	158	25	how	how	SCONJ
ijpds-7762	158	26	ai	ai	VERB
ijpds-7762	158	27	technologies	technology	NOUN
ijpds-7762	158	28	will	will	AUX
ijpds-7762	158	29	impact	impact	VERB
ijpds-7762	158	30	the	the	DET
ijpds-7762	158	31	pharmaceutical	pharmaceutical	NOUN
ijpds-7762	158	32	industry	industry	NOUN
ijpds-7762	158	33	at	at	ADP
ijpds-7762	158	34	the	the	DET
ijpds-7762	158	35	drug	drug	NOUN
ijpds-7762	158	36	trial	trial	NOUN
ijpds-7762	158	37	level	level	NOUN
ijpds-7762	158	38	.	.	PUNCT
ijpds-7762	159	1	table	table	NOUN
ijpds-7762	159	2	2	2	NUM
ijpds-7762	159	3	:	:	PUNCT
ijpds-7762	159	4	ai	ai	VERB
ijpds-7762	159	5	tools	tool	NOUN
ijpds-7762	159	6	/	/	SYM
ijpds-7762	159	7	techniques	technique	NOUN
ijpds-7762	159	8	employed	employ	VERB
ijpds-7762	159	9	in	in	ADP
ijpds-7762	159	10	drug	drug	NOUN
ijpds-7762	159	11	discovery	discovery	NOUN
ijpds-7762	160	1	[	[	X
ijpds-7762	160	2	1	1	NUM
ijpds-7762	160	3	,	,	PUNCT
ijpds-7762	160	4	17	17	NUM
ijpds-7762	160	5	]	]	PUNCT
ijpds-7762	160	6	s.	s.	PROPN
ijpds-7762	160	7	no	no	DET
ijpds-7762	160	8	tool	tool	NOUN
ijpds-7762	160	9	/	/	SYM
ijpds-7762	160	10	technique	technique	NOUN
ijpds-7762	160	11	name	name	NOUN
ijpds-7762	160	12	description	description	NOUN
ijpds-7762	160	13	1	1	NUM
ijpds-7762	160	14	machine	machine	NOUN
ijpds-7762	160	15	learning	learning	NOUN
ijpds-7762	160	16	predicts	predict	VERB
ijpds-7762	160	17	drug	drug	NOUN
ijpds-7762	160	18	-	-	PUNCT
ijpds-7762	160	19	target	target	NOUN
ijpds-7762	160	20	interactions	interaction	NOUN
ijpds-7762	160	21	,	,	PUNCT
ijpds-7762	160	22	helps	help	VERB
ijpds-7762	160	23	analyse	analyse	VERB
ijpds-7762	160	24	biological	biological	ADJ
ijpds-7762	160	25	activity	activity	NOUN
ijpds-7762	160	26	,	,	PUNCT
ijpds-7762	160	27	and	and	CCONJ
ijpds-7762	160	28	optimizes	optimize	VERB
ijpds-7762	160	29	lead	lead	VERB
ijpds-7762	160	30	molecular	molecular	ADJ
ijpds-7762	160	31	compounds	compound	NOUN
ijpds-7762	160	32	2	2	NUM
ijpds-7762	160	33	deep	deep	ADJ
ijpds-7762	160	34	learning	learning	NOUN
ijpds-7762	160	35	helps	help	VERB
ijpds-7762	160	36	in	in	ADP
ijpds-7762	160	37	de	de	PROPN
ijpds-7762	160	38	novo	novo	NOUN
ijpds-7762	160	39	drug	drug	NOUN
ijpds-7762	160	40	designing	designing	NOUN
ijpds-7762	160	41	,	,	PUNCT
ijpds-7762	160	42	virtual	virtual	ADJ
ijpds-7762	160	43	screening	screening	NOUN
ijpds-7762	160	44	,	,	PUNCT
ijpds-7762	160	45	and	and	CCONJ
ijpds-7762	160	46	predicting	predict	VERB
ijpds-7762	160	47	drug	drug	NOUN
ijpds-7762	160	48	properties	property	NOUN
ijpds-7762	160	49	3	3	NUM
ijpds-7762	160	50	reinforcement	reinforcement	NOUN
ijpds-7762	160	51	learning	learning	NOUN
ijpds-7762	160	52	applied	apply	VERB
ijpds-7762	160	53	to	to	PART
ijpds-7762	160	54	optimize	optimize	VERB
ijpds-7762	160	55	drug	drug	NOUN
ijpds-7762	160	56	combinations	combination	NOUN
ijpds-7762	160	57	and	and	CCONJ
ijpds-7762	160	58	dosages	dosage	NOUN
ijpds-7762	160	59	by	by	ADP
ijpds-7762	160	60	taking	take	VERB
ijpds-7762	160	61	multiple	multiple	ADJ
ijpds-7762	160	62	variables	variable	NOUN
ijpds-7762	160	63	into	into	ADP
ijpds-7762	160	64	consideration	consideration	NOUN
ijpds-7762	160	65	and	and	CCONJ
ijpds-7762	160	66	maximizing	maximize	VERB
ijpds-7762	160	67	desired	desire	VERB
ijpds-7762	160	68	outcomes	outcome	NOUN
ijpds-7762	160	69	4	4	NUM
ijpds-7762	160	70	neural	neural	ADJ
ijpds-7762	160	71	graph	graph	NOUN
ijpds-7762	160	72	fingerprints	fingerprint	NOUN
ijpds-7762	160	73	helps	help	VERB
ijpds-7762	160	74	in	in	ADP
ijpds-7762	160	75	various	various	ADJ
ijpds-7762	160	76	aspects	aspect	NOUN
ijpds-7762	160	77	of	of	ADP
ijpds-7762	160	78	drug	drug	NOUN
ijpds-7762	160	79	discovery	discovery	NOUN
ijpds-7762	160	80	,	,	PUNCT
ijpds-7762	160	81	such	such	ADJ
ijpds-7762	160	82	as	as	ADP
ijpds-7762	160	83	lead	lead	NOUN
ijpds-7762	160	84	optimization	optimization	NOUN
ijpds-7762	160	85	,	,	PUNCT
ijpds-7762	160	86	virtual	virtual	ADJ
ijpds-7762	160	87	screening	screening	NOUN
ijpds-7762	160	88	,	,	PUNCT
ijpds-7762	160	89	and	and	CCONJ
ijpds-7762	160	90	drug	drug	NOUN
ijpds-7762	160	91	properties	property	NOUN
ijpds-7762	160	92	’	'	PUNCT
ijpds-7762	160	93	prediction	prediction	NOUN
ijpds-7762	160	94	5	5	NUM
ijpds-7762	160	95	deepchem	deepchem	NOUN
ijpds-7762	160	96	uses	use	VERB
ijpds-7762	160	97	a	a	DET
ijpds-7762	160	98	python	python	NOUN
ijpds-7762	160	99	-	-	PUNCT
ijpds-7762	160	100	based	base	VERB
ijpds-7762	160	101	ai	ai	NOUN
ijpds-7762	160	102	system	system	NOUN
ijpds-7762	160	103	to	to	PART
ijpds-7762	160	104	find	find	VERB
ijpds-7762	160	105	a	a	DET
ijpds-7762	160	106	suitable	suitable	ADJ
ijpds-7762	160	107	candidate	candidate	NOUN
ijpds-7762	160	108	in	in	ADP
ijpds-7762	160	109	drug	drug	NOUN
ijpds-7762	160	110	discovery	discovery	NOUN
ijpds-7762	160	111	6	6	NUM
ijpds-7762	160	112	alphafold	alphafold	ADJ
ijpds-7762	160	113	predicts	predict	NOUN
ijpds-7762	160	114	3d	3d	NUM
ijpds-7762	160	115	structures	structure	NOUN
ijpds-7762	160	116	of	of	ADP
ijpds-7762	160	117	target	target	NOUN
ijpds-7762	160	118	proteins	protein	NOUN
ijpds-7762	160	119	7	7	NUM
ijpds-7762	160	120	potentialnet	potentialnet	NOUN
ijpds-7762	160	121	uses	use	VERB
ijpds-7762	160	122	neural	neural	ADJ
ijpds-7762	160	123	networks	network	NOUN
ijpds-7762	160	124	to	to	PART
ijpds-7762	160	125	predict	predict	VERB
ijpds-7762	160	126	binding	binding	ADJ
ijpds-7762	160	127	affinity	affinity	NOUN
ijpds-7762	160	128	of	of	ADP
ijpds-7762	160	129	ligands	ligand	NOUN
ijpds-7762	160	130	8	8	NUM
ijpds-7762	160	131	deeptox	deeptox	NOUN
ijpds-7762	160	132	software	software	NOUN
ijpds-7762	160	133	that	that	PRON
ijpds-7762	160	134	predicts	predict	VERB
ijpds-7762	160	135	the	the	DET
ijpds-7762	160	136	toxicity	toxicity	NOUN
ijpds-7762	160	137	of	of	ADP
ijpds-7762	160	138	around	around	ADV
ijpds-7762	160	139	12,000	12,000	NUM
ijpds-7762	160	140	drugs	drug	NOUN
ijpds-7762	160	141	role	role	NOUN
ijpds-7762	160	142	of	of	ADP
ijpds-7762	160	143	ai	ai	VERB
ijpds-7762	160	144	in	in	ADP
ijpds-7762	160	145	drug	drug	NOUN
ijpds-7762	160	146	repurposing	repurpose	VERB
ijpds-7762	160	147	the	the	DET
ijpds-7762	160	148	process	process	NOUN
ijpds-7762	160	149	of	of	ADP
ijpds-7762	160	150	bringing	bring	VERB
ijpds-7762	160	151	new	new	ADJ
ijpds-7762	160	152	drugs	drug	NOUN
ijpds-7762	160	153	to	to	ADP
ijpds-7762	160	154	the	the	DET
ijpds-7762	160	155	market	market	NOUN
ijpds-7762	160	156	has	have	VERB
ijpds-7762	160	157	significant	significant	ADJ
ijpds-7762	160	158	hurdles	hurdle	NOUN
ijpds-7762	160	159	in	in	ADP
ijpds-7762	160	160	terms	term	NOUN
ijpds-7762	160	161	of	of	ADP
ijpds-7762	160	162	time	time	NOUN
ijpds-7762	160	163	,	,	PUNCT
ijpds-7762	160	164	labour	labour	NOUN
ijpds-7762	160	165	,	,	PUNCT
ijpds-7762	160	166	and	and	CCONJ
ijpds-7762	160	167	cost	cost	NOUN
ijpds-7762	160	168	.	.	PUNCT
ijpds-7762	161	1	but	but	CCONJ
ijpds-7762	161	2	finding	find	VERB
ijpds-7762	161	3	new	new	ADJ
ijpds-7762	161	4	indications	indication	NOUN
ijpds-7762	161	5	for	for	ADP
ijpds-7762	161	6	an	an	DET
ijpds-7762	161	7	already	already	ADV
ijpds-7762	161	8	existing	exist	VERB
ijpds-7762	161	9	drug	drug	NOUN
ijpds-7762	161	10	can	can	AUX
ijpds-7762	161	11	considerably	considerably	ADV
ijpds-7762	161	12	reduce	reduce	VERB
ijpds-7762	161	13	these	these	DET
ijpds-7762	161	14	costs	cost	NOUN
ijpds-7762	161	15	by	by	ADP
ijpds-7762	161	16	repurposing	repurpose	VERB
ijpds-7762	161	17	or	or	CCONJ
ijpds-7762	161	18	repositioning	reposition	VERB
ijpds-7762	161	19	it	it	PRON
ijpds-7762	161	20	for	for	ADP
ijpds-7762	161	21	other	other	ADJ
ijpds-7762	161	22	diseases	disease	NOUN
ijpds-7762	161	23	[	[	X
ijpds-7762	161	24	48	48	NUM
ijpds-7762	161	25	]	]	PUNCT
ijpds-7762	161	26	.	.	PUNCT
ijpds-7762	162	1	drug	drug	NOUN
ijpds-7762	162	2	repurposing	repurposing	NOUN
ijpds-7762	162	3	allows	allow	VERB
ijpds-7762	162	4	the	the	DET
ijpds-7762	162	5	drug	drug	NOUN
ijpds-7762	162	6	in	in	ADP
ijpds-7762	162	7	question	question	NOUN
ijpds-7762	162	8	to	to	PART
ijpds-7762	162	9	enter	enter	VERB
ijpds-7762	162	10	phase	phase	NOUN
ijpds-7762	162	11	ii	ii	PROPN
ijpds-7762	162	12	and	and	CCONJ
ijpds-7762	162	13	iii	iii	NUM
ijpds-7762	162	14	clinical	clinical	ADJ
ijpds-7762	162	15	trials	trial	NOUN
ijpds-7762	162	16	instantly	instantly	ADV
ijpds-7762	162	17	,	,	PUNCT
ijpds-7762	162	18	with	with	ADP
ijpds-7762	162	19	notably	notably	ADV
ijpds-7762	162	20	lower	low	ADJ
ijpds-7762	162	21	development	development	NOUN
ijpds-7762	162	22	costs	cost	NOUN
ijpds-7762	162	23	,	,	PUNCT
ijpds-7762	162	24	as	as	SCONJ
ijpds-7762	162	25	pharmacokinetic	pharmacokinetic	ADJ
ijpds-7762	162	26	,	,	PUNCT
ijpds-7762	162	27	pharmacodynamic	pharmacodynamic	ADJ
ijpds-7762	162	28	,	,	PUNCT
ijpds-7762	162	29	and	and	CCONJ
ijpds-7762	162	30	toxicity	toxicity	NOUN
ijpds-7762	162	31	profiles	profile	NOUN
ijpds-7762	162	32	of	of	ADP
ijpds-7762	162	33	the	the	DET
ijpds-7762	162	34	drug	drug	NOUN
ijpds-7762	162	35	are	be	AUX
ijpds-7762	162	36	already	already	ADV
ijpds-7762	162	37	established	establish	VERB
ijpds-7762	162	38	[	[	PUNCT
ijpds-7762	162	39	48	48	NUM
ijpds-7762	162	40	]	]	PUNCT
ijpds-7762	162	41	.	.	PUNCT
ijpds-7762	163	1	reker	reker	NOUN
ijpds-7762	163	2	,	,	PUNCT
ijpds-7762	163	3	et	et	PROPN
ijpds-7762	163	4	al	al	PROPN
ijpds-7762	163	5	have	have	AUX
ijpds-7762	163	6	developed	develop	VERB
ijpds-7762	163	7	a	a	DET
ijpds-7762	163	8	method	method	NOUN
ijpds-7762	163	9	called	call	VERB
ijpds-7762	163	10	self	self	NOUN
ijpds-7762	163	11	-	-	PUNCT
ijpds-7762	163	12	organizing	organize	VERB
ijpds-7762	163	13	map	map	NOUN
ijpds-7762	163	14	-	-	PUNCT
ijpds-7762	163	15	based	base	VERB
ijpds-7762	163	16	prediction	prediction	NOUN
ijpds-7762	163	17	of	of	ADP
ijpds-7762	163	18	drug	drug	NOUN
ijpds-7762	163	19	equivalence	equivalence	NOUN
ijpds-7762	163	20	relationships	relationship	NOUN
ijpds-7762	163	21	(	(	PUNCT
ijpds-7762	163	22	spider	spider	NOUN
ijpds-7762	163	23	)	)	PUNCT
ijpds-7762	163	24	.	.	PUNCT
ijpds-7762	164	1	the	the	DET
ijpds-7762	164	2	model	model	NOUN
ijpds-7762	164	3	predicts	predict	VERB
ijpds-7762	164	4	molecular	molecular	ADJ
ijpds-7762	164	5	targets	target	NOUN
ijpds-7762	164	6	of	of	ADP
ijpds-7762	164	7	known	know	VERB
ijpds-7762	164	8	drugs	drug	NOUN
ijpds-7762	164	9	,	,	PUNCT
ijpds-7762	164	10	including	include	VERB
ijpds-7762	164	11	key	key	ADJ
ijpds-7762	164	12	-	-	PUNCT
ijpds-7762	164	13	target	target	NOUN
ijpds-7762	164	14	and	and	CCONJ
ijpds-7762	164	15	off	off	ADP
ijpds-7762	164	16	-	-	PUNCT
ijpds-7762	164	17	target	target	NOUN
ijpds-7762	164	18	proteins	protein	NOUN
ijpds-7762	164	19	[	[	X
ijpds-7762	164	20	49	49	NUM
ijpds-7762	164	21	]	]	PUNCT
ijpds-7762	164	22	.	.	PUNCT
ijpds-7762	165	1	benevolent	benevolent	PROPN
ijpds-7762	165	2	ai	ai	PROPN
ijpds-7762	165	3	,	,	PUNCT
ijpds-7762	165	4	an	an	DET
ijpds-7762	165	5	ai	ai	ADJ
ijpds-7762	165	6	-	-	PUNCT
ijpds-7762	165	7	enabled	enable	VERB
ijpds-7762	165	8	drug	drug	NOUN
ijpds-7762	165	9	discovery	discovery	NOUN
ijpds-7762	165	10	company	company	NOUN
ijpds-7762	165	11	,	,	PUNCT
ijpds-7762	165	12	utilizes	utilize	VERB
ijpds-7762	165	13	ai	ai	VERB
ijpds-7762	165	14	tools	tool	NOUN
ijpds-7762	165	15	to	to	PART
ijpds-7762	165	16	unwrap	unwrap	VERB
ijpds-7762	165	17	novel	novel	ADJ
ijpds-7762	165	18	connections	connection	NOUN
ijpds-7762	165	19	within	within	ADP
ijpds-7762	165	20	vast	vast	ADJ
ijpds-7762	165	21	,	,	PUNCT
ijpds-7762	165	22	unstructured	unstructured	ADJ
ijpds-7762	165	23	datasets	dataset	NOUN
ijpds-7762	165	24	with	with	ADP
ijpds-7762	165	25	respect	respect	NOUN
ijpds-7762	165	26	to	to	ADP
ijpds-7762	165	27	drugs	drug	NOUN
ijpds-7762	165	28	,	,	PUNCT
ijpds-7762	165	29	and	and	CCONJ
ijpds-7762	165	30	their	their	PRON
ijpds-7762	165	31	clinical	clinical	ADJ
ijpds-7762	165	32	trial	trial	NOUN
ijpds-7762	165	33	information	information	NOUN
ijpds-7762	165	34	,	,	PUNCT
ijpds-7762	165	35	enabling	enable	VERB
ijpds-7762	165	36	drug	drug	NOUN
ijpds-7762	165	37	repurposing	repurpose	VERB
ijpds-7762	165	38	and	and	CCONJ
ijpds-7762	165	39	facilitating	facilitate	VERB
ijpds-7762	165	40	the	the	DET
ijpds-7762	165	41	discovery	discovery	NOUN
ijpds-7762	165	42	of	of	ADP
ijpds-7762	165	43	valuable	valuable	ADJ
ijpds-7762	165	44	new	new	ADJ
ijpds-7762	165	45	indications	indication	NOUN
ijpds-7762	165	46	of	of	ADP
ijpds-7762	165	47	the	the	DET
ijpds-7762	165	48	same	same	ADJ
ijpds-7762	165	49	.	.	PUNCT
ijpds-7762	166	1	benevolent	benevolent	ADJ
ijpds-7762	166	2	ai	ai	NOUN
ijpds-7762	166	3	,	,	PUNCT
ijpds-7762	166	4	in	in	ADP
ijpds-7762	166	5	collaboration	collaboration	NOUN
ijpds-7762	166	6	with	with	ADP
ijpds-7762	166	7	johnson	johnson	PROPN
ijpds-7762	166	8	&	&	CCONJ
ijpds-7762	166	9	johnson	johnson	PROPN
ijpds-7762	166	10	,	,	PUNCT
ijpds-7762	166	11	has	have	AUX
ijpds-7762	166	12	been	be	AUX
ijpds-7762	166	13	redeveloping	redevelop	VERB
ijpds-7762	166	14	histamine	histamine	NOUN
ijpds-7762	166	15	h3	h3	NOUN
ijpds-7762	166	16	receptor	receptor	NOUN
ijpds-7762	166	17	inverse	inverse	NOUN
ijpds-7762	166	18	agonist	agonist	NOUN
ijpds-7762	166	19	,	,	PUNCT
ijpds-7762	166	20	bavisant	bavisant	ADJ
ijpds-7762	166	21	,	,	PUNCT
ijpds-7762	166	22	which	which	PRON
ijpds-7762	166	23	was	be	AUX
ijpds-7762	166	24	originally	originally	ADV
ijpds-7762	166	25	intended	intend	VERB
ijpds-7762	166	26	for	for	ADP
ijpds-7762	166	27	attention	attention	NOUN
ijpds-7762	166	28	deficit	deficit	NOUN
ijpds-7762	166	29	hyperactivity	hyperactivity	NOUN
ijpds-7762	166	30	disorder	disorder	NOUN
ijpds-7762	166	31	(	(	PUNCT
ijpds-7762	166	32	adhd	adhd	NOUN
ijpds-7762	166	33	)	)	PUNCT
ijpds-7762	166	34	,	,	PUNCT
ijpds-7762	166	35	and	and	CCONJ
ijpds-7762	166	36	has	have	AUX
ijpds-7762	166	37	been	be	AUX
ijpds-7762	166	38	repositioned	reposition	VERB
ijpds-7762	166	39	for	for	ADP
ijpds-7762	166	40	the	the	DET
ijpds-7762	166	41	treatment	treatment	NOUN
ijpds-7762	166	42	of	of	ADP
ijpds-7762	166	43	extreme	extreme	ADJ
ijpds-7762	166	44	daytime	daytime	ADJ
ijpds-7762	166	45	sleepiness	sleepiness	NOUN
ijpds-7762	166	46	in	in	ADP
ijpds-7762	166	47	parkinson	parkinson	NOUN
ijpds-7762	166	48	’s	’s	PART
ijpds-7762	166	49	disease	disease	NOUN
ijpds-7762	167	1	[	[	X
ijpds-7762	167	2	50	50	NUM
ijpds-7762	167	3	,	,	PUNCT
ijpds-7762	167	4	51	51	NUM
ijpds-7762	167	5	]	]	PUNCT
ijpds-7762	167	6	.	.	PUNCT
ijpds-7762	168	1	the	the	DET
ijpds-7762	168	2	synergy	synergy	NOUN
ijpds-7762	168	3	between	between	ADP
ijpds-7762	168	4	ai	ai	NOUN
ijpds-7762	168	5	and	and	CCONJ
ijpds-7762	168	6	drug	drug	NOUN
ijpds-7762	168	7	repurposing	repurposing	NOUN
ijpds-7762	168	8	is	be	AUX
ijpds-7762	168	9	therefore	therefore	ADV
ijpds-7762	168	10	of	of	ADP
ijpds-7762	168	11	paramount	paramount	ADJ
ijpds-7762	168	12	importance	importance	NOUN
ijpds-7762	168	13	for	for	ADP
ijpds-7762	168	14	addressing	address	VERB
ijpds-7762	168	15	the	the	DET
ijpds-7762	168	16	unmet	unmet	NOUN
ijpds-7762	168	17	medical	medical	ADJ
ijpds-7762	168	18	needs	need	NOUN
ijpds-7762	168	19	.	.	PUNCT
ijpds-7762	169	1	challenges	challenge	NOUN
ijpds-7762	169	2	and	and	CCONJ
ijpds-7762	169	3	obstacles	obstacle	NOUN
ijpds-7762	169	4	to	to	ADP
ijpds-7762	169	5	using	use	VERB
ijpds-7762	169	6	ai	ai	NOUN
ijpds-7762	169	7	despite	despite	SCONJ
ijpds-7762	169	8	the	the	DET
ijpds-7762	169	9	significant	significant	ADJ
ijpds-7762	169	10	potential	potential	NOUN
ijpds-7762	169	11	of	of	ADP
ijpds-7762	169	12	ai	ai	NOUN
ijpds-7762	169	13	in	in	ADP
ijpds-7762	169	14	transforming	transform	VERB
ijpds-7762	169	15	the	the	DET
ijpds-7762	169	16	landscape	landscape	NOUN
ijpds-7762	169	17	of	of	ADP
ijpds-7762	169	18	the	the	DET
ijpds-7762	169	19	pharmaceutical	pharmaceutical	NOUN
ijpds-7762	169	20	industry	industry	NOUN
ijpds-7762	169	21	,	,	PUNCT
ijpds-7762	169	22	several	several	ADJ
ijpds-7762	169	23	challenges	challenge	NOUN
ijpds-7762	169	24	are	be	AUX
ijpds-7762	169	25	prevalent	prevalent	ADJ
ijpds-7762	169	26	and	and	CCONJ
ijpds-7762	169	27	need	need	VERB
ijpds-7762	169	28	to	to	PART
ijpds-7762	169	29	be	be	AUX
ijpds-7762	169	30	addressed	address	VERB
ijpds-7762	169	31	.	.	PUNCT
ijpds-7762	170	1	a	a	DET
ijpds-7762	170	2	few	few	ADJ
ijpds-7762	170	3	of	of	ADP
ijpds-7762	170	4	the	the	DET
ijpds-7762	170	5	challenges	challenge	NOUN
ijpds-7762	170	6	include	include	VERB
ijpds-7762	170	7	resource	resource	NOUN
ijpds-7762	170	8	sustainability	sustainability	NOUN
ijpds-7762	170	9	,	,	PUNCT
ijpds-7762	170	10	the	the	DET
ijpds-7762	170	11	quality	quality	NOUN
ijpds-7762	170	12	and	and	CCONJ
ijpds-7762	170	13	suitability	suitability	NOUN
ijpds-7762	170	14	of	of	ADP
ijpds-7762	170	15	data	datum	NOUN
ijpds-7762	170	16	used	use	VERB
ijpds-7762	170	17	to	to	PART
ijpds-7762	170	18	train	train	NOUN
ijpds-7762	170	19	models	model	NOUN
ijpds-7762	170	20	,	,	PUNCT
ijpds-7762	170	21	and	and	CCONJ
ijpds-7762	170	22	potential	potential	ADJ
ijpds-7762	170	23	for	for	ADP
ijpds-7762	170	24	bias	bias	NOUN
ijpds-7762	170	25	,	,	PUNCT
ijpds-7762	170	26	all	all	PRON
ijpds-7762	170	27	of	of	ADP
ijpds-7762	170	28	which	which	PRON
ijpds-7762	170	29	could	could	AUX
ijpds-7762	170	30	result	result	VERB
ijpds-7762	170	31	in	in	ADP
ijpds-7762	170	32	unequal	unequal	ADJ
ijpds-7762	170	33	access	access	NOUN
ijpds-7762	170	34	to	to	ADP
ijpds-7762	170	35	medical	medical	ADJ
ijpds-7762	170	36	treatment	treatment	NOUN
ijpds-7762	170	37	of	of	ADP
ijpds-7762	170	38	certain	certain	ADJ
ijpds-7762	170	39	groups	group	NOUN
ijpds-7762	170	40	of	of	ADP
ijpds-7762	170	41	people	people	NOUN
ijpds-7762	170	42	,	,	PUNCT
ijpds-7762	170	43	undermining	undermine	VERB
ijpds-7762	170	44	the	the	DET
ijpds-7762	170	45	principles	principle	NOUN
ijpds-7762	170	46	of	of	ADP
ijpds-7762	170	47	equality	equality	NOUN
ijpds-7762	170	48	and	and	CCONJ
ijpds-7762	170	49	justice	justice	NOUN
ijpds-7762	171	1	[	[	X
ijpds-7762	171	2	25	25	NUM
ijpds-7762	171	3	]	]	PUNCT
ijpds-7762	171	4	.	.	PUNCT
ijpds-7762	172	1	an	an	DET
ijpds-7762	172	2	example	example	NOUN
ijpds-7762	172	3	explaining	explain	VERB
ijpds-7762	172	4	the	the	DET
ijpds-7762	172	5	likelihood	likelihood	NOUN
ijpds-7762	172	6	of	of	ADP
ijpds-7762	172	7	bias	bias	NOUN
ijpds-7762	172	8	is	be	AUX
ijpds-7762	172	9	during	during	ADP
ijpds-7762	172	10	drug	drug	NOUN
ijpds-7762	172	11	target	target	NOUN
ijpds-7762	172	12	prediction	prediction	NOUN
ijpds-7762	172	13	,	,	PUNCT
ijpds-7762	172	14	when	when	SCONJ
ijpds-7762	172	15	the	the	DET
ijpds-7762	172	16	training	training	NOUN
ijpds-7762	172	17	dataset	dataset	NOUN
ijpds-7762	172	18	contains	contain	VERB
ijpds-7762	172	19	an	an	DET
ijpds-7762	172	20	excess	excess	ADJ
ijpds-7762	172	21	amount	amount	NOUN
ijpds-7762	172	22	of	of	ADP
ijpds-7762	172	23	target	target	NOUN
ijpds-7762	172	24	data	datum	NOUN
ijpds-7762	172	25	related	relate	VERB
ijpds-7762	172	26	to	to	ADP
ijpds-7762	172	27	a	a	DET
ijpds-7762	172	28	‘	'	PUNCT
ijpds-7762	172	29	x	x	NOUN
ijpds-7762	172	30	’	'	PUNCT
ijpds-7762	172	31	disease	disease	NOUN
ijpds-7762	172	32	while	while	SCONJ
ijpds-7762	172	33	having	have	VERB
ijpds-7762	172	34	insufficient	insufficient	ADJ
ijpds-7762	172	35	data	datum	NOUN
ijpds-7762	172	36	for	for	ADP
ijpds-7762	172	37	the	the	DET
ijpds-7762	172	38	disease	disease	NOUN
ijpds-7762	172	39	‘	'	PUNCT
ijpds-7762	172	40	y	y	NOUN
ijpds-7762	172	41	’	'	PUNCT
ijpds-7762	172	42	,	,	PUNCT
ijpds-7762	172	43	the	the	DET
ijpds-7762	172	44	model	model	NOUN
ijpds-7762	172	45	may	may	AUX
ijpds-7762	172	46	agrawal	agrawal	VERB
ijpds-7762	172	47	and	and	CCONJ
ijpds-7762	172	48	kulkarni	kulkarni	PROPN
ijpds-7762	172	49	ai	ai	VERB
ijpds-7762	172	50	applications	application	NOUN
ijpds-7762	172	51	in	in	ADP
ijpds-7762	172	52	drug	drug	NOUN
ijpds-7762	172	53	discovery	discovery	NOUN
ijpds-7762	172	54	and	and	CCONJ
ijpds-7762	172	55	development	development	NOUN
ijpds-7762	172	56	online	online	PROPN
ijpds-7762	172	57	first	first	PROPN
ijpds-7762	172	58	indian	indian	PROPN
ijpds-7762	172	59	j	j	PROPN
ijpds-7762	172	60	pharm	pharm	PROPN
ijpds-7762	172	61	drug	drug	PROPN
ijpds-7762	172	62	studies	study	NOUN
ijpds-7762	172	63	|	|	ADV
ijpds-7762	172	64	5	5	NUM
ijpds-7762	172	65	predict	predict	VERB
ijpds-7762	172	66	targets	target	NOUN
ijpds-7762	172	67	for	for	ADP
ijpds-7762	172	68	the	the	DET
ijpds-7762	172	69	‘	'	PUNCT
ijpds-7762	172	70	x	x	NOUN
ijpds-7762	172	71	’	'	PUNCT
ijpds-7762	172	72	more	more	ADV
ijpds-7762	172	73	accurately	accurately	ADV
ijpds-7762	172	74	,	,	PUNCT
ijpds-7762	172	75	while	while	SCONJ
ijpds-7762	172	76	predictions	prediction	NOUN
ijpds-7762	172	77	for	for	ADP
ijpds-7762	172	78	‘	'	PUNCT
ijpds-7762	172	79	y	y	NOUN
ijpds-7762	172	80	’	'	PUNCT
ijpds-7762	172	81	may	may	AUX
ijpds-7762	172	82	be	be	AUX
ijpds-7762	172	83	biased	bias	VERB
ijpds-7762	172	84	,	,	PUNCT
ijpds-7762	172	85	thereby	thereby	ADV
ijpds-7762	172	86	affecting	affect	VERB
ijpds-7762	172	87	the	the	DET
ijpds-7762	172	88	accuracy	accuracy	NOUN
ijpds-7762	172	89	,	,	PUNCT
ijpds-7762	172	90	specificity	specificity	NOUN
ijpds-7762	172	91	,	,	PUNCT
ijpds-7762	172	92	and	and	CCONJ
ijpds-7762	172	93	efficacy	efficacy	NOUN
ijpds-7762	172	94	of	of	ADP
ijpds-7762	172	95	a	a	DET
ijpds-7762	172	96	new	new	ADJ
ijpds-7762	172	97	drug	drug	NOUN
ijpds-7762	172	98	development	development	NOUN
ijpds-7762	172	99	[	[	X
ijpds-7762	172	100	18	18	NUM
ijpds-7762	172	101	]	]	PUNCT
ijpds-7762	172	102	.	.	PUNCT
ijpds-7762	173	1	the	the	DET
ijpds-7762	173	2	use	use	NOUN
ijpds-7762	173	3	of	of	ADP
ijpds-7762	173	4	ai	ai	VERB
ijpds-7762	173	5	also	also	ADV
ijpds-7762	173	6	raises	raise	VERB
ijpds-7762	173	7	concerns	concern	NOUN
ijpds-7762	173	8	about	about	ADP
ijpds-7762	173	9	job	job	NOUN
ijpds-7762	173	10	losses	loss	NOUN
ijpds-7762	173	11	due	due	ADP
ijpds-7762	173	12	to	to	ADP
ijpds-7762	173	13	the	the	DET
ijpds-7762	173	14	emergence	emergence	NOUN
ijpds-7762	173	15	of	of	ADP
ijpds-7762	173	16	automated	automate	VERB
ijpds-7762	173	17	technologies	technology	NOUN
ijpds-7762	173	18	.	.	PUNCT
ijpds-7762	174	1	additionally	additionally	ADV
ijpds-7762	174	2	,	,	PUNCT
ijpds-7762	174	3	the	the	DET
ijpds-7762	174	4	use	use	NOUN
ijpds-7762	174	5	of	of	ADP
ijpds-7762	174	6	ai	ai	NOUN
ijpds-7762	174	7	in	in	ADP
ijpds-7762	174	8	the	the	DET
ijpds-7762	174	9	pharmaceutical	pharmaceutical	NOUN
ijpds-7762	174	10	industry	industry	NOUN
ijpds-7762	174	11	sparks	spark	VERB
ijpds-7762	174	12	debate	debate	VERB
ijpds-7762	174	13	about	about	ADP
ijpds-7762	174	14	data	datum	NOUN
ijpds-7762	174	15	privacy	privacy	NOUN
ijpds-7762	174	16	and	and	CCONJ
ijpds-7762	174	17	security	security	NOUN
ijpds-7762	174	18	breaches	breach	NOUN
ijpds-7762	174	19	.	.	PUNCT
ijpds-7762	175	1	as	as	SCONJ
ijpds-7762	175	2	ai	ai	PROPN
ijpds-7762	175	3	systems	system	NOUN
ijpds-7762	175	4	depend	depend	VERB
ijpds-7762	175	5	on	on	ADP
ijpds-7762	175	6	large	large	ADJ
ijpds-7762	175	7	amounts	amount	NOUN
ijpds-7762	175	8	of	of	ADP
ijpds-7762	175	9	data	datum	NOUN
ijpds-7762	175	10	in	in	ADP
ijpds-7762	175	11	order	order	NOUN
ijpds-7762	175	12	to	to	PART
ijpds-7762	175	13	function	function	VERB
ijpds-7762	175	14	,	,	PUNCT
ijpds-7762	175	15	the	the	DET
ijpds-7762	175	16	probability	probability	NOUN
ijpds-7762	175	17	of	of	ADP
ijpds-7762	175	18	sensitive	sensitive	ADJ
ijpds-7762	175	19	personal	personal	ADJ
ijpds-7762	175	20	information	information	NOUN
ijpds-7762	175	21	being	be	AUX
ijpds-7762	175	22	accessed	access	VERB
ijpds-7762	175	23	or	or	CCONJ
ijpds-7762	175	24	misused	misuse	VERB
ijpds-7762	175	25	increases	increase	NOUN
ijpds-7762	175	26	.	.	PUNCT
ijpds-7762	176	1	it	it	PRON
ijpds-7762	176	2	is	be	AUX
ijpds-7762	176	3	imperative	imperative	ADJ
ijpds-7762	176	4	that	that	SCONJ
ijpds-7762	176	5	the	the	DET
ijpds-7762	176	6	collection	collection	NOUN
ijpds-7762	176	7	and	and	CCONJ
ijpds-7762	176	8	use	use	NOUN
ijpds-7762	176	9	of	of	ADP
ijpds-7762	176	10	personal	personal	ADJ
ijpds-7762	176	11	data	datum	NOUN
ijpds-7762	176	12	be	be	AUX
ijpds-7762	176	13	done	do	VERB
ijpds-7762	176	14	in	in	ADP
ijpds-7762	176	15	a	a	DET
ijpds-7762	176	16	way	way	NOUN
ijpds-7762	176	17	that	that	PRON
ijpds-7762	176	18	respects	respect	VERB
ijpds-7762	176	19	the	the	DET
ijpds-7762	176	20	privacy	privacy	NOUN
ijpds-7762	176	21	of	of	ADP
ijpds-7762	176	22	individuals	individual	NOUN
ijpds-7762	176	23	and	and	CCONJ
ijpds-7762	176	24	is	be	AUX
ijpds-7762	176	25	in	in	ADP
ijpds-7762	176	26	accordance	accordance	NOUN
ijpds-7762	176	27	with	with	ADP
ijpds-7762	176	28	the	the	DET
ijpds-7762	176	29	relevant	relevant	ADJ
ijpds-7762	176	30	regulations	regulation	NOUN
ijpds-7762	176	31	[	[	X
ijpds-7762	176	32	52	52	NUM
ijpds-7762	176	33	]	]	PUNCT
ijpds-7762	176	34	.	.	PUNCT
ijpds-7762	177	1	future	future	ADJ
ijpds-7762	177	2	perspectives	perspective	NOUN
ijpds-7762	177	3	as	as	ADP
ijpds-7762	177	4	ai	ai	PRON
ijpds-7762	177	5	technology	technology	NOUN
ijpds-7762	177	6	continues	continue	VERB
ijpds-7762	177	7	to	to	PART
ijpds-7762	177	8	evolve	evolve	VERB
ijpds-7762	177	9	,	,	PUNCT
ijpds-7762	177	10	its	its	PRON
ijpds-7762	177	11	role	role	NOUN
ijpds-7762	177	12	in	in	ADP
ijpds-7762	177	13	drug	drug	NOUN
ijpds-7762	177	14	discovery	discovery	NOUN
ijpds-7762	177	15	and	and	CCONJ
ijpds-7762	177	16	other	other	ADJ
ijpds-7762	177	17	aspects	aspect	NOUN
ijpds-7762	177	18	is	be	AUX
ijpds-7762	177	19	expected	expect	VERB
ijpds-7762	177	20	to	to	PART
ijpds-7762	177	21	expand	expand	VERB
ijpds-7762	177	22	as	as	ADV
ijpds-7762	177	23	well	well	ADV
ijpds-7762	177	24	.	.	PUNCT
ijpds-7762	178	1	a	a	DET
ijpds-7762	178	2	major	major	ADJ
ijpds-7762	178	3	breakthrough	breakthrough	NOUN
ijpds-7762	178	4	was	be	AUX
ijpds-7762	178	5	sought	seek	VERB
ijpds-7762	178	6	recently	recently	ADV
ijpds-7762	178	7	when	when	SCONJ
ijpds-7762	178	8	the	the	DET
ijpds-7762	178	9	pharmaceutical	pharmaceutical	NOUN
ijpds-7762	178	10	industry	industry	NOUN
ijpds-7762	178	11	’s	’s	PART
ijpds-7762	178	12	first	first	ADJ
ijpds-7762	178	13	ai	ai	ADJ
ijpds-7762	178	14	-	-	PUNCT
ijpds-7762	178	15	driven	drive	VERB
ijpds-7762	178	16	drug	drug	NOUN
ijpds-7762	178	17	discovery	discovery	NOUN
ijpds-7762	178	18	,	,	PUNCT
ijpds-7762	178	19	developed	develop	VERB
ijpds-7762	178	20	by	by	ADP
ijpds-7762	178	21	insilico	insilico	NOUN
ijpds-7762	178	22	medicine	medicine	NOUN
ijpds-7762	178	23	,	,	PUNCT
ijpds-7762	178	24	was	be	AUX
ijpds-7762	178	25	approved	approve	VERB
ijpds-7762	178	26	by	by	ADP
ijpds-7762	178	27	the	the	DET
ijpds-7762	178	28	fda	fda	PROPN
ijpds-7762	178	29	for	for	ADP
ijpds-7762	178	30	clinical	clinical	ADJ
ijpds-7762	178	31	trials	trial	NOUN
ijpds-7762	178	32	,	,	PUNCT
ijpds-7762	178	33	which	which	PRON
ijpds-7762	178	34	is	be	AUX
ijpds-7762	178	35	in	in	ADP
ijpds-7762	178	36	phase	phase	NOUN
ijpds-7762	178	37	ii	ii	NOUN
ijpds-7762	178	38	trials	trial	NOUN
ijpds-7762	178	39	at	at	ADP
ijpds-7762	178	40	the	the	DET
ijpds-7762	178	41	moment	moment	NOUN
ijpds-7762	178	42	.	.	PUNCT
ijpds-7762	179	1	the	the	DET
ijpds-7762	179	2	drug	drug	NOUN
ijpds-7762	179	3	in	in	ADP
ijpds-7762	179	4	question	question	NOUN
ijpds-7762	179	5	is	be	AUX
ijpds-7762	179	6	rentosertib	rentosertib	ADJ
ijpds-7762	179	7	,	,	PUNCT
ijpds-7762	179	8	also	also	ADV
ijpds-7762	179	9	known	know	VERB
ijpds-7762	179	10	as	as	ADP
ijpds-7762	179	11	ism001	ism001	PROPN
ijpds-7762	179	12	-	-	PUNCT
ijpds-7762	179	13	055	055	NOUN
ijpds-7762	179	14	,	,	PUNCT
ijpds-7762	179	15	developed	develop	VERB
ijpds-7762	179	16	for	for	ADP
ijpds-7762	179	17	the	the	DET
ijpds-7762	179	18	treatment	treatment	NOUN
ijpds-7762	179	19	of	of	ADP
ijpds-7762	179	20	idiopathic	idiopathic	ADJ
ijpds-7762	179	21	pulmonary	pulmonary	ADJ
ijpds-7762	179	22	fibrosis	fibrosis	NOUN
ijpds-7762	179	23	(	(	PUNCT
ijpds-7762	179	24	ipf	ipf	NOUN
ijpds-7762	179	25	)	)	PUNCT
ijpds-7762	179	26	using	use	VERB
ijpds-7762	179	27	their	their	PRON
ijpds-7762	179	28	inhouse	inhouse	NOUN
ijpds-7762	179	29	generative	generative	NOUN
ijpds-7762	180	1	ai	ai	VERB
ijpds-7762	180	2	platform	platform	NOUN
ijpds-7762	180	3	called	call	VERB
ijpds-7762	180	4	pharma.ai	pharma.ai	PRON
ijpds-7762	181	1	[	[	X
ijpds-7762	181	2	52	52	NUM
ijpds-7762	181	3	]	]	PUNCT
ijpds-7762	181	4	.	.	PUNCT
ijpds-7762	182	1	this	this	DET
ijpds-7762	182	2	development	development	NOUN
ijpds-7762	182	3	substantially	substantially	ADV
ijpds-7762	182	4	paves	pave	VERB
ijpds-7762	182	5	the	the	DET
ijpds-7762	182	6	way	way	NOUN
ijpds-7762	182	7	for	for	ADP
ijpds-7762	182	8	further	further	ADJ
ijpds-7762	182	9	expansion	expansion	NOUN
ijpds-7762	182	10	.	.	PUNCT
ijpds-7762	183	1	latest	late	ADJ
ijpds-7762	183	2	tools	tool	NOUN
ijpds-7762	183	3	,	,	PUNCT
ijpds-7762	183	4	such	such	ADJ
ijpds-7762	183	5	as	as	ADP
ijpds-7762	183	6	quantum	quantum	NOUN
ijpds-7762	183	7	computing	computing	NOUN
ijpds-7762	183	8	,	,	PUNCT
ijpds-7762	183	9	could	could	AUX
ijpds-7762	183	10	supplement	supplement	VERB
ijpds-7762	183	11	ai	ai	VERB
ijpds-7762	183	12	’s	’s	PART
ijpds-7762	183	13	computational	computational	ADJ
ijpds-7762	183	14	abilities	ability	NOUN
ijpds-7762	183	15	,	,	PUNCT
ijpds-7762	183	16	enabling	enable	VERB
ijpds-7762	183	17	rapid	rapid	ADJ
ijpds-7762	183	18	and	and	CCONJ
ijpds-7762	183	19	more	more	ADV
ijpds-7762	183	20	precise	precise	ADJ
ijpds-7762	183	21	predictions	prediction	NOUN
ijpds-7762	183	22	[	[	X
ijpds-7762	183	23	20	20	NUM
ijpds-7762	183	24	]	]	PUNCT
ijpds-7762	183	25	.	.	PUNCT
ijpds-7762	184	1	it	it	PRON
ijpds-7762	184	2	is	be	AUX
ijpds-7762	184	3	very	very	ADV
ijpds-7762	184	4	much	much	ADV
ijpds-7762	184	5	possible	possible	ADJ
ijpds-7762	184	6	that	that	SCONJ
ijpds-7762	184	7	the	the	DET
ijpds-7762	184	8	future	future	NOUN
ijpds-7762	184	9	of	of	ADP
ijpds-7762	184	10	ai	ai	VERB
ijpds-7762	184	11	-	-	PUNCT
ijpds-7762	184	12	assisted	assist	VERB
ijpds-7762	184	13	drug	drug	NOUN
ijpds-7762	184	14	discovery	discovery	NOUN
ijpds-7762	184	15	would	would	AUX
ijpds-7762	184	16	pivot	pivot	VERB
ijpds-7762	184	17	on	on	ADP
ijpds-7762	184	18	developing	develop	VERB
ijpds-7762	184	19	a	a	DET
ijpds-7762	184	20	virtual	virtual	ADJ
ijpds-7762	184	21	human	human	NOUN
ijpds-7762	184	22	,	,	PUNCT
ijpds-7762	184	23	allowing	allow	VERB
ijpds-7762	184	24	for	for	ADP
ijpds-7762	184	25	accurate	accurate	ADJ
ijpds-7762	184	26	predictions	prediction	NOUN
ijpds-7762	184	27	of	of	ADP
ijpds-7762	184	28	all	all	DET
ijpds-7762	184	29	interactions	interaction	NOUN
ijpds-7762	184	30	between	between	ADP
ijpds-7762	184	31	drug	drug	NOUN
ijpds-7762	184	32	molecules	molecule	NOUN
ijpds-7762	184	33	and	and	CCONJ
ijpds-7762	184	34	exploring	explore	VERB
ijpds-7762	184	35	all	all	DET
ijpds-7762	184	36	therapeutic	therapeutic	ADJ
ijpds-7762	184	37	capabilities	capability	NOUN
ijpds-7762	184	38	and	and	CCONJ
ijpds-7762	184	39	adverse	adverse	ADJ
ijpds-7762	184	40	side	side	NOUN
ijpds-7762	184	41	effects	effect	NOUN
ijpds-7762	184	42	[	[	X
ijpds-7762	184	43	2	2	NUM
ijpds-7762	184	44	]	]	PUNCT
ijpds-7762	184	45	.	.	PUNCT
ijpds-7762	185	1	association	association	NOUN
ijpds-7762	185	2	between	between	ADP
ijpds-7762	185	3	ai	ai	PROPN
ijpds-7762	185	4	organizations	organization	NOUN
ijpds-7762	185	5	,	,	PUNCT
ijpds-7762	185	6	pharmaceutical	pharmaceutical	NOUN
ijpds-7762	185	7	companies	company	NOUN
ijpds-7762	185	8	,	,	PUNCT
ijpds-7762	185	9	and	and	CCONJ
ijpds-7762	185	10	policymakers	policymaker	NOUN
ijpds-7762	185	11	will	will	AUX
ijpds-7762	185	12	be	be	AUX
ijpds-7762	185	13	vital	vital	ADJ
ijpds-7762	185	14	for	for	ADP
ijpds-7762	185	15	creating	create	VERB
ijpds-7762	185	16	an	an	DET
ijpds-7762	185	17	ecosystem	ecosystem	NOUN
ijpds-7762	185	18	in	in	ADP
ijpds-7762	185	19	which	which	PRON
ijpds-7762	185	20	ai	ai	NOUN
ijpds-7762	185	21	-	-	PUNCT
ijpds-7762	185	22	powered	power	VERB
ijpds-7762	185	23	drug	drug	NOUN
ijpds-7762	185	24	discovery	discovery	NOUN
ijpds-7762	185	25	and	and	CCONJ
ijpds-7762	185	26	development	development	NOUN
ijpds-7762	185	27	becomes	become	VERB
ijpds-7762	185	28	the	the	DET
ijpds-7762	185	29	customary	customary	ADJ
ijpds-7762	185	30	standard	standard	NOUN
ijpds-7762	185	31	[	[	X
ijpds-7762	185	32	20	20	NUM
ijpds-7762	185	33	]	]	PUNCT
ijpds-7762	185	34	.	.	PUNCT
ijpds-7762	186	1	conclusion	conclusion	NOUN
ijpds-7762	186	2	artificial	artificial	ADJ
ijpds-7762	186	3	intelligence	intelligence	NOUN
ijpds-7762	186	4	has	have	VERB
ijpds-7762	186	5	a	a	DET
ijpds-7762	186	6	crucial	crucial	ADJ
ijpds-7762	186	7	role	role	NOUN
ijpds-7762	186	8	in	in	ADP
ijpds-7762	186	9	the	the	DET
ijpds-7762	186	10	various	various	ADJ
ijpds-7762	186	11	stages	stage	NOUN
ijpds-7762	186	12	of	of	ADP
ijpds-7762	186	13	drug	drug	NOUN
ijpds-7762	186	14	development	development	NOUN
ijpds-7762	186	15	,	,	PUNCT
ijpds-7762	186	16	ranging	range	VERB
ijpds-7762	186	17	from	from	ADP
ijpds-7762	186	18	drug	drug	NOUN
ijpds-7762	186	19	discovery	discovery	NOUN
ijpds-7762	186	20	,	,	PUNCT
ijpds-7762	186	21	design	design	NOUN
ijpds-7762	186	22	,	,	PUNCT
ijpds-7762	186	23	formulation	formulation	NOUN
ijpds-7762	186	24	,	,	PUNCT
ijpds-7762	186	25	clinical	clinical	ADJ
ijpds-7762	186	26	trials	trial	NOUN
ijpds-7762	186	27	,	,	PUNCT
ijpds-7762	186	28	repositioning	repositioning	NOUN
ijpds-7762	186	29	,	,	PUNCT
ijpds-7762	186	30	and	and	CCONJ
ijpds-7762	186	31	up	up	ADP
ijpds-7762	186	32	to	to	ADP
ijpds-7762	186	33	the	the	DET
ijpds-7762	186	34	final	final	ADJ
ijpds-7762	186	35	market	market	NOUN
ijpds-7762	186	36	introduction	introduction	NOUN
ijpds-7762	186	37	.	.	PUNCT
ijpds-7762	187	1	various	various	ADJ
ijpds-7762	187	2	tools	tool	NOUN
ijpds-7762	187	3	assist	assist	VERB
ijpds-7762	187	4	in	in	ADP
ijpds-7762	187	5	all	all	DET
ijpds-7762	187	6	the	the	DET
ijpds-7762	187	7	stages	stage	NOUN
ijpds-7762	187	8	,	,	PUNCT
ijpds-7762	187	9	enhancing	enhance	VERB
ijpds-7762	187	10	efficiency	efficiency	NOUN
ijpds-7762	187	11	and	and	CCONJ
ijpds-7762	187	12	outcomes	outcome	NOUN
ijpds-7762	187	13	,	,	PUNCT
ijpds-7762	187	14	while	while	SCONJ
ijpds-7762	187	15	needing	need	VERB
ijpds-7762	187	16	less	less	ADJ
ijpds-7762	187	17	time	time	NOUN
ijpds-7762	187	18	and	and	CCONJ
ijpds-7762	187	19	man	man	NOUN
ijpds-7762	187	20	-	-	PUNCT
ijpds-7762	187	21	power	power	NOUN
ijpds-7762	187	22	.	.	PUNCT
ijpds-7762	188	1	forging	forge	VERB
ijpds-7762	188	2	ahead	ahead	ADV
ijpds-7762	188	3	,	,	PUNCT
ijpds-7762	188	4	there	there	PRON
ijpds-7762	188	5	is	be	VERB
ijpds-7762	188	6	a	a	DET
ijpds-7762	188	7	need	need	NOUN
ijpds-7762	188	8	to	to	PART
ijpds-7762	188	9	strengthen	strengthen	VERB
ijpds-7762	188	10	data	datum	NOUN
ijpds-7762	188	11	management	management	NOUN
ijpds-7762	188	12	,	,	PUNCT
ijpds-7762	188	13	elucidate	elucidate	VERB
ijpds-7762	188	14	superior	superior	ADJ
ijpds-7762	188	15	ai	ai	NOUN
ijpds-7762	188	16	models	model	NOUN
ijpds-7762	188	17	,	,	PUNCT
ijpds-7762	188	18	ensuring	ensure	VERB
ijpds-7762	188	19	vigorous	vigorous	ADJ
ijpds-7762	188	20	ethical	ethical	ADJ
ijpds-7762	188	21	and	and	CCONJ
ijpds-7762	188	22	legal	legal	ADJ
ijpds-7762	188	23	considerations	consideration	NOUN
ijpds-7762	188	24	,	,	PUNCT
ijpds-7762	188	25	with	with	ADP
ijpds-7762	188	26	the	the	DET
ijpds-7762	188	27	aim	aim	NOUN
ijpds-7762	188	28	of	of	ADP
ijpds-7762	188	29	sustainable	sustainable	ADJ
ijpds-7762	188	30	and	and	CCONJ
ijpds-7762	188	31	robust	robust	ADJ
ijpds-7762	188	32	development	development	NOUN
ijpds-7762	188	33	of	of	ADP
ijpds-7762	188	34	ai	ai	NOUN
ijpds-7762	188	35	in	in	ADP
ijpds-7762	188	36	the	the	DET
ijpds-7762	188	37	pharmaceutical	pharmaceutical	ADJ
ijpds-7762	188	38	industry	industry	NOUN
ijpds-7762	188	39	.	.	PUNCT
ijpds-7762	189	1	references	reference	NOUN
ijpds-7762	189	2	1	1	NUM
ijpds-7762	189	3	.	.	X
ijpds-7762	189	4	ali	ali	PROPN
ijpds-7762	189	5	,	,	PUNCT
ijpds-7762	189	6	k.a	k.a	PROPN
ijpds-7762	189	7	.	.	PROPN
ijpds-7762	189	8	,	,	PUNCT
ijpds-7762	189	9	mohin	mohin	PROPN
ijpds-7762	189	10	,	,	PUNCT
ijpds-7762	189	11	s.	s.	PROPN
ijpds-7762	189	12	,	,	PUNCT
ijpds-7762	189	13	mondal	mondal	PROPN
ijpds-7762	189	14	,	,	PUNCT
ijpds-7762	189	15	p.	p.	NOUN
ijpds-7762	189	16	et	et	NOUN
ijpds-7762	190	1	al	al	PROPN
ijpds-7762	190	2	.	.	PROPN
ijpds-7762	190	3	influence	influence	NOUN
ijpds-7762	190	4	of	of	ADP
ijpds-7762	190	5	artificial	artificial	ADJ
ijpds-7762	190	6	intelligence	intelligence	NOUN
ijpds-7762	190	7	in	in	ADP
ijpds-7762	190	8	modern	modern	ADJ
ijpds-7762	190	9	pharmaceutical	pharmaceutical	ADJ
ijpds-7762	190	10	formulation	formulation	NOUN
ijpds-7762	190	11	and	and	CCONJ
ijpds-7762	190	12	drug	drug	NOUN
ijpds-7762	190	13	development	development	NOUN
ijpds-7762	190	14	.	.	PUNCT
ijpds-7762	191	1	futur	futur	PROPN
ijpds-7762	191	2	j	j	PROPN
ijpds-7762	191	3	pharm	pharm	PROPN
ijpds-7762	191	4	sci	sci	PROPN
ijpds-7762	191	5	.	.	PUNCT
ijpds-7762	191	6	2024;10:53	2024;10:53	NUM
ijpds-7762	191	7	.	.	PUNCT
ijpds-7762	192	1	doi:10.1186	doi:10.1186	PROPN
ijpds-7762	192	2	/	/	SYM
ijpds-7762	192	3	s43094	s43094	NOUN
ijpds-7762	192	4	-	-	PUNCT
ijpds-7762	192	5	024	024	NUM
ijpds-7762	192	6	-	-	PUNCT
ijpds-7762	192	7	00625	00625	NUM
ijpds-7762	192	8	-	-	SYM
ijpds-7762	192	9	1	1	NUM
ijpds-7762	192	10	2	2	NUM
ijpds-7762	192	11	.	.	PUNCT
ijpds-7762	193	1	blanco	blanco	PROPN
ijpds-7762	193	2	-	-	PUNCT
ijpds-7762	193	3	gonzález	gonzález	PROPN
ijpds-7762	193	4	a	a	PRON
ijpds-7762	193	5	,	,	PUNCT
ijpds-7762	193	6	cabezón	cabezón	PROPN
ijpds-7762	193	7	a	a	DET
ijpds-7762	193	8	,	,	PUNCT
ijpds-7762	193	9	seco	seco	PROPN
ijpds-7762	193	10	-	-	PROPN
ijpds-7762	193	11	gonzález	gonzález	PROPN
ijpds-7762	193	12	a	a	PRON
ijpds-7762	193	13	,	,	PUNCT
ijpds-7762	193	14	et	et	PROPN
ijpds-7762	193	15	al	al	PROPN
ijpds-7762	193	16	.	.	PUNCT
ijpds-7762	194	1	the	the	DET
ijpds-7762	194	2	role	role	NOUN
ijpds-7762	194	3	of	of	ADP
ijpds-7762	194	4	ai	ai	VERB
ijpds-7762	194	5	in	in	ADP
ijpds-7762	194	6	drug	drug	NOUN
ijpds-7762	194	7	discovery	discovery	NOUN
ijpds-7762	194	8	:	:	PUNCT
ijpds-7762	194	9	challenges	challenge	NOUN
ijpds-7762	194	10	,	,	PUNCT
ijpds-7762	194	11	opportunities	opportunity	NOUN
ijpds-7762	194	12	,	,	PUNCT
ijpds-7762	194	13	and	and	CCONJ
ijpds-7762	194	14	strategies	strategy	NOUN
ijpds-7762	194	15	.	.	PUNCT
ijpds-7762	195	1	pharmaceuticals	pharmaceutical	NOUN
ijpds-7762	195	2	.	.	PUNCT
ijpds-7762	196	1	2023	2023	NUM
ijpds-7762	196	2	jun	jun	PROPN
ijpds-7762	196	3	18;16(6):891	18;16(6):891	NUM
ijpds-7762	196	4	.	.	PUNCT
ijpds-7762	197	1	doi	doi	NOUN
ijpds-7762	197	2	:	:	PUNCT
ijpds-7762	197	3	10.3390	10.3390	NUM
ijpds-7762	197	4	/	/	SYM
ijpds-7762	197	5	ph16060891	ph16060891	NOUN
ijpds-7762	197	6	.	.	PUNCT
ijpds-7762	198	1	pmid	pmid	NOUN
ijpds-7762	198	2	:	:	PUNCT
ijpds-7762	198	3	37375838	37375838	NUM
ijpds-7762	198	4	;	;	PUNCT
ijpds-7762	198	5	pmcid	pmcid	ADJ
ijpds-7762	198	6	:	:	PUNCT
ijpds-7762	198	7	pmc10302890	pmc10302890	NOUN
ijpds-7762	198	8	.	.	PUNCT
ijpds-7762	199	1	3	3	X
ijpds-7762	199	2	.	.	X
ijpds-7762	199	3	khan	khan	PROPN
ijpds-7762	199	4	sr	sr	PROPN
ijpds-7762	199	5	,	,	PUNCT
ijpds-7762	199	6	baghdasarian	baghdasarian	PROPN
ijpds-7762	199	7	a	a	PRON
ijpds-7762	199	8	,	,	PUNCT
ijpds-7762	199	9	fahlman	fahlman	NOUN
ijpds-7762	199	10	rp	rp	NOUN
ijpds-7762	199	11	,	,	PUNCT
ijpds-7762	199	12	et	et	PROPN
ijpds-7762	199	13	al	al	PROPN
ijpds-7762	199	14	.	.	PUNCT
ijpds-7762	199	15	current	current	ADJ
ijpds-7762	199	16	status	status	NOUN
ijpds-7762	199	17	and	and	CCONJ
ijpds-7762	199	18	future	future	ADJ
ijpds-7762	199	19	prospects	prospect	NOUN
ijpds-7762	199	20	of	of	ADP
ijpds-7762	199	21	toxicogenomics	toxicogenomic	NOUN
ijpds-7762	199	22	in	in	ADP
ijpds-7762	199	23	drug	drug	NOUN
ijpds-7762	199	24	discovery	discovery	NOUN
ijpds-7762	199	25	.	.	PUNCT
ijpds-7762	200	1	drug	drug	NOUN
ijpds-7762	200	2	discov	discov	NOUN
ijpds-7762	200	3	.	.	PUNCT
ijpds-7762	201	1	today	today	NOUN
ijpds-7762	201	2	.	.	PUNCT
ijpds-7762	202	1	2014	2014	NUM
ijpds-7762	202	2	may	may	AUX
ijpds-7762	202	3	1;19(5):56278.doi:10.1016	1;19(5):56278.doi:10.1016	NUM
ijpds-7762	202	4	/	/	SYM
ijpds-7762	202	5	j.drudis	j.drudi	NOUN
ijpds-7762	202	6	.	.	PUNCT
ijpds-7762	203	1	2013.11.001	2013.11.001	NUM
ijpds-7762	203	2	.	.	PUNCT
ijpds-7762	204	1	4	4	X
ijpds-7762	204	2	.	.	PUNCT
ijpds-7762	204	3	j.	j.	PROPN
ijpds-7762	204	4	a.	a.	PROPN
ijpds-7762	204	5	dimasi	dimasi	PROPN
ijpds-7762	204	6	,	,	PUNCT
ijpds-7762	204	7	h.	h.	PROPN
ijpds-7762	204	8	g.	g.	PROPN
ijpds-7762	204	9	grabowski	grabowski	PROPN
ijpds-7762	204	10	,	,	PUNCT
ijpds-7762	204	11	r.	r.	PROPN
ijpds-7762	204	12	w.	w.	PROPN
ijpds-7762	204	13	hansen	hansen	PROPN
ijpds-7762	204	14	.	.	PROPN
ijpds-7762	205	1	integrated	integrate	VERB
ijpds-7762	205	2	continuous	continuous	ADJ
ijpds-7762	205	3	pharmaceutical	pharmaceutical	ADJ
ijpds-7762	205	4	technologies	technology	NOUN
ijpds-7762	205	5	—	—	PUNCT
ijpds-7762	205	6	a	a	DET
ijpds-7762	205	7	review	review	NOUN
ijpds-7762	205	8	.	.	PUNCT
ijpds-7762	206	1	j	j	PROPN
ijpds-7762	206	2	health	health	PROPN
ijpds-7762	206	3	econ	econ	PROPN
ijpds-7762	206	4	.	.	PUNCT
ijpds-7762	207	1	2016;47:20	2016;47:20	NUM
ijpds-7762	207	2	-	-	SYM
ijpds-7762	207	3	33	33	NUM
ijpds-7762	207	4	.	.	PUNCT
ijpds-7762	208	1	doi:10.1016	doi:10.1016	PROPN
ijpds-7762	208	2	/	/	SYM
ijpds-7762	208	3	j.jhealeco.2016.01.012	j.jhealeco.2016.01.012	PROPN
ijpds-7762	208	4	.	.	PROPN
ijpds-7762	209	1	5	5	NUM
ijpds-7762	209	2	.	.	X
ijpds-7762	209	3	m.	m.	NOUN
ijpds-7762	209	4	bordukova	bordukova	PROPN
ijpds-7762	209	5	,	,	PUNCT
ijpds-7762	209	6	n.	n.	PROPN
ijpds-7762	209	7	makarov	makarov	PROPN
ijpds-7762	209	8	,	,	PUNCT
ijpds-7762	209	9	r.	r.	PROPN
ijpds-7762	209	10	rodriguez	rodriguez	PROPN
ijpds-7762	209	11	-	-	PUNCT
ijpds-7762	209	12	esteban	esteban	PROPN
ijpds-7762	209	13	,	,	PUNCT
ijpds-7762	209	14	et	et	PROPN
ijpds-7762	209	15	al	al	PROPN
ijpds-7762	209	16	.	.	PROPN
ijpds-7762	210	1	generative	generative	ADJ
ijpds-7762	210	2	artificial	artificial	ADJ
ijpds-7762	210	3	intelligence	intelligence	NOUN
ijpds-7762	210	4	empowers	empower	VERB
ijpds-7762	210	5	digital	digital	ADJ
ijpds-7762	210	6	twins	twin	NOUN
ijpds-7762	210	7	in	in	ADP
ijpds-7762	210	8	drug	drug	NOUN
ijpds-7762	210	9	discovery	discovery	NOUN
ijpds-7762	210	10	and	and	CCONJ
ijpds-7762	210	11	clinical	clinical	ADJ
ijpds-7762	210	12	trials	trial	NOUN
ijpds-7762	210	13	.	.	PUNCT
ijpds-7762	211	1	expert	expert	NOUN
ijpds-7762	211	2	opin	opin	NOUN
ijpds-7762	211	3	drug	drug	NOUN
ijpds-7762	211	4	discov	discov	NOUN
ijpds-7762	211	5	.	.	PUNCT
ijpds-7762	212	1	2024;19:33–42	2024;19:33–42	NUM
ijpds-7762	212	2	.	.	PUNCT
ijpds-7762	212	3	doi:10	doi:10	PROPN
ijpds-7762	212	4	.	.	PUNCT
ijpds-7762	213	1	1080/17460441.2023.2273839	1080/17460441.2023.2273839	NUM
ijpds-7762	213	2	.	.	PUNCT
ijpds-7762	214	1	6	6	NUM
ijpds-7762	214	2	.	.	X
ijpds-7762	214	3	b.	b.	PROPN
ijpds-7762	214	4	w.	w.	PROPN
ijpds-7762	214	5	wirtz	wirtz	PROPN
ijpds-7762	214	6	,	,	PUNCT
ijpds-7762	214	7	j.	j.	PROPN
ijpds-7762	214	8	c.	c.	PROPN
ijpds-7762	214	9	weyerer	weyerer	PROPN
ijpds-7762	214	10	,	,	PUNCT
ijpds-7762	214	11	c.	c.	PROPN
ijpds-7762	214	12	geyer	geyer	PROPN
ijpds-7762	214	13	.	.	PUNCT
ijpds-7762	215	1	role	role	NOUN
ijpds-7762	215	2	of	of	ADP
ijpds-7762	215	3	ai	ai	VERB
ijpds-7762	215	4	in	in	ADP
ijpds-7762	215	5	drug	drug	NOUN
ijpds-7762	215	6	discovery	discovery	NOUN
ijpds-7762	215	7	.	.	PUNCT
ijpds-7762	216	1	ijpa	ijpa	PROPN
ijpds-7762	216	2	.	.	PUNCT
ijpds-7762	216	3	2019;42:596–615	2019;42:596–615	PROPN
ijpds-7762	216	4	.	.	PUNCT
ijpds-7762	216	5	doi:10.1080/01900692	doi:10.1080/01900692	PROPN
ijpds-7762	216	6	.	.	PUNCT
ijpds-7762	217	1	2018.1498103	2018.1498103	NUM
ijpds-7762	217	2	.	.	PUNCT
ijpds-7762	218	1	7	7	X
ijpds-7762	218	2	.	.	X
ijpds-7762	218	3	xu	xu	PROPN
ijpds-7762	219	1	y	y	PROPN
ijpds-7762	219	2	,	,	PUNCT
ijpds-7762	219	3	liu	liu	PROPN
ijpds-7762	219	4	x	x	PROPN
ijpds-7762	219	5	,	,	PUNCT
ijpds-7762	219	6	cao	cao	PROPN
ijpds-7762	219	7	x	x	PROPN
ijpds-7762	219	8	,	,	PUNCT
ijpds-7762	219	9	et	et	PROPN
ijpds-7762	219	10	al	al	PROPN
ijpds-7762	219	11	.	.	PUNCT
ijpds-7762	219	12	artificial	artificial	ADJ
ijpds-7762	219	13	intelligence	intelligence	NOUN
ijpds-7762	219	14	:	:	PUNCT
ijpds-7762	219	15	a	a	DET
ijpds-7762	219	16	powerful	powerful	ADJ
ijpds-7762	219	17	paradigm	paradigm	NOUN
ijpds-7762	219	18	for	for	ADP
ijpds-7762	219	19	scientific	scientific	ADJ
ijpds-7762	219	20	research	research	NOUN
ijpds-7762	219	21	.	.	PUNCT
ijpds-7762	220	1	innovation	innovation	NOUN
ijpds-7762	220	2	.	.	PUNCT
ijpds-7762	221	1	2021	2021	NUM
ijpds-7762	221	2	oct	oct	PROPN
ijpds-7762	221	3	28;2(4):100179	28;2(4):100179	PROPN
ijpds-7762	221	4	.	.	PUNCT
ijpds-7762	222	1	doi	doi	NOUN
ijpds-7762	222	2	:	:	PUNCT
ijpds-7762	222	3	10.1016	10.1016	NUM
ijpds-7762	222	4	/	/	SYM
ijpds-7762	222	5	j.xinn.2021.100179	j.xinn.2021.100179	PROPN
ijpds-7762	222	6	.	.	PUNCT
ijpds-7762	223	1	8	8	X
ijpds-7762	223	2	.	.	PUNCT
ijpds-7762	223	3	pu	pu	PROPN
ijpds-7762	223	4	l	l	PROPN
ijpds-7762	223	5	,	,	PUNCT
ijpds-7762	223	6	naderi	naderi	PROPN
ijpds-7762	223	7	m	m	PROPN
ijpds-7762	223	8	,	,	PUNCT
ijpds-7762	223	9	liu	liu	PROPN
ijpds-7762	223	10	t	t	PROPN
ijpds-7762	223	11	,	,	PUNCT
ijpds-7762	223	12	wu	wu	PROPN
ijpds-7762	223	13	hc	hc	PROPN
ijpds-7762	223	14	,	,	PUNCT
ijpds-7762	223	15	et	et	PROPN
ijpds-7762	223	16	al	al	PROPN
ijpds-7762	223	17	.	.	PUNCT
ijpds-7762	224	1	a	a	DET
ijpds-7762	224	2	machine	machine	NOUN
ijpds-7762	224	3	learning	learning	NOUN
ijpds-7762	224	4	-	-	PUNCT
ijpds-7762	224	5	based	base	VERB
ijpds-7762	224	6	approach	approach	NOUN
ijpds-7762	224	7	to	to	PART
ijpds-7762	224	8	estimate	estimate	VERB
ijpds-7762	224	9	the	the	DET
ijpds-7762	224	10	toxicity	toxicity	NOUN
ijpds-7762	224	11	of	of	ADP
ijpds-7762	224	12	drug	drug	NOUN
ijpds-7762	224	13	candidates	candidate	NOUN
ijpds-7762	224	14	.	.	PUNCT
ijpds-7762	225	1	bmc	bmc	PROPN
ijpds-7762	225	2	pharmacol	pharmacol	PROPN
ijpds-7762	225	3	toxicol	toxicol	PROPN
ijpds-7762	225	4	.	.	PUNCT
ijpds-7762	226	1	2019	2019	NUM
ijpds-7762	226	2	jan	jan	PROPN
ijpds-7762	226	3	8;20(1):2	8;20(1):2	NUM
ijpds-7762	226	4	.	.	PUNCT
ijpds-7762	227	1	doi	doi	NOUN
ijpds-7762	227	2	:	:	PUNCT
ijpds-7762	227	3	10.1186	10.1186	NUM
ijpds-7762	227	4	/	/	SYM
ijpds-7762	227	5	s40360	s40360	PROPN
ijpds-7762	227	6	-	-	PUNCT
ijpds-7762	227	7	0180282	0180282	NUM
ijpds-7762	227	8	-	-	PUNCT
ijpds-7762	227	9	6	6	NUM
ijpds-7762	227	10	.	.	NOUN
ijpds-7762	227	11	9	9	NUM
ijpds-7762	227	12	.	.	X
ijpds-7762	227	13	m.	m.	NOUN
ijpds-7762	227	14	j.	j.	PROPN
ijpds-7762	227	15	lamberti	lamberti	PROPN
ijpds-7762	227	16	,	,	PUNCT
ijpds-7762	227	17	m.	m.	PROPN
ijpds-7762	227	18	wilkinson	wilkinson	PROPN
ijpds-7762	227	19	,	,	PUNCT
ijpds-7762	227	20	b.	b.	PROPN
ijpds-7762	227	21	a.	a.	PROPN
ijpds-7762	227	22	donzanti	donzanti	PROPN
ijpds-7762	227	23	,	,	PUNCT
ijpds-7762	227	24	g.	g.	PROPN
ijpds-7762	227	25	e.	e.	PROPN
ijpds-7762	227	26	,	,	PUNCT
ijpds-7762	227	27	et	et	PROPN
ijpds-7762	227	28	al	al	PROPN
ijpds-7762	227	29	.	.	PUNCT
ijpds-7762	228	1	a	a	DET
ijpds-7762	228	2	study	study	NOUN
ijpds-7762	228	3	on	on	ADP
ijpds-7762	228	4	the	the	DET
ijpds-7762	228	5	application	application	NOUN
ijpds-7762	228	6	and	and	CCONJ
ijpds-7762	228	7	use	use	NOUN
ijpds-7762	228	8	of	of	ADP
ijpds-7762	228	9	artificial	artificial	ADJ
ijpds-7762	228	10	intelligence	intelligence	NOUN
ijpds-7762	228	11	to	to	PART
ijpds-7762	228	12	support	support	VERB
ijpds-7762	228	13	.	.	PUNCT
ijpds-7762	229	1	drug	drug	NOUN
ijpds-7762	229	2	development	development	PROPN
ijpds-7762	229	3	.	.	PUNCT
ijpds-7762	230	1	clin	clin	PROPN
ijpds-7762	230	2	ther	ther	ADV
ijpds-7762	230	3	.	.	PUNCT
ijpds-7762	231	1	2019;41:1414–1426	2019;41:1414–1426	X
ijpds-7762	231	2	.	.	PUNCT
ijpds-7762	232	1	doi:10	doi:10	PROPN
ijpds-7762	232	2	.	.	PUNCT
ijpds-7762	233	1	1016	1016	NUM
ijpds-7762	233	2	/	/	SYM
ijpds-7762	233	3	j.clinthera.2019.05.018	j.clinthera.2019.05.018	PROPN
ijpds-7762	233	4	.	.	PUNCT
ijpds-7762	234	1	10	10	NUM
ijpds-7762	234	2	.	.	PUNCT
ijpds-7762	235	1	s.	s.	PROPN
ijpds-7762	235	2	padte	padte	PROPN
ijpds-7762	235	3	,	,	PUNCT
ijpds-7762	235	4	v.	v.	ADP
ijpds-7762	235	5	samala	samala	PROPN
ijpds-7762	235	6	venkata	venkata	PROPN
ijpds-7762	235	7	,	,	PUNCT
ijpds-7762	235	8	p.	p.	PROPN
ijpds-7762	235	9	mehta	mehta	PROPN
ijpds-7762	235	10	,	,	PUNCT
ijpds-7762	235	11	et	et	PROPN
ijpds-7762	235	12	al	al	PROPN
ijpds-7762	235	13	.	.	PROPN
ijpds-7762	235	14	21st	21st	ADJ
ijpds-7762	235	15	century	century	NOUN
ijpds-7762	235	16	critical	critical	ADJ
ijpds-7762	235	17	care	care	NOUN
ijpds-7762	235	18	medicine	medicine	NOUN
ijpds-7762	235	19	:	:	PUNCT
ijpds-7762	235	20	an	an	DET
ijpds-7762	235	21	overview	overview	NOUN
ijpds-7762	235	22	,	,	PUNCT
ijpds-7762	235	23	world	world	NOUN
ijpds-7762	235	24	j.	j.	PROPN
ijpds-7762	235	25	crit	crit	PROPN
ijpds-7762	235	26	.	.	PUNCT
ijpds-7762	236	1	care	care	PROPN
ijpds-7762	236	2	med	med	PROPN
ijpds-7762	236	3	.	.	PUNCT
ijpds-7762	237	1	2024	2024	NUM
ijpds-7762	237	2	.	.	PUNCT
ijpds-7762	238	1	90176	90176	NUM
ijpds-7762	238	2	.	.	PUNCT
ijpds-7762	239	1	doi	doi	NOUN
ijpds-7762	239	2	:	:	PUNCT
ijpds-7762	239	3	10.5492	10.5492	NUM
ijpds-7762	239	4	/	/	SYM
ijpds-7762	239	5	wjccm.v13.i1.90176	wjccm.v13.i1.90176	NOUN
ijpds-7762	239	6	.	.	PUNCT
ijpds-7762	240	1	11	11	NUM
ijpds-7762	240	2	.	.	PUNCT
ijpds-7762	240	3	sutiene	sutiene	PROPN
ijpds-7762	240	4	k	k	NOUN
ijpds-7762	240	5	,	,	PUNCT
ijpds-7762	240	6	schwendner	schwendner	NOUN
ijpds-7762	240	7	p	p	NOUN
ijpds-7762	240	8	,	,	PUNCT
ijpds-7762	240	9	sipos	sipos	NOUN
ijpds-7762	240	10	c	c	NOUN
ijpds-7762	240	11	,	,	PUNCT
ijpds-7762	240	12	et	et	PROPN
ijpds-7762	240	13	al	al	PROPN
ijpds-7762	240	14	.	.	PROPN
ijpds-7762	240	15	enhancing	enhance	VERB
ijpds-7762	240	16	portfolio	portfolio	NOUN
ijpds-7762	240	17	management	management	NOUN
ijpds-7762	240	18	using	use	VERB
ijpds-7762	240	19	artificial	artificial	ADJ
ijpds-7762	240	20	intelligence	intelligence	NOUN
ijpds-7762	240	21	:	:	PUNCT
ijpds-7762	240	22	literature	literature	PROPN
ijpds-7762	240	23	review	review	PROPN
ijpds-7762	240	24	.	.	PUNCT
ijpds-7762	241	1	front	front	ADJ
ijpds-7762	241	2	artif	artif	PROPN
ijpds-7762	241	3	intell	intell	PROPN
ijpds-7762	241	4	.	.	PUNCT
ijpds-7762	242	1	2024	2024	NUM
ijpds-7762	242	2	apr	apr	NOUN
ijpds-7762	242	3	8;7:1371502	8;7:1371502	NUM
ijpds-7762	242	4	.	.	PUNCT
ijpds-7762	243	1	doi	doi	NOUN
ijpds-7762	243	2	:	:	PUNCT
ijpds-7762	243	3	10.3389	10.3389	NUM
ijpds-7762	243	4	/	/	SYM
ijpds-7762	243	5	frai.2024.1371502	frai.2024.1371502	NOUN
ijpds-7762	243	6	.	.	PUNCT
ijpds-7762	244	1	12	12	NUM
ijpds-7762	244	2	.	.	PUNCT
ijpds-7762	245	1	ding	ding	PROPN
ijpds-7762	245	2	h	h	PROPN
ijpds-7762	245	3	,	,	PUNCT
ijpds-7762	245	4	tian	tian	PROPN
ijpds-7762	245	5	j	j	PROPN
ijpds-7762	245	6	,	,	PUNCT
ijpds-7762	245	7	yu	yu	PROPN
ijpds-7762	245	8	w	w	PROPN
ijpds-7762	245	9	,	,	PUNCT
ijpds-7762	245	10	wilson	wilson	PROPN
ijpds-7762	245	11	di	di	PROPN
ijpds-7762	245	12	,	,	PUNCT
ijpds-7762	245	13	et	et	PROPN
ijpds-7762	245	14	al	al	PROPN
ijpds-7762	245	15	.	.	PUNCT
ijpds-7762	246	1	the	the	DET
ijpds-7762	246	2	application	application	NOUN
ijpds-7762	246	3	of	of	ADP
ijpds-7762	246	4	artificial	artificial	ADJ
ijpds-7762	246	5	intelligence	intelligence	NOUN
ijpds-7762	246	6	and	and	CCONJ
ijpds-7762	246	7	big	big	ADJ
ijpds-7762	246	8	data	datum	NOUN
ijpds-7762	246	9	in	in	ADP
ijpds-7762	246	10	the	the	DET
ijpds-7762	246	11	food	food	NOUN
ijpds-7762	246	12	industry	industry	NOUN
ijpds-7762	246	13	.	.	PUNCT
ijpds-7762	247	1	foods	food	NOUN
ijpds-7762	247	2	.	.	PUNCT
ijpds-7762	248	1	2023	2023	NUM
ijpds-7762	248	2	dec	dec	PROPN
ijpds-7762	248	3	18;12(24):4511	18;12(24):4511	NUM
ijpds-7762	248	4	.	.	PUNCT
ijpds-7762	249	1	doi	doi	NOUN
ijpds-7762	249	2	:	:	PUNCT
ijpds-7762	249	3	10.3390	10.3390	NUM
ijpds-7762	249	4	/	/	SYM
ijpds-7762	249	5	foods12244511	foods12244511	PROPN
ijpds-7762	249	6	.	.	PUNCT
ijpds-7762	250	1	13	13	NUM
ijpds-7762	250	2	.	.	X
ijpds-7762	250	3	sierpe	sierpe	PROPN
ijpds-7762	250	4	a	a	PRON
ijpds-7762	250	5	,	,	PUNCT
ijpds-7762	250	6	yen	yen	NOUN
ijpds-7762	250	7	rw	rw	NOUN
ijpds-7762	250	8	,	,	PUNCT
ijpds-7762	250	9	stevens	stevens	PROPN
ijpds-7762	250	10	g	g	PROPN
ijpds-7762	250	11	,	,	PUNCT
ijpds-7762	250	12	et	et	PROPN
ijpds-7762	250	13	al	al	PROPN
ijpds-7762	250	14	.	.	PUNCT
ijpds-7762	251	1	agenda	agenda	NOUN
ijpds-7762	251	2	-	-	PUNCT
ijpds-7762	251	3	setting	setting	NOUN
ijpds-7762	251	4	in	in	ADP
ijpds-7762	251	5	the	the	DET
ijpds-7762	251	6	clinical	clinical	ADJ
ijpds-7762	251	7	encounter	encounter	NOUN
ijpds-7762	251	8	:	:	PUNCT
ijpds-7762	251	9	a	a	DET
ijpds-7762	251	10	systematic	systematic	ADJ
ijpds-7762	251	11	review	review	NOUN
ijpds-7762	251	12	protocol	protocol	NOUN
ijpds-7762	251	13	.	.	PUNCT
ijpds-7762	252	1	plos	plos	PROPN
ijpds-7762	252	2	one	one	NUM
ijpds-7762	252	3	.	.	PUNCT
ijpds-7762	253	1	2024	2024	NUM
ijpds-7762	253	2	oct	oct	PROPN
ijpds-7762	253	3	24;19(10):e0312613	24;19(10):e0312613	NUM
ijpds-7762	253	4	.	.	PUNCT
ijpds-7762	253	5	doi	doi	NOUN
ijpds-7762	253	6	:	:	PUNCT
ijpds-7762	253	7	10.1371	10.1371	NUM
ijpds-7762	253	8	/	/	SYM
ijpds-7762	253	9	journal.pone.0312613	journal.pone.0312613	PROPN
ijpds-7762	253	10	.	.	PROPN
ijpds-7762	253	11	14	14	NUM
ijpds-7762	253	12	.	.	PUNCT
ijpds-7762	254	1	gonzález	gonzález	PROPN
ijpds-7762	254	2	garcía	garcía	PROPN
ijpds-7762	254	3	c	c	PROPN
ijpds-7762	254	4	,	,	PUNCT
ijpds-7762	254	5	núñez	núñez	PROPN
ijpds-7762	254	6	valdéz	valdéz	PROPN
ijpds-7762	254	7	er	er	INTJ
ijpds-7762	254	8	,	,	PUNCT
ijpds-7762	254	9	garcía	garcía	ADJ
ijpds-7762	254	10	díaz	díaz	PROPN
ijpds-7762	254	11	v	v	PROPN
ijpds-7762	254	12	,	,	PUNCT
ijpds-7762	254	13	et	et	PROPN
ijpds-7762	254	14	al	al	PROPN
ijpds-7762	254	15	.	.	PUNCT
ijpds-7762	255	1	a	a	DET
ijpds-7762	255	2	review	review	NOUN
ijpds-7762	255	3	of	of	ADP
ijpds-7762	255	4	artificial	artificial	ADJ
ijpds-7762	255	5	intelligence	intelligence	NOUN
ijpds-7762	255	6	in	in	ADP
ijpds-7762	255	7	the	the	DET
ijpds-7762	255	8	internet	internet	NOUN
ijpds-7762	255	9	of	of	ADP
ijpds-7762	255	10	things	thing	NOUN
ijpds-7762	255	11	.	.	PUNCT
ijpds-7762	256	1	ijimai	ijimai	PROPN
ijpds-7762	256	2	.	.	PUNCT
ijpds-7762	257	1	2019;5:9–20	2019;5:9–20	NUM
ijpds-7762	257	2	.	.	PUNCT
ijpds-7762	258	1	doi	doi	NOUN
ijpds-7762	258	2	:	:	PUNCT
ijpds-7762	258	3	10.9781	10.9781	NUM
ijpds-7762	258	4	/	/	SYM
ijpds-7762	258	5	ijimai.2018.03.004	ijimai.2018.03.004	NOUN
ijpds-7762	258	6	15	15	NUM
ijpds-7762	258	7	.	.	PUNCT
ijpds-7762	259	1	bellini	bellini	PROPN
ijpds-7762	259	2	v	v	NOUN
ijpds-7762	259	3	,	,	PUNCT
ijpds-7762	259	4	rafano	rafano	ADJ
ijpds-7762	259	5	carnà	carnà	PROPN
ijpds-7762	259	6	e	e	NOUN
ijpds-7762	259	7	,	,	PUNCT
ijpds-7762	259	8	russo	russo	PROPN
ijpds-7762	259	9	m	m	PROPN
ijpds-7762	259	10	,	,	PUNCT
ijpds-7762	259	11	et	et	PROPN
ijpds-7762	259	12	al	al	PROPN
ijpds-7762	259	13	.	.	PUNCT
ijpds-7762	259	14	artificial	artificial	ADJ
ijpds-7762	259	15	intelligence	intelligence	NOUN
ijpds-7762	259	16	and	and	CCONJ
ijpds-7762	259	17	anesthesia	anesthesia	PROPN
ijpds-7762	259	18	:	:	PUNCT
ijpds-7762	259	19	a	a	DET
ijpds-7762	259	20	narrative	narrative	NOUN
ijpds-7762	259	21	review	review	NOUN
ijpds-7762	259	22	.	.	PUNCT
ijpds-7762	260	1	ann	ann	PROPN
ijpds-7762	260	2	transl	transl	PROPN
ijpds-7762	260	3	med	med	PROPN
ijpds-7762	260	4	.	.	PUNCT
ijpds-7762	261	1	2022;10(9):528	2022;10(9):528	NUM
ijpds-7762	261	2	.	.	PUNCT
ijpds-7762	262	1	doi	doi	NOUN
ijpds-7762	262	2	:	:	PUNCT
ijpds-7762	262	3	10.21037	10.21037	NUM
ijpds-7762	262	4	/	/	SYM
ijpds-7762	262	5	atm-21	atm-21	PROPN
ijpds-7762	262	6	-	-	PUNCT
ijpds-7762	262	7	7031	7031	NUM
ijpds-7762	262	8	.	.	PUNCT
ijpds-7762	263	1	16	16	NUM
ijpds-7762	263	2	.	.	PUNCT
ijpds-7762	264	1	bellini	bellini	PROPN
ijpds-7762	264	2	v	v	NOUN
ijpds-7762	264	3	,	,	PUNCT
ijpds-7762	264	4	cascella	cascella	PROPN
ijpds-7762	264	5	m	m	PROPN
ijpds-7762	264	6	,	,	PUNCT
ijpds-7762	264	7	cutugno	cutugno	PROPN
ijpds-7762	264	8	f	f	PROPN
ijpds-7762	264	9	,	,	PUNCT
ijpds-7762	264	10	et	et	PROPN
ijpds-7762	264	11	al	al	PROPN
ijpds-7762	264	12	.	.	PUNCT
ijpds-7762	264	13	understanding	understand	VERB
ijpds-7762	264	14	basic	basic	ADJ
ijpds-7762	264	15	principles	principle	NOUN
ijpds-7762	264	16	of	of	ADP
ijpds-7762	264	17	artificial	artificial	ADJ
ijpds-7762	264	18	intelligence	intelligence	NOUN
ijpds-7762	264	19	:	:	PUNCT
ijpds-7762	264	20	a	a	DET
ijpds-7762	264	21	practical	practical	ADJ
ijpds-7762	264	22	guide	guide	NOUN
ijpds-7762	264	23	for	for	ADP
ijpds-7762	264	24	intensivists	intensivist	NOUN
ijpds-7762	264	25	.	.	PUNCT
ijpds-7762	265	1	acta	acta	PROPN
ijpds-7762	265	2	biomed	biome	VERB
ijpds-7762	265	3	.	.	PUNCT
ijpds-7762	266	1	2022	2022	NUM
ijpds-7762	266	2	oct	oct	PROPN
ijpds-7762	266	3	26;93(5):e2022297	26;93(5):e2022297	NUM
ijpds-7762	266	4	.	.	PUNCT
ijpds-7762	267	1	doi	doi	NOUN
ijpds-7762	267	2	:	:	PUNCT
ijpds-7762	267	3	10.23750	10.23750	NUM
ijpds-7762	267	4	/	/	SYM
ijpds-7762	267	5	abm.v93i5.13626	abm.v93i5.13626	PROPN
ijpds-7762	267	6	.	.	PROPN
ijpds-7762	267	7	17	17	NUM
ijpds-7762	267	8	.	.	PUNCT
ijpds-7762	268	1	paul	paul	PROPN
ijpds-7762	268	2	d	d	PROPN
ijpds-7762	268	3	,	,	PUNCT
ijpds-7762	268	4	sanap	sanap	ADJ
ijpds-7762	268	5	g	g	NOUN
ijpds-7762	268	6	,	,	PUNCT
ijpds-7762	268	7	shenoy	shenoy	NOUN
ijpds-7762	268	8	s	s	PROPN
ijpds-7762	268	9	,	,	PUNCT
ijpds-7762	268	10	et	et	PROPN
ijpds-7762	268	11	al	al	PROPN
ijpds-7762	268	12	.	.	PUNCT
ijpds-7762	268	13	artificial	artificial	ADJ
ijpds-7762	268	14	intelligence	intelligence	NOUN
ijpds-7762	268	15	in	in	ADP
ijpds-7762	268	16	drug	drug	NOUN
ijpds-7762	268	17	discovery	discovery	NOUN
ijpds-7762	268	18	and	and	CCONJ
ijpds-7762	268	19	development	development	NOUN
ijpds-7762	268	20	.	.	PUNCT
ijpds-7762	269	1	drug	drug	NOUN
ijpds-7762	269	2	discov	discov	PROPN
ijpds-7762	269	3	today	today	NOUN
ijpds-7762	269	4	.	.	PUNCT
ijpds-7762	270	1	2021	2021	NUM
ijpds-7762	270	2	jan;26(1):80	jan;26(1):80	PROPN
ijpds-7762	270	3	-	-	PUNCT
ijpds-7762	270	4	93	93	NUM
ijpds-7762	270	5	.	.	PUNCT
ijpds-7762	271	1	doi	doi	NOUN
ijpds-7762	271	2	:	:	PUNCT
ijpds-7762	271	3	10.1016	10.1016	NUM
ijpds-7762	271	4	/	/	SYM
ijpds-7762	271	5	j.drudis.2020.10.010	j.drudis.2020.10.010	PROPN
ijpds-7762	271	6	.	.	PROPN
ijpds-7762	272	1	18	18	NUM
ijpds-7762	272	2	.	.	PUNCT
ijpds-7762	272	3	fu	fu	PROPN
ijpds-7762	272	4	c	c	PROPN
ijpds-7762	272	5	,	,	PUNCT
ijpds-7762	272	6	chen	chen	PROPN
ijpds-7762	272	7	q.	q.	PROPN
ijpds-7762	272	8	the	the	DET
ijpds-7762	272	9	future	future	NOUN
ijpds-7762	272	10	of	of	ADP
ijpds-7762	272	11	pharmaceuticals	pharmaceutical	NOUN
ijpds-7762	272	12	:	:	PUNCT
ijpds-7762	272	13	artificial	artificial	ADJ
ijpds-7762	272	14	intelligence	intelligence	NOUN
ijpds-7762	272	15	in	in	ADP
ijpds-7762	272	16	drug	drug	NOUN
ijpds-7762	272	17	discovery	discovery	NOUN
ijpds-7762	272	18	and	and	CCONJ
ijpds-7762	272	19	development	development	NOUN
ijpds-7762	272	20	.	.	PUNCT
ijpds-7762	273	1	j.	j.	PROPN
ijpds-7762	273	2	pharm	pharm	PROPN
ijpds-7762	273	3	.	.	PUNCT
ijpds-7762	274	1	anal	anal	ADJ
ijpds-7762	274	2	.	.	PUNCT
ijpds-7762	275	1	2025	2025	NUM
ijpds-7762	275	2	feb	feb	X
ijpds-7762	275	3	26:101248	26:101248	NUM
ijpds-7762	275	4	.	.	PUNCT
ijpds-7762	276	1	doi	doi	NOUN
ijpds-7762	276	2	:	:	PUNCT
ijpds-7762	276	3	10.1016	10.1016	NUM
ijpds-7762	276	4	/	/	SYM
ijpds-7762	276	5	j.jpha.2025.101248	j.jpha.2025.101248	NOUN
ijpds-7762	276	6	19	19	NUM
ijpds-7762	276	7	.	.	PUNCT
ijpds-7762	276	8	giammarile	giammarile	PROPN
ijpds-7762	276	9	f	f	PROPN
ijpds-7762	276	10	,	,	PUNCT
ijpds-7762	276	11	paez	paez	PROPN
ijpds-7762	276	12	d	d	PROPN
ijpds-7762	276	13	,	,	PUNCT
ijpds-7762	276	14	zimmermann	zimmermann	PROPN
ijpds-7762	276	15	r	r	PROPN
ijpds-7762	276	16	,	,	PUNCT
ijpds-7762	276	17	et	et	PROPN
ijpds-7762	276	18	al	al	PROPN
ijpds-7762	276	19	.	.	PUNCT
ijpds-7762	276	20	production	production	NOUN
ijpds-7762	276	21	and	and	CCONJ
ijpds-7762	276	22	regulatory	regulatory	ADJ
ijpds-7762	276	23	issues	issue	NOUN
ijpds-7762	276	24	for	for	ADP
ijpds-7762	276	25	theranostics	theranostic	NOUN
ijpds-7762	276	26	.	.	PUNCT
ijpds-7762	277	1	lancet	lancet	PROPN
ijpds-7762	277	2	oncol	oncol	PROPN
ijpds-7762	277	3	.	.	PUNCT
ijpds-7762	278	1	2024	2024	NUM
ijpds-7762	278	2	jun;25(6):e260	jun;25(6):e260	PROPN
ijpds-7762	278	3	-	-	PUNCT
ijpds-7762	278	4	e269	e269	PROPN
ijpds-7762	278	5	.	.	PUNCT
ijpds-7762	279	1	doi	doi	NOUN
ijpds-7762	279	2	:	:	PUNCT
ijpds-7762	279	3	10.1016	10.1016	NUM
ijpds-7762	279	4	/	/	SYM
ijpds-7762	279	5	s1470	s1470	PROPN
ijpds-7762	279	6	-	-	PUNCT
ijpds-7762	279	7	2045(24)00041	2045(24)00041	NOUN
ijpds-7762	279	8	-	-	PUNCT
ijpds-7762	279	9	x.	x.	NOUN
ijpds-7762	279	10	20	20	NUM
ijpds-7762	279	11	.	.	PUNCT
ijpds-7762	280	1	nicole	nicole	PROPN
ijpds-7762	280	2	a.	a.	PROPN
ijpds-7762	280	3	colwell	colwell	PROPN
ijpds-7762	280	4	.	.	PUNCT
ijpds-7762	281	1	harnessing	harness	VERB
ijpds-7762	281	2	artificial	artificial	ADJ
ijpds-7762	281	3	intelligence	intelligence	NOUN
ijpds-7762	281	4	in	in	ADP
ijpds-7762	281	5	drug	drug	NOUN
ijpds-7762	281	6	discovery	discovery	NOUN
ijpds-7762	281	7	and	and	CCONJ
ijpds-7762	281	8	development	development	NOUN
ijpds-7762	281	9	.	.	PUNCT
ijpds-7762	282	1	accc	accc	PROPN
ijpds-7762	282	2	.	.	PUNCT
ijpds-7762	283	1	december	december	PROPN
ijpds-7762	283	2	20	20	NUM
ijpds-7762	283	3	2024	2024	NUM
ijpds-7762	283	4	.	.	PUNCT
ijpds-7762	284	1	21	21	NUM
ijpds-7762	284	2	.	.	PUNCT
ijpds-7762	284	3	amorim	amorim	PROPN
ijpds-7762	284	4	amb	amb	PROPN
ijpds-7762	284	5	,	,	PUNCT
ijpds-7762	284	6	piochi	piochi	PROPN
ijpds-7762	284	7	lf	lf	PROPN
ijpds-7762	284	8	,	,	PUNCT
ijpds-7762	284	9	gaspar	gaspar	PROPN
ijpds-7762	284	10	at	at	ADP
ijpds-7762	284	11	,	,	PUNCT
ijpds-7762	284	12	et	et	PROPN
ijpds-7762	284	13	al	al	PROPN
ijpds-7762	284	14	.	.	PUNCT
ijpds-7762	285	1	advancing	advance	VERB
ijpds-7762	285	2	drug	drug	NOUN
ijpds-7762	285	3	safety	safety	NOUN
ijpds-7762	285	4	in	in	ADP
ijpds-7762	285	5	drug	drug	NOUN
ijpds-7762	285	6	development	development	NOUN
ijpds-7762	285	7	:	:	PUNCT
ijpds-7762	285	8	bridging	bridge	VERB
ijpds-7762	285	9	computational	computational	ADJ
ijpds-7762	285	10	predictions	prediction	NOUN
ijpds-7762	285	11	for	for	ADP
ijpds-7762	285	12	enhanced	enhanced	ADJ
ijpds-7762	285	13	toxicity	toxicity	NOUN
ijpds-7762	285	14	prediction	prediction	NOUN
ijpds-7762	285	15	.	.	PUNCT
ijpds-7762	286	1	chem	chem	NOUN
ijpds-7762	286	2	res	re	NOUN
ijpds-7762	286	3	toxicol	toxicol	NOUN
ijpds-7762	286	4	.	.	PUNCT
ijpds-7762	287	1	2024	2024	NUM
ijpds-7762	287	2	jun	jun	PROPN
ijpds-7762	287	3	17;37(6):827	17;37(6):827	NUM
ijpds-7762	287	4	-	-	SYM
ijpds-7762	287	5	849	849	NUM
ijpds-7762	287	6	.	.	PUNCT
ijpds-7762	287	7	doi	doi	NOUN
ijpds-7762	287	8	:	:	PUNCT
ijpds-7762	287	9	10.1021	10.1021	NUM
ijpds-7762	287	10	/	/	SYM
ijpds-7762	287	11	acs.chemrestox.3c00352	acs.chemrestox.3c00352	ADJ
ijpds-7762	287	12	22	22	NUM
ijpds-7762	287	13	.	.	PUNCT
ijpds-7762	288	1	mak	mak	PROPN
ijpds-7762	288	2	kk	kk	PROPN
ijpds-7762	288	3	,	,	PUNCT
ijpds-7762	288	4	pichika	pichika	PROPN
ijpds-7762	288	5	mr	mr	PROPN
ijpds-7762	288	6	.	.	PROPN
ijpds-7762	288	7	artificial	artificial	ADJ
ijpds-7762	288	8	intelligence	intelligence	NOUN
ijpds-7762	288	9	in	in	ADP
ijpds-7762	288	10	drug	drug	NOUN
ijpds-7762	288	11	development	development	NOUN
ijpds-7762	288	12	:	:	PUNCT
ijpds-7762	288	13	present	present	ADJ
ijpds-7762	288	14	status	status	NOUN
ijpds-7762	288	15	and	and	CCONJ
ijpds-7762	288	16	future	future	ADJ
ijpds-7762	288	17	prospects	prospect	NOUN
ijpds-7762	288	18	.	.	PUNCT
ijpds-7762	289	1	drug	drug	NOUN
ijpds-7762	289	2	discov	discov	NOUN
ijpds-7762	289	3	.	.	PUNCT
ijpds-7762	290	1	today	today	NOUN
ijpds-7762	290	2	.	.	PUNCT
ijpds-7762	291	1	2019	2019	NUM
ijpds-7762	291	2	mar	mar	PROPN
ijpds-7762	291	3	1;24(3):773	1;24(3):773	NUM
ijpds-7762	291	4	-	-	SYM
ijpds-7762	291	5	80	80	NUM
ijpds-7762	291	6	.	.	PUNCT
ijpds-7762	292	1	doi:10.1016	doi:10.1016	PROPN
ijpds-7762	292	2	/	/	SYM
ijpds-7762	292	3	j.drudis.2018.11.014	j.drudis.2018.11.014	PROPN
ijpds-7762	292	4	23	23	NUM
ijpds-7762	292	5	.	.	PUNCT
ijpds-7762	293	1	zhang	zhang	PROPN
ijpds-7762	293	2	l	l	PROPN
ijpds-7762	293	3	,	,	PUNCT
ijpds-7762	293	4	tan	tan	PROPN
ijpds-7762	293	5	j	j	PROPN
ijpds-7762	293	6	,	,	PUNCT
ijpds-7762	293	7	han	han	PROPN
ijpds-7762	293	8	d	d	PROPN
ijpds-7762	293	9	,	,	PUNCT
ijpds-7762	293	10	et	et	PROPN
ijpds-7762	293	11	al	al	PROPN
ijpds-7762	293	12	.	.	PROPN
ijpds-7762	293	13	from	from	ADP
ijpds-7762	293	14	machine	machine	NOUN
ijpds-7762	293	15	learning	learn	VERB
ijpds-7762	293	16	to	to	ADP
ijpds-7762	293	17	deep	deep	ADJ
ijpds-7762	293	18	learning	learning	NOUN
ijpds-7762	293	19	:	:	PUNCT
ijpds-7762	293	20	progress	progress	NOUN
ijpds-7762	293	21	in	in	ADP
ijpds-7762	293	22	machine	machine	NOUN
ijpds-7762	293	23	intelligence	intelligence	NOUN
ijpds-7762	293	24	for	for	ADP
ijpds-7762	293	25	rational	rational	ADJ
ijpds-7762	293	26	drug	drug	NOUN
ijpds-7762	293	27	https://doi.org/10.1186/s43094-024-00625-1	https://doi.org/10.1186/s43094-024-00625-1	NUM
ijpds-7762	293	28	https://doi.org/10.1016/j.drudis.%202013.11.001	https://doi.org/10.1016/j.drudis.%202013.11.001	PROPN
ijpds-7762	293	29	https://doi.org/10.1016/j.jpha.2025.101248	https://doi.org/10.1016/j.jpha.2025.101248	PROPN
ijpds-7762	293	30	https://doi.org/10.1016/j.drudis.2018.11.014	https://doi.org/10.1016/j.drudis.2018.11.014	NOUN
ijpds-7762	293	31	agrawal	agrawal	PROPN
ijpds-7762	293	32	and	and	CCONJ
ijpds-7762	293	33	kulkarni	kulkarni	PROPN
ijpds-7762	293	34	ai	ai	VERB
ijpds-7762	293	35	applications	application	NOUN
ijpds-7762	293	36	in	in	ADP
ijpds-7762	293	37	drug	drug	NOUN
ijpds-7762	293	38	discovery	discovery	NOUN
ijpds-7762	293	39	and	and	CCONJ
ijpds-7762	293	40	development	development	NOUN
ijpds-7762	293	41	online	online	PROPN
ijpds-7762	293	42	first	first	PROPN
ijpds-7762	293	43	indian	indian	PROPN
ijpds-7762	293	44	j	j	PROPN
ijpds-7762	293	45	pharm	pharm	PROPN
ijpds-7762	293	46	drug	drug	PROPN
ijpds-7762	293	47	studies	study	NOUN
ijpds-7762	293	48	|	|	ADV
ijpds-7762	293	49	6	6	NUM
ijpds-7762	293	50	discovery	discovery	NOUN
ijpds-7762	293	51	.	.	PUNCT
ijpds-7762	294	1	drug	drug	NOUN
ijpds-7762	294	2	discov	discov	PROPN
ijpds-7762	294	3	today	today	NOUN
ijpds-7762	294	4	.	.	PUNCT
ijpds-7762	295	1	2017	2017	NUM
ijpds-7762	295	2	nov;22(11):1680	nov;22(11):1680	NOUN
ijpds-7762	295	3	-	-	PUNCT
ijpds-7762	295	4	1685	1685	NUM
ijpds-7762	295	5	.	.	PUNCT
ijpds-7762	296	1	doi	doi	NOUN
ijpds-7762	296	2	:	:	PUNCT
ijpds-7762	296	3	10.1016	10.1016	NUM
ijpds-7762	296	4	/	/	SYM
ijpds-7762	296	5	j.drudis.2017.08.010	j.drudis.2017.08.010	PROPN
ijpds-7762	296	6	.	.	PROPN
ijpds-7762	297	1	24	24	NUM
ijpds-7762	297	2	.	.	PUNCT
ijpds-7762	297	3	gentile	gentile	NOUN
ijpds-7762	297	4	f	f	PROPN
ijpds-7762	297	5	,	,	PUNCT
ijpds-7762	297	6	yaacoub	yaacoub	PROPN
ijpds-7762	297	7	jc	jc	PROPN
ijpds-7762	297	8	,	,	PUNCT
ijpds-7762	297	9	gleave	gleave	PROPN
ijpds-7762	297	10	j	j	PROPN
ijpds-7762	297	11	,	,	PUNCT
ijpds-7762	297	12	et	et	PROPN
ijpds-7762	297	13	al	al	PROPN
ijpds-7762	297	14	.	.	PUNCT
ijpds-7762	297	15	artificial	artificial	ADJ
ijpds-7762	297	16	intelligenceenabled	intelligenceenable	VERB
ijpds-7762	297	17	virtual	virtual	ADJ
ijpds-7762	297	18	screening	screening	NOUN
ijpds-7762	297	19	of	of	ADP
ijpds-7762	297	20	ultra	ultra	ADJ
ijpds-7762	297	21	-	-	ADJ
ijpds-7762	297	22	large	large	ADJ
ijpds-7762	297	23	chemical	chemical	NOUN
ijpds-7762	297	24	libraries	library	NOUN
ijpds-7762	297	25	with	with	ADP
ijpds-7762	297	26	deep	deep	ADJ
ijpds-7762	297	27	docking	docking	NOUN
ijpds-7762	297	28	.	.	PUNCT
ijpds-7762	298	1	nat	nat	PROPN
ijpds-7762	298	2	protoc	protoc	VERB
ijpds-7762	298	3	.	.	PUNCT
ijpds-7762	299	1	2022	2022	NUM
ijpds-7762	299	2	mar;17(3):672	mar;17(3):672	PROPN
ijpds-7762	299	3	-	-	PUNCT
ijpds-7762	299	4	697	697	NUM
ijpds-7762	299	5	.	.	PUNCT
ijpds-7762	300	1	doi	doi	NOUN
ijpds-7762	300	2	:	:	PUNCT
ijpds-7762	300	3	10.1038	10.1038	NUM
ijpds-7762	300	4	/	/	SYM
ijpds-7762	300	5	s41596	s41596	NOUN
ijpds-7762	300	6	-	-	PUNCT
ijpds-7762	300	7	021	021	NUM
ijpds-7762	300	8	-	-	PUNCT
ijpds-7762	300	9	00659	00659	NUM
ijpds-7762	300	10	-	-	PUNCT
ijpds-7762	300	11	2	2	NUM
ijpds-7762	300	12	.	.	NUM
ijpds-7762	300	13	25	25	NUM
ijpds-7762	300	14	.	.	PUNCT
ijpds-7762	301	1	rehman	rehman	PROPN
ijpds-7762	301	2	au	au	PROPN
ijpds-7762	301	3	,	,	PUNCT
ijpds-7762	301	4	li	li	PROPN
ijpds-7762	301	5	m	m	PROPN
ijpds-7762	301	6	,	,	PUNCT
ijpds-7762	301	7	wu	wu	PROPN
ijpds-7762	301	8	b	b	PROPN
ijpds-7762	301	9	,	,	PUNCT
ijpds-7762	301	10	et	et	PROPN
ijpds-7762	301	11	al	al	PROPN
ijpds-7762	301	12	.	.	PROPN
ijpds-7762	301	13	role	role	NOUN
ijpds-7762	301	14	of	of	ADP
ijpds-7762	301	15	artificial	artificial	ADJ
ijpds-7762	301	16	intelligence	intelligence	NOUN
ijpds-7762	301	17	in	in	ADP
ijpds-7762	301	18	revolutionizing	revolutionize	VERB
ijpds-7762	301	19	drug	drug	NOUN
ijpds-7762	301	20	discovery	discovery	NOUN
ijpds-7762	301	21	.	.	PUNCT
ijpds-7762	302	1	fundam	fundam	ADJ
ijpds-7762	302	2	res	re	NOUN
ijpds-7762	302	3	.	.	PUNCT
ijpds-7762	302	4	2024	2024	NUM
ijpds-7762	302	5	may	may	PROPN
ijpds-7762	302	6	9;5(3):1273	9;5(3):1273	NUM
ijpds-7762	302	7	-	-	PUNCT
ijpds-7762	302	8	1287	1287	NUM
ijpds-7762	302	9	.	.	PUNCT
ijpds-7762	303	1	doi	doi	NOUN
ijpds-7762	303	2	:	:	PUNCT
ijpds-7762	303	3	10.1016	10.1016	NUM
ijpds-7762	303	4	/	/	SYM
ijpds-7762	303	5	j.fmre.2024.04.021	j.fmre.2024.04.021	PROPN
ijpds-7762	303	6	.	.	PROPN
ijpds-7762	304	1	26	26	NUM
ijpds-7762	304	2	.	.	PUNCT
ijpds-7762	304	3	carpenter	carpenter	PROPN
ijpds-7762	304	4	ka	ka	PROPN
ijpds-7762	304	5	,	,	PUNCT
ijpds-7762	304	6	huang	huang	PROPN
ijpds-7762	304	7	x.	x.	PROPN
ijpds-7762	304	8	machine	machine	PROPN
ijpds-7762	304	9	learning	learning	NOUN
ijpds-7762	304	10	-	-	PUNCT
ijpds-7762	304	11	based	base	VERB
ijpds-7762	304	12	virtual	virtual	ADJ
ijpds-7762	304	13	screening	screening	NOUN
ijpds-7762	304	14	and	and	CCONJ
ijpds-7762	304	15	its	its	PRON
ijpds-7762	304	16	applications	application	NOUN
ijpds-7762	304	17	to	to	ADP
ijpds-7762	304	18	alzheimer	alzheimer	PROPN
ijpds-7762	304	19	's	's	PART
ijpds-7762	304	20	drug	drug	NOUN
ijpds-7762	304	21	discovery	discovery	NOUN
ijpds-7762	304	22	:	:	PUNCT
ijpds-7762	304	23	a	a	DET
ijpds-7762	304	24	review	review	NOUN
ijpds-7762	304	25	.	.	PUNCT
ijpds-7762	305	1	curr	curr	PROPN
ijpds-7762	305	2	pharm	pharm	PROPN
ijpds-7762	305	3	des	des	PROPN
ijpds-7762	305	4	.	.	PROPN
ijpds-7762	305	5	2018;24(28):3347	2018;24(28):3347	PROPN
ijpds-7762	305	6	-	-	NOUN
ijpds-7762	305	7	3358	3358	NUM
ijpds-7762	305	8	.	.	PUNCT
ijpds-7762	306	1	doi	doi	NOUN
ijpds-7762	306	2	:	:	PUNCT
ijpds-7762	306	3	10.2174/1381612824666180607124038	10.2174/1381612824666180607124038	NUM
ijpds-7762	306	4	.	.	PROPN
ijpds-7762	306	5	27	27	NUM
ijpds-7762	306	6	.	.	PUNCT
ijpds-7762	307	1	zhu	zhu	PROPN
ijpds-7762	307	2	h.	h.	PROPN
ijpds-7762	307	3	big	big	PROPN
ijpds-7762	307	4	data	datum	NOUN
ijpds-7762	307	5	and	and	CCONJ
ijpds-7762	307	6	artificial	artificial	ADJ
ijpds-7762	307	7	intelligence	intelligence	NOUN
ijpds-7762	307	8	modeling	modeling	NOUN
ijpds-7762	307	9	for	for	ADP
ijpds-7762	307	10	drug	drug	NOUN
ijpds-7762	307	11	discovery	discovery	NOUN
ijpds-7762	307	12	.	.	PUNCT
ijpds-7762	308	1	annu	annu	PROPN
ijpds-7762	308	2	rev	rev	VERB
ijpds-7762	308	3	pharmacol	pharmacol	PROPN
ijpds-7762	308	4	toxicol	toxicol	PROPN
ijpds-7762	308	5	.	.	PUNCT
ijpds-7762	309	1	2020	2020	NUM
ijpds-7762	309	2	jan	jan	PROPN
ijpds-7762	309	3	6;60:573	6;60:573	PROPN
ijpds-7762	309	4	-	-	SYM
ijpds-7762	309	5	589	589	NUM
ijpds-7762	309	6	.	.	PUNCT
ijpds-7762	310	1	doi	doi	NOUN
ijpds-7762	310	2	:	:	PUNCT
ijpds-7762	310	3	10.1146	10.1146	NUM
ijpds-7762	310	4	/	/	SYM
ijpds-7762	310	5	annurev	annurev	NOUN
ijpds-7762	310	6	-	-	PUNCT
ijpds-7762	310	7	pharmtox-010919	pharmtox-010919	NOUN
ijpds-7762	310	8	-	-	PUNCT
ijpds-7762	310	9	023324	023324	NUM
ijpds-7762	310	10	.	.	PUNCT
ijpds-7762	311	1	28	28	NUM
ijpds-7762	311	2	.	.	PUNCT
ijpds-7762	312	1	cai	cai	PROPN
ijpds-7762	312	2	h	h	PROPN
ijpds-7762	312	3	,	,	PUNCT
ijpds-7762	312	4	zhang	zhang	PROPN
ijpds-7762	312	5	h	h	PROPN
ijpds-7762	312	6	,	,	PUNCT
ijpds-7762	312	7	zhao	zhao	PROPN
ijpds-7762	312	8	d	d	PROPN
ijpds-7762	312	9	,	,	PUNCT
ijpds-7762	312	10	et	et	PROPN
ijpds-7762	312	11	al	al	PROPN
ijpds-7762	312	12	.	.	PUNCT
ijpds-7762	312	13	fp	fp	PROPN
ijpds-7762	312	14	-	-	PUNCT
ijpds-7762	312	15	gnn	gnn	NOUN
ijpds-7762	312	16	:	:	PUNCT
ijpds-7762	312	17	a	a	DET
ijpds-7762	312	18	versatile	versatile	ADJ
ijpds-7762	312	19	deep	deep	ADJ
ijpds-7762	312	20	learning	learning	NOUN
ijpds-7762	312	21	architecture	architecture	NOUN
ijpds-7762	312	22	for	for	ADP
ijpds-7762	312	23	enhanced	enhance	VERB
ijpds-7762	312	24	molecular	molecular	ADJ
ijpds-7762	312	25	property	property	NOUN
ijpds-7762	312	26	prediction	prediction	NOUN
ijpds-7762	312	27	.	.	PUNCT
ijpds-7762	313	1	brief	brief	ADJ
ijpds-7762	313	2	bioinform	bioinform	NOUN
ijpds-7762	313	3	.	.	PUNCT
ijpds-7762	314	1	2022	2022	NUM
ijpds-7762	314	2	nov	nov	PROPN
ijpds-7762	314	3	19;23(6):bbac408	19;23(6):bbac408	NUM
ijpds-7762	314	4	.	.	PUNCT
ijpds-7762	315	1	doi	doi	NOUN
ijpds-7762	315	2	:	:	PUNCT
ijpds-7762	315	3	10.1093	10.1093	NUM
ijpds-7762	315	4	/	/	SYM
ijpds-7762	315	5	bib	bib	NOUN
ijpds-7762	315	6	/	/	SYM
ijpds-7762	315	7	bbac408	bbac408	PROPN
ijpds-7762	315	8	.	.	PROPN
ijpds-7762	316	1	29	29	NUM
ijpds-7762	316	2	.	.	PUNCT
ijpds-7762	316	3	feinberg	feinberg	PROPN
ijpds-7762	316	4	en	en	PROPN
ijpds-7762	316	5	,	,	PUNCT
ijpds-7762	316	6	joshi	joshi	PROPN
ijpds-7762	316	7	e	e	PROPN
ijpds-7762	316	8	,	,	PUNCT
ijpds-7762	316	9	pande	pande	NOUN
ijpds-7762	316	10	vs	vs	ADP
ijpds-7762	316	11	,	,	PUNCT
ijpds-7762	316	12	et	et	PROPN
ijpds-7762	316	13	al	al	PROPN
ijpds-7762	316	14	.	.	PUNCT
ijpds-7762	316	15	improvement	improvement	NOUN
ijpds-7762	316	16	in	in	ADP
ijpds-7762	316	17	admet	admet	PROPN
ijpds-7762	316	18	prediction	prediction	NOUN
ijpds-7762	316	19	with	with	ADP
ijpds-7762	316	20	multitask	multitask	ADJ
ijpds-7762	316	21	deep	deep	ADJ
ijpds-7762	316	22	featurization	featurization	NOUN
ijpds-7762	316	23	.	.	PUNCT
ijpds-7762	317	1	j	j	PROPN
ijpds-7762	317	2	med	med	PROPN
ijpds-7762	317	3	chem	chem	NOUN
ijpds-7762	317	4	.	.	PUNCT
ijpds-7762	318	1	2020	2020	NUM
ijpds-7762	318	2	aug	aug	PROPN
ijpds-7762	318	3	27;63(16):8835	27;63(16):8835	NOUN
ijpds-7762	318	4	-	-	SYM
ijpds-7762	318	5	8848	8848	NUM
ijpds-7762	318	6	.	.	PUNCT
ijpds-7762	319	1	doi	doi	NOUN
ijpds-7762	319	2	:	:	PUNCT
ijpds-7762	319	3	10.1021	10.1021	NUM
ijpds-7762	319	4	/	/	SYM
ijpds-7762	319	5	acs.jmedchem.9b02187	acs.jmedchem.9b02187	NOUN
ijpds-7762	319	6	.	.	PUNCT
ijpds-7762	320	1	30	30	NUM
ijpds-7762	320	2	.	.	PUNCT
ijpds-7762	321	1	wan	wan	PROPN
ijpds-7762	321	2	f	f	PROPN
ijpds-7762	321	3	,	,	PUNCT
ijpds-7762	321	4	zeng	zeng	PROPN
ijpds-7762	321	5	j.	j.	PROPN
ijpds-7762	321	6	deep	deep	PROPN
ijpds-7762	321	7	learning	learn	VERB
ijpds-7762	321	8	with	with	ADP
ijpds-7762	321	9	feature	feature	NOUN
ijpds-7762	321	10	embedding	embed	VERB
ijpds-7762	321	11	for	for	ADP
ijpds-7762	321	12	compound	compound	NOUN
ijpds-7762	321	13	-	-	PUNCT
ijpds-7762	321	14	protein	protein	NOUN
ijpds-7762	321	15	interaction	interaction	NOUN
ijpds-7762	321	16	prediction	prediction	NOUN
ijpds-7762	321	17	.	.	PUNCT
ijpds-7762	322	1	biorxiv	biorxiv	NOUN
ijpds-7762	322	2	.	.	PUNCT
ijpds-7762	323	1	2016	2016	NUM
ijpds-7762	323	2	nov	nov	PROPN
ijpds-7762	323	3	7:086033	7:086033	NUM
ijpds-7762	323	4	.	.	PUNCT
ijpds-7762	324	1	doi	doi	NOUN
ijpds-7762	324	2	:	:	PUNCT
ijpds-7762	324	3	10.1101/086033	10.1101/086033	NUM
ijpds-7762	324	4	31	31	NUM
ijpds-7762	324	5	.	.	PUNCT
ijpds-7762	325	1	achenbach	achenbach	PROPN
ijpds-7762	325	2	j	j	PROPN
ijpds-7762	325	3	,	,	PUNCT
ijpds-7762	325	4	tiikkainen	tiikkainen	PROPN
ijpds-7762	325	5	p	p	NOUN
ijpds-7762	325	6	,	,	PUNCT
ijpds-7762	325	7	franke	franke	PROPN
ijpds-7762	325	8	l	l	NOUN
ijpds-7762	325	9	,	,	PUNCT
ijpds-7762	325	10	et	et	PROPN
ijpds-7762	325	11	al	al	PROPN
ijpds-7762	325	12	.	.	PUNCT
ijpds-7762	326	1	computational	computational	ADJ
ijpds-7762	326	2	tools	tool	NOUN
ijpds-7762	326	3	for	for	ADP
ijpds-7762	326	4	polypharmacology	polypharmacology	NOUN
ijpds-7762	326	5	and	and	CCONJ
ijpds-7762	326	6	repurposing	repurposing	NOUN
ijpds-7762	326	7	.	.	PUNCT
ijpds-7762	327	1	future	future	ADJ
ijpds-7762	327	2	med	med	ADJ
ijpds-7762	327	3	chem	chem	NOUN
ijpds-7762	327	4	.	.	PUNCT
ijpds-7762	328	1	2011	2011	NUM
ijpds-7762	329	1	jun;3(8):961	jun;3(8):961	PROPN
ijpds-7762	329	2	-	-	PUNCT
ijpds-7762	329	3	8	8	NUM
ijpds-7762	329	4	.	.	PUNCT
ijpds-7762	330	1	doi	doi	NOUN
ijpds-7762	330	2	:	:	PUNCT
ijpds-7762	330	3	10.4155	10.4155	NUM
ijpds-7762	330	4	/	/	SYM
ijpds-7762	330	5	fmc.11.62	fmc.11.62	NOUN
ijpds-7762	330	6	.	.	PUNCT
ijpds-7762	331	1	32	32	NUM
ijpds-7762	331	2	.	.	PUNCT
ijpds-7762	332	1	tunyasuvunakool	tunyasuvunakool	VERB
ijpds-7762	332	2	k	k	PROPN
ijpds-7762	332	3	,	,	PUNCT
ijpds-7762	332	4	adler	adler	PROPN
ijpds-7762	332	5	j	j	PROPN
ijpds-7762	332	6	,	,	PUNCT
ijpds-7762	332	7	wu	wu	PROPN
ijpds-7762	333	1	z	z	PROPN
ijpds-7762	333	2	,	,	PUNCT
ijpds-7762	333	3	et	et	PROPN
ijpds-7762	333	4	al	al	PROPN
ijpds-7762	333	5	.	.	PUNCT
ijpds-7762	334	1	highly	highly	ADV
ijpds-7762	334	2	accurate	accurate	ADJ
ijpds-7762	334	3	protein	protein	NOUN
ijpds-7762	334	4	structure	structure	NOUN
ijpds-7762	334	5	prediction	prediction	NOUN
ijpds-7762	334	6	for	for	ADP
ijpds-7762	334	7	the	the	DET
ijpds-7762	334	8	human	human	ADJ
ijpds-7762	334	9	proteome	proteome	PROPN
ijpds-7762	334	10	.	.	PUNCT
ijpds-7762	335	1	nature	nature	NOUN
ijpds-7762	335	2	.	.	PUNCT
ijpds-7762	336	1	2021	2021	NUM
ijpds-7762	336	2	aug;596(7873):590	aug;596(7873):590	NUM
ijpds-7762	336	3	-	-	NOUN
ijpds-7762	336	4	596	596	NUM
ijpds-7762	336	5	.	.	PUNCT
ijpds-7762	337	1	doi	doi	NOUN
ijpds-7762	337	2	:	:	PUNCT
ijpds-7762	337	3	10.1038	10.1038	NUM
ijpds-7762	337	4	/	/	SYM
ijpds-7762	337	5	s41586	s41586	ADJ
ijpds-7762	337	6	-	-	PUNCT
ijpds-7762	337	7	021	021	NUM
ijpds-7762	337	8	-	-	PUNCT
ijpds-7762	337	9	03828	03828	NUM
ijpds-7762	337	10	-	-	PUNCT
ijpds-7762	337	11	1	1	NUM
ijpds-7762	337	12	.	.	NOUN
ijpds-7762	337	13	33	33	NUM
ijpds-7762	337	14	.	.	PUNCT
ijpds-7762	338	1	feng	feng	PROPN
ijpds-7762	338	2	q	q	PROPN
ijpds-7762	338	3	,	,	PUNCT
ijpds-7762	338	4	dueva	dueva	NOUN
ijpds-7762	338	5	e	e	NOUN
ijpds-7762	338	6	,	,	PUNCT
ijpds-7762	338	7	cherkasov	cherkasov	VERB
ijpds-7762	338	8	a	a	DET
ijpds-7762	338	9	,	,	PUNCT
ijpds-7762	338	10	ester	ester	NOUN
ijpds-7762	338	11	m.	m.	NOUN
ijpds-7762	338	12	padme	padme	PROPN
ijpds-7762	338	13	:	:	PUNCT
ijpds-7762	338	14	a	a	DET
ijpds-7762	338	15	deep	deep	ADJ
ijpds-7762	338	16	learningbased	learningbase	VERB
ijpds-7762	338	17	framework	framework	NOUN
ijpds-7762	338	18	for	for	ADP
ijpds-7762	338	19	drug	drug	NOUN
ijpds-7762	338	20	-	-	PUNCT
ijpds-7762	338	21	target	target	NOUN
ijpds-7762	338	22	interaction	interaction	NOUN
ijpds-7762	338	23	prediction	prediction	NOUN
ijpds-7762	338	24	.	.	PUNCT
ijpds-7762	339	1	arxiv	arxiv	PROPN
ijpds-7762	339	2	preprint	preprint	NOUN
ijpds-7762	339	3	arxiv:1807.09741	arxiv:1807.09741	NUM
ijpds-7762	339	4	.	.	PUNCT
ijpds-7762	340	1	2018	2018	NUM
ijpds-7762	340	2	jul	jul	PROPN
ijpds-7762	340	3	25.doi	25.doi	PROPN
ijpds-7762	340	4	:	:	PUNCT
ijpds-7762	340	5	10.48550	10.48550	NUM
ijpds-7762	340	6	/	/	SYM
ijpds-7762	340	7	arxiv.1807.09741	arxiv.1807.09741	ADJ
ijpds-7762	340	8	34	34	NUM
ijpds-7762	340	9	.	.	PUNCT
ijpds-7762	341	1	mostafa	mostafa	PROPN
ijpds-7762	341	2	karimi	karimi	PROPN
ijpds-7762	341	3	,	,	PUNCT
ijpds-7762	341	4	di	di	PROPN
ijpds-7762	341	5	wu	wu	PROPN
ijpds-7762	341	6	,	,	PUNCT
ijpds-7762	341	7	zhangyang	zhangyang	PROPN
ijpds-7762	341	8	wang	wang	PROPN
ijpds-7762	341	9	,	,	PUNCT
ijpds-7762	341	10	et	et	PROPN
ijpds-7762	341	11	al	al	PROPN
ijpds-7762	341	12	.	.	PROPN
ijpds-7762	341	13	deepaffinity	deepaffinity	PROPN
ijpds-7762	341	14	:	:	PUNCT
ijpds-7762	341	15	interpretable	interpretable	ADJ
ijpds-7762	341	16	deep	deep	ADJ
ijpds-7762	341	17	learning	learning	NOUN
ijpds-7762	341	18	of	of	ADP
ijpds-7762	341	19	compound	compound	NOUN
ijpds-7762	341	20	–	–	PUNCT
ijpds-7762	341	21	protein	protein	NOUN
ijpds-7762	341	22	affinity	affinity	NOUN
ijpds-7762	341	23	through	through	ADP
ijpds-7762	341	24	unified	unified	ADJ
ijpds-7762	341	25	recurrent	recurrent	NOUN
ijpds-7762	341	26	and	and	CCONJ
ijpds-7762	341	27	convolutional	convolutional	ADJ
ijpds-7762	341	28	neural	neural	ADJ
ijpds-7762	341	29	networks	network	NOUN
ijpds-7762	341	30	.	.	PUNCT
ijpds-7762	342	1	bioinformatics	bioinformatic	NOUN
ijpds-7762	342	2	.	.	PUNCT
ijpds-7762	343	1	2019;35(18):3329–3338	2019;35(18):3329–3338	NUM
ijpds-7762	343	2	.	.	PUNCT
ijpds-7762	343	3	doi:10.1093	doi:10.1093	NOUN
ijpds-7762	343	4	/	/	SYM
ijpds-7762	343	5	bioinformatics	bioinformatics	PROPN
ijpds-7762	343	6	/	/	SYM
ijpds-7762	343	7	btz111	btz111	PROPN
ijpds-7762	343	8	35	35	NUM
ijpds-7762	343	9	.	.	PUNCT
ijpds-7762	344	1	hessler	hessler	PROPN
ijpds-7762	344	2	g	g	PROPN
ijpds-7762	344	3	,	,	PUNCT
ijpds-7762	344	4	baringhaus	baringhaus	PROPN
ijpds-7762	344	5	kh	kh	PROPN
ijpds-7762	344	6	.	.	PUNCT
ijpds-7762	344	7	artificial	artificial	ADJ
ijpds-7762	344	8	intelligence	intelligence	NOUN
ijpds-7762	344	9	in	in	ADP
ijpds-7762	344	10	drug	drug	NOUN
ijpds-7762	344	11	design	design	NOUN
ijpds-7762	344	12	.	.	PUNCT
ijpds-7762	345	1	molecules	molecule	NOUN
ijpds-7762	345	2	.	.	PUNCT
ijpds-7762	346	1	2018	2018	NUM
ijpds-7762	346	2	oct	oct	PROPN
ijpds-7762	346	3	2;23(10):2520	2;23(10):2520	NUM
ijpds-7762	346	4	.	.	PUNCT
ijpds-7762	347	1	doi	doi	NOUN
ijpds-7762	347	2	:	:	PUNCT
ijpds-7762	347	3	10.3390	10.3390	NUM
ijpds-7762	347	4	/	/	SYM
ijpds-7762	347	5	molecules23102520	molecules23102520	PROPN
ijpds-7762	347	6	.	.	PUNCT
ijpds-7762	348	1	36	36	NUM
ijpds-7762	348	2	.	.	PUNCT
ijpds-7762	349	1	popova	popova	PROPN
ijpds-7762	349	2	m	m	PROPN
ijpds-7762	349	3	,	,	PUNCT
ijpds-7762	349	4	isayev	isayev	INTJ
ijpds-7762	349	5	o	o	NOUN
ijpds-7762	349	6	,	,	PUNCT
ijpds-7762	349	7	tropsha	tropsha	PROPN
ijpds-7762	349	8	a.	a.	PROPN
ijpds-7762	349	9	deep	deep	PROPN
ijpds-7762	349	10	reinforcement	reinforcement	NOUN
ijpds-7762	349	11	learning	learning	NOUN
ijpds-7762	349	12	for	for	ADP
ijpds-7762	349	13	de	de	X
ijpds-7762	349	14	novo	novo	PROPN
ijpds-7762	349	15	drug	drug	NOUN
ijpds-7762	349	16	design	design	NOUN
ijpds-7762	349	17	.	.	PUNCT
ijpds-7762	350	1	sci	sci	PROPN
ijpds-7762	350	2	adv	adv	PROPN
ijpds-7762	350	3	.	.	PROPN
ijpds-7762	350	4	2018	2018	NUM
ijpds-7762	350	5	jul	jul	PROPN
ijpds-7762	350	6	25;4(7):eaap7885	25;4(7):eaap7885	PROPN
ijpds-7762	350	7	.	.	PUNCT
ijpds-7762	351	1	doi	doi	NOUN
ijpds-7762	351	2	:	:	PUNCT
ijpds-7762	351	3	10.1126	10.1126	NUM
ijpds-7762	351	4	/	/	SYM
ijpds-7762	351	5	sciadv.aap7885	sciadv.aap7885	NOUN
ijpds-7762	351	6	.	.	PUNCT
ijpds-7762	352	1	37	37	NUM
ijpds-7762	352	2	.	.	PUNCT
ijpds-7762	353	1	segler	segler	NOUN
ijpds-7762	353	2	mhs	mhs	PROPN
ijpds-7762	353	3	,	,	PUNCT
ijpds-7762	353	4	kogej	kogej	PROPN
ijpds-7762	353	5	t	t	PROPN
ijpds-7762	353	6	,	,	PUNCT
ijpds-7762	353	7	tyrchan	tyrchan	PROPN
ijpds-7762	353	8	c	c	NOUN
ijpds-7762	353	9	,	,	PUNCT
ijpds-7762	353	10	et	et	PROPN
ijpds-7762	353	11	al	al	PROPN
ijpds-7762	353	12	.	.	PROPN
ijpds-7762	354	1	generating	generate	VERB
ijpds-7762	354	2	focused	focused	ADJ
ijpds-7762	354	3	molecule	molecule	NOUN
ijpds-7762	354	4	libraries	library	NOUN
ijpds-7762	354	5	for	for	ADP
ijpds-7762	354	6	drug	drug	NOUN
ijpds-7762	354	7	discovery	discovery	NOUN
ijpds-7762	354	8	with	with	ADP
ijpds-7762	354	9	recurrent	recurrent	ADJ
ijpds-7762	354	10	neural	neural	ADJ
ijpds-7762	354	11	networks	network	NOUN
ijpds-7762	354	12	.	.	PUNCT
ijpds-7762	355	1	acs	acs	PROPN
ijpds-7762	355	2	cent	cent	PROPN
ijpds-7762	355	3	sci	sci	PROPN
ijpds-7762	355	4	.	.	PROPN
ijpds-7762	355	5	2018	2018	NUM
ijpds-7762	355	6	jan	jan	PROPN
ijpds-7762	355	7	24;4(1):120	24;4(1):120	NUM
ijpds-7762	355	8	-	-	SYM
ijpds-7762	355	9	131	131	NUM
ijpds-7762	355	10	.	.	PUNCT
ijpds-7762	356	1	doi	doi	NOUN
ijpds-7762	356	2	:	:	PUNCT
ijpds-7762	356	3	10.1021	10.1021	NUM
ijpds-7762	356	4	/	/	SYM
ijpds-7762	356	5	acscentsci.7b00512	acscentsci.7b00512	PROPN
ijpds-7762	356	6	.	.	PUNCT
ijpds-7762	357	1	38	38	NUM
ijpds-7762	357	2	.	.	PUNCT
ijpds-7762	358	1	schneider	schneider	PROPN
ijpds-7762	358	2	g	g	PROPN
ijpds-7762	358	3	,	,	PUNCT
ijpds-7762	358	4	clark	clark	PROPN
ijpds-7762	358	5	de	de	PROPN
ijpds-7762	358	6	.	.	PROPN
ijpds-7762	358	7	automated	automate	VERB
ijpds-7762	358	8	de	de	PROPN
ijpds-7762	358	9	novo	novo	PROPN
ijpds-7762	358	10	drug	drug	NOUN
ijpds-7762	358	11	design	design	NOUN
ijpds-7762	358	12	:	:	PUNCT
ijpds-7762	358	13	are	be	AUX
ijpds-7762	358	14	we	we	PRON
ijpds-7762	358	15	nearly	nearly	ADV
ijpds-7762	358	16	there	there	ADV
ijpds-7762	358	17	yet	yet	ADV
ijpds-7762	358	18	?	?	PUNCT
ijpds-7762	359	1	angew	angew	PROPN
ijpds-7762	359	2	chem	chem	NOUN
ijpds-7762	359	3	int	int	PROPN
ijpds-7762	359	4	ed	ed	PROPN
ijpds-7762	359	5	engl	engl	PROPN
ijpds-7762	359	6	.	.	PROPN
ijpds-7762	360	1	2019	2019	NUM
ijpds-7762	360	2	aug	aug	PROPN
ijpds-7762	360	3	5;58(32):10792	5;58(32):10792	NUM
ijpds-7762	360	4	-	-	SYM
ijpds-7762	360	5	10803	10803	NUM
ijpds-7762	360	6	.	.	PUNCT
ijpds-7762	361	1	doi	doi	NOUN
ijpds-7762	361	2	:	:	PUNCT
ijpds-7762	361	3	10.1002	10.1002	NUM
ijpds-7762	361	4	/	/	SYM
ijpds-7762	361	5	anie.201814681	anie.201814681	PROPN
ijpds-7762	361	6	.	.	NOUN
ijpds-7762	361	7	39	39	NUM
ijpds-7762	361	8	.	.	PUNCT
ijpds-7762	362	1	creemers	creemers	PROPN
ijpds-7762	362	2	jha	jha	PROPN
ijpds-7762	362	3	,	,	PUNCT
ijpds-7762	362	4	ankan	ankan	PROPN
ijpds-7762	362	5	a	a	PRON
ijpds-7762	362	6	,	,	PUNCT
ijpds-7762	362	7	roes	roes	PROPN
ijpds-7762	362	8	kcb	kcb	PROPN
ijpds-7762	362	9	,	,	PUNCT
ijpds-7762	362	10	et	et	PROPN
ijpds-7762	362	11	al	al	PROPN
ijpds-7762	362	12	.	.	PROPN
ijpds-7762	363	1	in	in	ADP
ijpds-7762	363	2	silico	silico	NOUN
ijpds-7762	363	3	cancer	cancer	NOUN
ijpds-7762	363	4	immunotherapy	immunotherapy	NOUN
ijpds-7762	363	5	trials	trial	NOUN
ijpds-7762	363	6	uncover	uncover	VERB
ijpds-7762	363	7	the	the	DET
ijpds-7762	363	8	consequences	consequence	NOUN
ijpds-7762	363	9	of	of	ADP
ijpds-7762	363	10	therapyspecific	therapyspecific	ADJ
ijpds-7762	363	11	response	response	NOUN
ijpds-7762	363	12	patterns	pattern	NOUN
ijpds-7762	363	13	for	for	ADP
ijpds-7762	363	14	clinical	clinical	ADJ
ijpds-7762	363	15	trial	trial	NOUN
ijpds-7762	363	16	design	design	NOUN
ijpds-7762	363	17	and	and	CCONJ
ijpds-7762	363	18	outcome	outcome	NOUN
ijpds-7762	363	19	.	.	PUNCT
ijpds-7762	364	1	nat	nat	PROPN
ijpds-7762	364	2	commun	commun	PROPN
ijpds-7762	364	3	.	.	PUNCT
ijpds-7762	365	1	2023	2023	NUM
ijpds-7762	365	2	apr	apr	NOUN
ijpds-7762	365	3	24;14(1):2348	24;14(1):2348	NUM
ijpds-7762	365	4	.	.	PUNCT
ijpds-7762	366	1	doi	doi	NOUN
ijpds-7762	366	2	:	:	PUNCT
ijpds-7762	366	3	10.1038	10.1038	NUM
ijpds-7762	366	4	/	/	SYM
ijpds-7762	366	5	s41467	s41467	NOUN
ijpds-7762	366	6	-	-	PUNCT
ijpds-7762	366	7	02337933	02337933	NUM
ijpds-7762	366	8	-	-	SYM
ijpds-7762	366	9	8	8	NUM
ijpds-7762	366	10	.	.	NUM
ijpds-7762	366	11	40	40	NUM
ijpds-7762	366	12	.	.	PUNCT
ijpds-7762	367	1	ramella	ramella	PROPN
ijpds-7762	367	2	a	a	DET
ijpds-7762	367	3	,	,	PUNCT
ijpds-7762	367	4	migliavacca	migliavacca	NOUN
ijpds-7762	367	5	f	f	PROPN
ijpds-7762	367	6	,	,	PUNCT
ijpds-7762	367	7	rodriguez	rodriguez	PROPN
ijpds-7762	367	8	matas	matas	PROPN
ijpds-7762	367	9	jf	jf	PROPN
ijpds-7762	367	10	,	,	PUNCT
ijpds-7762	367	11	et	et	PROPN
ijpds-7762	367	12	al	al	PROPN
ijpds-7762	367	13	.	.	PROPN
ijpds-7762	367	14	applicability	applicability	NOUN
ijpds-7762	367	15	assessment	assessment	NOUN
ijpds-7762	367	16	for	for	ADP
ijpds-7762	367	17	in	in	ADP
ijpds-7762	367	18	-	-	PUNCT
ijpds-7762	367	19	silico	silico	NOUN
ijpds-7762	367	20	patient	patient	NOUN
ijpds-7762	367	21	-	-	PUNCT
ijpds-7762	367	22	specific	specific	ADJ
ijpds-7762	367	23	tevar	tevar	NOUN
ijpds-7762	367	24	procedures	procedure	NOUN
ijpds-7762	367	25	.	.	PUNCT
ijpds-7762	368	1	j	j	PROPN
ijpds-7762	368	2	biomech	biomech	PROPN
ijpds-7762	368	3	.	.	PUNCT
ijpds-7762	369	1	2023	2023	NUM
ijpds-7762	369	2	jan;146:111423	jan;146:111423	PROPN
ijpds-7762	369	3	.	.	PUNCT
ijpds-7762	370	1	doi	doi	NOUN
ijpds-7762	370	2	:	:	PUNCT
ijpds-7762	370	3	10.1016	10.1016	NUM
ijpds-7762	370	4	/	/	SYM
ijpds-7762	370	5	j.jbiomech.2022.111423	j.jbiomech.2022.111423	NOUN
ijpds-7762	370	6	.	.	PUNCT
ijpds-7762	371	1	41	41	NUM
ijpds-7762	371	2	.	.	PUNCT
ijpds-7762	372	1	musuamba	musuamba	PROPN
ijpds-7762	372	2	ft	ft	PROPN
ijpds-7762	372	3	,	,	PUNCT
ijpds-7762	372	4	skottheim	skottheim	PROPN
ijpds-7762	372	5	rusten	rusten	VERB
ijpds-7762	372	6	i	i	PRON
ijpds-7762	372	7	,	,	PUNCT
ijpds-7762	372	8	lesage	lesage	NOUN
ijpds-7762	372	9	r	r	NOUN
ijpds-7762	372	10	,	,	PUNCT
ijpds-7762	372	11	et	et	PROPN
ijpds-7762	372	12	al	al	PROPN
ijpds-7762	372	13	.	.	PROPN
ijpds-7762	373	1	scientific	scientific	ADJ
ijpds-7762	373	2	and	and	CCONJ
ijpds-7762	373	3	regulatory	regulatory	ADJ
ijpds-7762	373	4	evaluation	evaluation	NOUN
ijpds-7762	373	5	of	of	ADP
ijpds-7762	373	6	mechanistic	mechanistic	ADJ
ijpds-7762	373	7	in	in	ADP
ijpds-7762	373	8	silico	silico	NOUN
ijpds-7762	373	9	drug	drug	NOUN
ijpds-7762	373	10	and	and	CCONJ
ijpds-7762	373	11	disease	disease	NOUN
ijpds-7762	373	12	models	model	NOUN
ijpds-7762	373	13	in	in	ADP
ijpds-7762	373	14	drug	drug	NOUN
ijpds-7762	373	15	development	development	NOUN
ijpds-7762	373	16	:	:	PUNCT
ijpds-7762	373	17	building	build	VERB
ijpds-7762	373	18	model	model	NOUN
ijpds-7762	373	19	credibility	credibility	NOUN
ijpds-7762	373	20	.	.	PUNCT
ijpds-7762	374	1	cpt	cpt	PROPN
ijpds-7762	374	2	pharmacometrics	pharmacometrics	PROPN
ijpds-7762	374	3	syst	syst	PROPN
ijpds-7762	374	4	pharmacol	pharmacol	PROPN
ijpds-7762	374	5	.	.	PUNCT
ijpds-7762	374	6	2021	2021	NUM
ijpds-7762	374	7	aug;10(8):804	aug;10(8):804	PROPN
ijpds-7762	374	8	-	-	PUNCT
ijpds-7762	374	9	825	825	NUM
ijpds-7762	374	10	.	.	PUNCT
ijpds-7762	375	1	doi	doi	NOUN
ijpds-7762	375	2	:	:	PUNCT
ijpds-7762	375	3	10.1002	10.1002	NUM
ijpds-7762	375	4	/	/	SYM
ijpds-7762	375	5	psp4.12669	psp4.12669	PROPN
ijpds-7762	375	6	.	.	PUNCT
ijpds-7762	376	1	42	42	NUM
ijpds-7762	376	2	.	.	PUNCT
ijpds-7762	376	3	giaretta	giaretta	VERB
ijpds-7762	376	4	a	a	PRON
ijpds-7762	376	5	,	,	PUNCT
ijpds-7762	376	6	petrucci	petrucci	NOUN
ijpds-7762	376	7	g	g	PROPN
ijpds-7762	376	8	,	,	PUNCT
ijpds-7762	376	9	rocca	rocca	PROPN
ijpds-7762	376	10	b	b	PROPN
ijpds-7762	376	11	,	,	PUNCT
ijpds-7762	376	12	et	et	PROPN
ijpds-7762	376	13	al	al	PROPN
ijpds-7762	376	14	.	.	PROPN
ijpds-7762	377	1	physiologically	physiologically	ADV
ijpds-7762	377	2	based	base	VERB
ijpds-7762	377	3	modelling	modelling	NOUN
ijpds-7762	377	4	of	of	ADP
ijpds-7762	377	5	the	the	DET
ijpds-7762	377	6	antiplatelet	antiplatelet	ADJ
ijpds-7762	377	7	effect	effect	NOUN
ijpds-7762	377	8	of	of	ADP
ijpds-7762	377	9	aspirin	aspirin	NOUN
ijpds-7762	377	10	:	:	PUNCT
ijpds-7762	377	11	a	a	DET
ijpds-7762	377	12	tool	tool	NOUN
ijpds-7762	377	13	to	to	PART
ijpds-7762	377	14	characterize	characterize	VERB
ijpds-7762	377	15	drug	drug	NOUN
ijpds-7762	377	16	responsiveness	responsiveness	NOUN
ijpds-7762	377	17	and	and	CCONJ
ijpds-7762	377	18	inform	inform	VERB
ijpds-7762	377	19	precision	precision	NOUN
ijpds-7762	377	20	dosing	dose	VERB
ijpds-7762	377	21	.	.	PUNCT
ijpds-7762	378	1	plos	plos	PROPN
ijpds-7762	378	2	one	one	NUM
ijpds-7762	378	3	.	.	PUNCT
ijpds-7762	379	1	2022	2022	NUM
ijpds-7762	379	2	aug	aug	PROPN
ijpds-7762	379	3	17;17(8):e0268905	17;17(8):e0268905	NUM
ijpds-7762	379	4	.	.	PUNCT
ijpds-7762	380	1	doi	doi	NOUN
ijpds-7762	380	2	:	:	PUNCT
ijpds-7762	380	3	10.1371	10.1371	NUM
ijpds-7762	380	4	/	/	SYM
ijpds-7762	380	5	journal.pone.0268905	journal.pone.0268905	ADJ
ijpds-7762	380	6	.	.	PUNCT
ijpds-7762	381	1	43	43	NUM
ijpds-7762	381	2	.	.	PUNCT
ijpds-7762	382	1	gayvert	gayvert	PROPN
ijpds-7762	382	2	km	km	PROPN
ijpds-7762	382	3	,	,	PUNCT
ijpds-7762	382	4	madhukar	madhukar	NOUN
ijpds-7762	382	5	ns	n	VERB
ijpds-7762	382	6	,	,	PUNCT
ijpds-7762	382	7	elemento	elemento	NOUN
ijpds-7762	382	8	o.	o.	PROPN
ijpds-7762	382	9	a	a	DET
ijpds-7762	382	10	data	data	NOUN
ijpds-7762	382	11	-	-	PUNCT
ijpds-7762	382	12	driven	drive	VERB
ijpds-7762	382	13	approach	approach	NOUN
ijpds-7762	382	14	to	to	ADP
ijpds-7762	382	15	predicting	predict	VERB
ijpds-7762	382	16	successes	success	NOUN
ijpds-7762	382	17	and	and	CCONJ
ijpds-7762	382	18	failures	failure	NOUN
ijpds-7762	382	19	of	of	ADP
ijpds-7762	382	20	clinical	clinical	ADJ
ijpds-7762	382	21	trials	trial	NOUN
ijpds-7762	382	22	.	.	PUNCT
ijpds-7762	383	1	cell	cell	NOUN
ijpds-7762	383	2	chem	chem	NOUN
ijpds-7762	383	3	biol	biol	NOUN
ijpds-7762	383	4	.	.	PUNCT
ijpds-7762	384	1	2016	2016	NUM
ijpds-7762	384	2	oct	oct	NOUN
ijpds-7762	384	3	20;23(10):1294	20;23(10):1294	NUM
ijpds-7762	384	4	-	-	SYM
ijpds-7762	384	5	1301	1301	NUM
ijpds-7762	384	6	.	.	PUNCT
ijpds-7762	385	1	doi	doi	NOUN
ijpds-7762	385	2	:	:	PUNCT
ijpds-7762	385	3	10.1016	10.1016	NUM
ijpds-7762	385	4	/	/	SYM
ijpds-7762	385	5	j.chembiol.2016.07.023	j.chembiol.2016.07.023	PROPN
ijpds-7762	385	6	.	.	PROPN
ijpds-7762	385	7	44	44	NUM
ijpds-7762	385	8	.	.	PUNCT
ijpds-7762	386	1	lysenko	lysenko	PROPN
ijpds-7762	386	2	a	a	X
ijpds-7762	386	3	,	,	PUNCT
ijpds-7762	386	4	sharma	sharma	PROPN
ijpds-7762	386	5	a	a	PROPN
ijpds-7762	386	6	,	,	PUNCT
ijpds-7762	386	7	boroevich	boroevich	PROPN
ijpds-7762	386	8	ka	ka	PROPN
ijpds-7762	386	9	,	,	PUNCT
ijpds-7762	386	10	et	et	PROPN
ijpds-7762	386	11	al	al	PROPN
ijpds-7762	386	12	.	.	PUNCT
ijpds-7762	387	1	an	an	DET
ijpds-7762	387	2	integrative	integrative	ADJ
ijpds-7762	387	3	machine	machine	NOUN
ijpds-7762	387	4	learning	learn	VERB
ijpds-7762	387	5	approach	approach	NOUN
ijpds-7762	387	6	for	for	ADP
ijpds-7762	387	7	prediction	prediction	NOUN
ijpds-7762	387	8	of	of	ADP
ijpds-7762	387	9	toxicity	toxicity	NOUN
ijpds-7762	387	10	-	-	PUNCT
ijpds-7762	387	11	related	relate	VERB
ijpds-7762	387	12	drug	drug	NOUN
ijpds-7762	387	13	safety	safety	NOUN
ijpds-7762	387	14	.	.	PUNCT
ijpds-7762	388	1	life	life	NOUN
ijpds-7762	388	2	sci	sci	PROPN
ijpds-7762	388	3	alliance	alliance	PROPN
ijpds-7762	388	4	.	.	PUNCT
ijpds-7762	389	1	2018	2018	NUM
ijpds-7762	389	2	nov	nov	PROPN
ijpds-7762	389	3	28;1(6):e201800098	28;1(6):e201800098	PROPN
ijpds-7762	389	4	.	.	PUNCT
ijpds-7762	390	1	doi	doi	PROPN
ijpds-7762	390	2	:	:	PUNCT
ijpds-7762	390	3	10.26508	10.26508	NUM
ijpds-7762	390	4	/	/	SYM
ijpds-7762	390	5	lsa.201800098	lsa.201800098	PROPN
ijpds-7762	390	6	.	.	PROPN
ijpds-7762	391	1	45	45	NUM
ijpds-7762	391	2	.	.	PUNCT
ijpds-7762	392	1	labovitz	labovitz	PROPN
ijpds-7762	392	2	dl	dl	PROPN
ijpds-7762	392	3	,	,	PUNCT
ijpds-7762	392	4	shafner	shafner	NOUN
ijpds-7762	392	5	l	l	PROPN
ijpds-7762	392	6	,	,	PUNCT
ijpds-7762	392	7	reyes	reyes	PROPN
ijpds-7762	392	8	gil	gil	PROPN
ijpds-7762	392	9	m	m	PROPN
ijpds-7762	392	10	,	,	PUNCT
ijpds-7762	392	11	et	et	PROPN
ijpds-7762	392	12	al	al	PROPN
ijpds-7762	392	13	.	.	PUNCT
ijpds-7762	393	1	using	use	VERB
ijpds-7762	393	2	artificial	artificial	ADJ
ijpds-7762	393	3	intelligence	intelligence	NOUN
ijpds-7762	393	4	to	to	PART
ijpds-7762	393	5	reduce	reduce	VERB
ijpds-7762	393	6	the	the	DET
ijpds-7762	393	7	risk	risk	NOUN
ijpds-7762	393	8	of	of	ADP
ijpds-7762	393	9	nonadherence	nonadherence	NOUN
ijpds-7762	393	10	in	in	ADP
ijpds-7762	393	11	patients	patient	NOUN
ijpds-7762	393	12	on	on	ADP
ijpds-7762	393	13	anticoagulation	anticoagulation	NOUN
ijpds-7762	393	14	therapy	therapy	NOUN
ijpds-7762	393	15	.	.	PUNCT
ijpds-7762	394	1	stroke	stroke	NOUN
ijpds-7762	394	2	.	.	PUNCT
ijpds-7762	395	1	2017	2017	NUM
ijpds-7762	395	2	may;48(5):1416	may;48(5):1416	PROPN
ijpds-7762	395	3	-	-	PUNCT
ijpds-7762	395	4	1419	1419	NUM
ijpds-7762	395	5	.	.	PUNCT
ijpds-7762	396	1	doi	doi	NOUN
ijpds-7762	396	2	:	:	PUNCT
ijpds-7762	396	3	10.1161	10.1161	NUM
ijpds-7762	396	4	/	/	SYM
ijpds-7762	396	5	strokeaha.116.016281	strokeaha.116.016281	NOUN
ijpds-7762	396	6	.	.	NOUN
ijpds-7762	396	7	46	46	NUM
ijpds-7762	396	8	.	.	PUNCT
ijpds-7762	396	9	bain	bain	PROPN
ijpds-7762	396	10	ee	ee	PROPN
ijpds-7762	396	11	,	,	PUNCT
ijpds-7762	396	12	shafner	shafner	NOUN
ijpds-7762	396	13	l	l	NOUN
ijpds-7762	396	14	,	,	PUNCT
ijpds-7762	396	15	walling	wall	VERB
ijpds-7762	396	16	dp	dp	NOUN
ijpds-7762	396	17	,	,	PUNCT
ijpds-7762	396	18	et	et	PROPN
ijpds-7762	396	19	al	al	PROPN
ijpds-7762	396	20	.	.	PUNCT
ijpds-7762	396	21	use	use	NOUN
ijpds-7762	396	22	of	of	ADP
ijpds-7762	396	23	a	a	DET
ijpds-7762	396	24	novel	novel	ADJ
ijpds-7762	396	25	artificial	artificial	ADJ
ijpds-7762	396	26	intelligence	intelligence	NOUN
ijpds-7762	396	27	platform	platform	NOUN
ijpds-7762	396	28	on	on	ADP
ijpds-7762	396	29	mobile	mobile	ADJ
ijpds-7762	396	30	devices	device	NOUN
ijpds-7762	396	31	to	to	PART
ijpds-7762	396	32	assess	assess	VERB
ijpds-7762	396	33	dosing	dose	VERB
ijpds-7762	396	34	compliance	compliance	NOUN
ijpds-7762	396	35	in	in	ADP
ijpds-7762	396	36	a	a	DET
ijpds-7762	396	37	phase	phase	NOUN
ijpds-7762	396	38	2	2	NUM
ijpds-7762	396	39	clinical	clinical	ADJ
ijpds-7762	396	40	trial	trial	NOUN
ijpds-7762	396	41	in	in	ADP
ijpds-7762	396	42	subjects	subject	NOUN
ijpds-7762	396	43	with	with	ADP
ijpds-7762	396	44	schizophrenia	schizophrenia	NOUN
ijpds-7762	396	45	.	.	PUNCT
ijpds-7762	397	1	jmir	jmir	PROPN
ijpds-7762	397	2	mhealth	mhealth	PROPN
ijpds-7762	397	3	uhealth	uhealth	PROPN
ijpds-7762	397	4	.	.	PUNCT
ijpds-7762	398	1	2017	2017	NUM
ijpds-7762	398	2	feb	feb	PROPN
ijpds-7762	398	3	21;5(2):e18	21;5(2):e18	NUM
ijpds-7762	398	4	.	.	PUNCT
ijpds-7762	398	5	doi	doi	NOUN
ijpds-7762	398	6	:	:	PUNCT
ijpds-7762	398	7	10.2196	10.2196	NUM
ijpds-7762	398	8	/	/	SYM
ijpds-7762	398	9	mhealth.7030	mhealth.7030	PROPN
ijpds-7762	398	10	.	.	PROPN
ijpds-7762	398	11	47	47	NUM
ijpds-7762	398	12	.	.	PUNCT
ijpds-7762	399	1	kp	kp	PROPN
ijpds-7762	399	2	jayatunga	jayatunga	PROPN
ijpds-7762	399	3	m	m	PROPN
ijpds-7762	399	4	,	,	PUNCT
ijpds-7762	399	5	ayers	ayers	PROPN
ijpds-7762	399	6	m	m	PROPN
ijpds-7762	399	7	,	,	PUNCT
ijpds-7762	399	8	bruens	bruen	VERB
ijpds-7762	399	9	l	l	PROPN
ijpds-7762	399	10	,	,	PUNCT
ijpds-7762	399	11	et	et	PROPN
ijpds-7762	399	12	al	al	PROPN
ijpds-7762	399	13	.	.	PUNCT
ijpds-7762	400	1	how	how	SCONJ
ijpds-7762	400	2	successful	successful	ADJ
ijpds-7762	400	3	are	be	AUX
ijpds-7762	400	4	aidiscovered	aidiscovere	VERB
ijpds-7762	400	5	drugs	drug	NOUN
ijpds-7762	400	6	in	in	ADP
ijpds-7762	400	7	clinical	clinical	ADJ
ijpds-7762	400	8	trials	trial	NOUN
ijpds-7762	400	9	?	?	PUNCT
ijpds-7762	401	1	a	a	DET
ijpds-7762	401	2	first	first	ADJ
ijpds-7762	401	3	analysis	analysis	NOUN
ijpds-7762	401	4	and	and	CCONJ
ijpds-7762	401	5	emerging	emerge	VERB
ijpds-7762	401	6	lessons	lesson	NOUN
ijpds-7762	401	7	.	.	PUNCT
ijpds-7762	402	1	drug	drug	NOUN
ijpds-7762	402	2	discov	discov	PROPN
ijpds-7762	402	3	today	today	NOUN
ijpds-7762	402	4	.	.	PUNCT
ijpds-7762	403	1	2024	2024	NUM
ijpds-7762	403	2	jun;29(6):104009	jun;29(6):104009	PROPN
ijpds-7762	403	3	.	.	PROPN
ijpds-7762	403	4	doi	doi	PROPN
ijpds-7762	403	5	:	:	PUNCT
ijpds-7762	403	6	10.1016	10.1016	NUM
ijpds-7762	403	7	/	/	SYM
ijpds-7762	403	8	j.drudis.2024.104009	j.drudis.2024.104009	NOUN
ijpds-7762	403	9	.	.	PUNCT
ijpds-7762	404	1	48	48	NUM
ijpds-7762	404	2	.	.	PUNCT
ijpds-7762	405	1	datti	datti	ADJ
ijpds-7762	405	2	a.	a.	NOUN
ijpds-7762	405	3	academic	academic	PROPN
ijpds-7762	405	4	drug	drug	NOUN
ijpds-7762	405	5	discovery	discovery	NOUN
ijpds-7762	405	6	in	in	ADP
ijpds-7762	405	7	an	an	DET
ijpds-7762	405	8	age	age	NOUN
ijpds-7762	405	9	of	of	ADP
ijpds-7762	405	10	research	research	NOUN
ijpds-7762	405	11	abundance	abundance	NOUN
ijpds-7762	405	12	,	,	PUNCT
ijpds-7762	405	13	and	and	CCONJ
ijpds-7762	405	14	the	the	DET
ijpds-7762	405	15	curious	curious	ADJ
ijpds-7762	405	16	case	case	NOUN
ijpds-7762	405	17	of	of	ADP
ijpds-7762	405	18	chemical	chemical	ADJ
ijpds-7762	405	19	screens	screen	NOUN
ijpds-7762	405	20	toward	toward	ADP
ijpds-7762	405	21	drug	drug	NOUN
ijpds-7762	405	22	repositioning	repositioning	NOUN
ijpds-7762	405	23	.	.	PUNCT
ijpds-7762	406	1	drug	drug	NOUN
ijpds-7762	406	2	discov	discov	PROPN
ijpds-7762	406	3	today	today	NOUN
ijpds-7762	406	4	.	.	PUNCT
ijpds-7762	407	1	2023	2023	NUM
ijpds-7762	407	2	may;28(5):103522	may;28(5):103522	NOUN
ijpds-7762	407	3	.	.	PUNCT
ijpds-7762	408	1	doi	doi	NOUN
ijpds-7762	408	2	:	:	PUNCT
ijpds-7762	408	3	10.1016	10.1016	NUM
ijpds-7762	408	4	/	/	SYM
ijpds-7762	408	5	j.drudis.2023.103522	j.drudis.2023.103522	NOUN
ijpds-7762	408	6	.	.	PUNCT
ijpds-7762	409	1	49	49	NUM
ijpds-7762	409	2	.	.	PUNCT
ijpds-7762	410	1	reker	reker	NOUN
ijpds-7762	410	2	d	d	PROPN
ijpds-7762	410	3	,	,	PUNCT
ijpds-7762	410	4	rodrigues	rodrigues	PROPN
ijpds-7762	410	5	t	t	PROPN
ijpds-7762	410	6	,	,	PUNCT
ijpds-7762	410	7	schneider	schneider	PROPN
ijpds-7762	410	8	p	p	PROPN
ijpds-7762	410	9	,	,	PUNCT
ijpds-7762	410	10	et	et	PROPN
ijpds-7762	410	11	al	al	PROPN
ijpds-7762	410	12	.	.	PUNCT
ijpds-7762	411	1	identifying	identify	VERB
ijpds-7762	411	2	the	the	DET
ijpds-7762	411	3	macromolecular	macromolecular	ADJ
ijpds-7762	411	4	targets	target	NOUN
ijpds-7762	411	5	of	of	ADP
ijpds-7762	411	6	de	de	X
ijpds-7762	411	7	novo	novo	NOUN
ijpds-7762	411	8	-	-	PUNCT
ijpds-7762	411	9	designed	design	VERB
ijpds-7762	411	10	chemical	chemical	NOUN
ijpds-7762	411	11	entities	entity	NOUN
ijpds-7762	411	12	through	through	ADP
ijpds-7762	411	13	self	self	NOUN
ijpds-7762	411	14	-	-	PUNCT
ijpds-7762	411	15	organizing	organize	VERB
ijpds-7762	411	16	map	map	NOUN
ijpds-7762	411	17	consensus	consensus	NOUN
ijpds-7762	411	18	.	.	PUNCT
ijpds-7762	412	1	proc	proc	PROPN
ijpds-7762	412	2	natl	natl	PROPN
ijpds-7762	412	3	acad	acad	PROPN
ijpds-7762	412	4	sci	sci	PROPN
ijpds-7762	412	5	u	u	PROPN
ijpds-7762	412	6	s	s	PROPN
ijpds-7762	412	7	a.	a.	NOUN
ijpds-7762	412	8	2014	2014	NUM
ijpds-7762	412	9	mar	mar	PROPN
ijpds-7762	412	10	18;111(11):4067	18;111(11):4067	PROPN
ijpds-7762	412	11	-	-	PUNCT
ijpds-7762	412	12	72	72	NUM
ijpds-7762	412	13	.	.	PUNCT
ijpds-7762	413	1	doi	doi	NOUN
ijpds-7762	413	2	:	:	PUNCT
ijpds-7762	413	3	10.1073	10.1073	NUM
ijpds-7762	413	4	/	/	SYM
ijpds-7762	413	5	pnas.1320001111	pnas.1320001111	NOUN
ijpds-7762	413	6	.	.	NOUN
ijpds-7762	413	7	50	50	NUM
ijpds-7762	413	8	.	.	PUNCT
ijpds-7762	414	1	watanabe	watanabe	PROPN
ijpds-7762	414	2	h	h	PROPN
ijpds-7762	414	3	,	,	PUNCT
ijpds-7762	414	4	hattori	hattori	PROPN
ijpds-7762	414	5	t	t	PROPN
ijpds-7762	414	6	,	,	PUNCT
ijpds-7762	414	7	kume	kume	PROPN
ijpds-7762	414	8	a	a	X
ijpds-7762	414	9	,	,	PUNCT
ijpds-7762	414	10	et	et	PROPN
ijpds-7762	414	11	al	al	PROPN
ijpds-7762	414	12	.	.	PROPN
ijpds-7762	414	13	improved	improve	VERB
ijpds-7762	414	14	parkinsons	parkinson	NOUN
ijpds-7762	414	15	disease	disease	NOUN
ijpds-7762	414	16	motor	motor	NOUN
ijpds-7762	414	17	score	score	NOUN
ijpds-7762	414	18	in	in	ADP
ijpds-7762	414	19	a	a	DET
ijpds-7762	414	20	single	single	ADJ
ijpds-7762	414	21	-	-	PUNCT
ijpds-7762	414	22	arm	arm	NOUN
ijpds-7762	414	23	open	open	ADJ
ijpds-7762	414	24	-	-	PUNCT
ijpds-7762	414	25	label	label	NOUN
ijpds-7762	414	26	trial	trial	NOUN
ijpds-7762	414	27	of	of	ADP
ijpds-7762	414	28	febuxostat	febuxostat	NOUN
ijpds-7762	414	29	and	and	CCONJ
ijpds-7762	414	30	inosine	inosine	NOUN
ijpds-7762	414	31	.	.	PUNCT
ijpds-7762	415	1	medicine	medicine	NOUN
ijpds-7762	415	2	(	(	PUNCT
ijpds-7762	415	3	baltimore	baltimore	PROPN
ijpds-7762	415	4	)	)	PUNCT
ijpds-7762	415	5	.	.	PUNCT
ijpds-7762	416	1	2020	2020	NUM
ijpds-7762	416	2	aug	aug	PROPN
ijpds-7762	416	3	28;99(35):e21576	28;99(35):e21576	NUM
ijpds-7762	416	4	.	.	PUNCT
ijpds-7762	417	1	doi	doi	NOUN
ijpds-7762	417	2	:	:	PUNCT
ijpds-7762	417	3	10.1097	10.1097	NUM
ijpds-7762	417	4	/	/	SYM
ijpds-7762	417	5	md.0000000000021576	md.0000000000021576	NOUN
ijpds-7762	417	6	.	.	PUNCT
ijpds-7762	418	1	51	51	NUM
ijpds-7762	418	2	.	.	PUNCT
ijpds-7762	419	1	van	van	PROPN
ijpds-7762	419	2	der	der	PROPN
ijpds-7762	419	3	pol	pol	PROPN
ijpds-7762	419	4	kh	kh	PROPN
ijpds-7762	419	5	,	,	PUNCT
ijpds-7762	419	6	aljofan	aljofan	PROPN
ijpds-7762	419	7	m	m	PROPN
ijpds-7762	419	8	,	,	PUNCT
ijpds-7762	419	9	blin	blin	PROPN
ijpds-7762	419	10	o	o	PROPN
ijpds-7762	419	11	,	,	PUNCT
ijpds-7762	419	12	et	et	PROPN
ijpds-7762	419	13	al	al	PROPN
ijpds-7762	419	14	.	.	PROPN
ijpds-7762	420	1	drug	drug	NOUN
ijpds-7762	420	2	repurposing	repurposing	NOUN
ijpds-7762	420	3	of	of	ADP
ijpds-7762	420	4	generic	generic	ADJ
ijpds-7762	420	5	drugs	drug	NOUN
ijpds-7762	420	6	:	:	PUNCT
ijpds-7762	420	7	challenges	challenge	NOUN
ijpds-7762	420	8	and	and	CCONJ
ijpds-7762	420	9	the	the	DET
ijpds-7762	420	10	potential	potential	ADJ
ijpds-7762	420	11	role	role	NOUN
ijpds-7762	420	12	for	for	ADP
ijpds-7762	420	13	government	government	NOUN
ijpds-7762	420	14	.	.	PUNCT
ijpds-7762	421	1	appl	appl	PROPN
ijpds-7762	421	2	health	health	PROPN
ijpds-7762	421	3	econ	econ	PROPN
ijpds-7762	421	4	health	health	PROPN
ijpds-7762	421	5	policy	policy	NOUN
ijpds-7762	421	6	.	.	PUNCT
ijpds-7762	422	1	2023	2023	NUM
ijpds-7762	422	2	nov;21(6):831	nov;21(6):831	NUM
ijpds-7762	422	3	-	-	SYM
ijpds-7762	422	4	840	840	NUM
ijpds-7762	422	5	.	.	PUNCT
ijpds-7762	423	1	doi	doi	NOUN
ijpds-7762	423	2	:	:	PUNCT
ijpds-7762	423	3	10.1007	10.1007	NUM
ijpds-7762	423	4	/	/	SYM
ijpds-7762	423	5	s40258	s40258	PROPN
ijpds-7762	423	6	-	-	PUNCT
ijpds-7762	423	7	023	023	NUM
ijpds-7762	423	8	-	-	PUNCT
ijpds-7762	423	9	00816	00816	NUM
ijpds-7762	423	10	-	-	PUNCT
ijpds-7762	423	11	6	6	NUM
ijpds-7762	423	12	.	.	NOUN
ijpds-7762	423	13	52	52	NUM
ijpds-7762	423	14	.	.	PUNCT
ijpds-7762	424	1	xu	xu	PROPN
ijpds-7762	425	1	z	z	PROPN
ijpds-7762	425	2	,	,	PUNCT
ijpds-7762	425	3	ren	ren	PROPN
ijpds-7762	425	4	f	f	AUX
ijpds-7762	425	5	,	,	PUNCT
ijpds-7762	425	6	wang	wang	PROPN
ijpds-7762	425	7	p	p	PROPN
ijpds-7762	425	8	,	,	PUNCT
ijpds-7762	425	9	et	et	PROPN
ijpds-7762	425	10	al	al	PROPN
ijpds-7762	425	11	.	.	PUNCT
ijpds-7762	426	1	a	a	DET
ijpds-7762	426	2	generative	generative	ADJ
ijpds-7762	426	3	ai	ai	VERB
ijpds-7762	426	4	-	-	PUNCT
ijpds-7762	426	5	discovered	discover	VERB
ijpds-7762	426	6	tnik	tnik	NOUN
ijpds-7762	426	7	inhibitor	inhibitor	NOUN
ijpds-7762	426	8	for	for	ADP
ijpds-7762	426	9	idiopathic	idiopathic	ADJ
ijpds-7762	426	10	pulmonary	pulmonary	ADJ
ijpds-7762	426	11	fibrosis	fibrosis	NOUN
ijpds-7762	426	12	:	:	PUNCT
ijpds-7762	426	13	a	a	DET
ijpds-7762	426	14	randomized	randomized	ADJ
ijpds-7762	426	15	phase	phase	NOUN
ijpds-7762	426	16	2a	2a	NUM
ijpds-7762	426	17	trial	trial	NOUN
ijpds-7762	426	18	.	.	PUNCT
ijpds-7762	427	1	nat	nat	PROPN
ijpds-7762	427	2	med	med	PROPN
ijpds-7762	427	3	.	.	PUNCT
ijpds-7762	428	1	2025	2025	NUM
ijpds-7762	428	2	jun	jun	PROPN
ijpds-7762	428	3	3:1	3:1	NUM
ijpds-7762	428	4	-	-	SYM
ijpds-7762	428	5	9	9	NUM
ijpds-7762	428	6	.	.	PUNCT
ijpds-7762	428	7	doi:10.1038	doi:10.1038	NOUN
ijpds-7762	428	8	/	/	SYM
ijpds-7762	428	9	s41591	s41591	NOUN
ijpds-7762	428	10	-	-	PUNCT
ijpds-7762	428	11	025	025	NUM
ijpds-7762	428	12	-	-	PUNCT
ijpds-7762	428	13	03743	03743	NUM
ijpds-7762	428	14	-	-	SYM
ijpds-7762	428	15	2	2	NUM
ijpds-7762	428	16	.	.	PUNCT
ijpds-7762	428	17	how	how	SCONJ
ijpds-7762	428	18	to	to	PART
ijpds-7762	428	19	cite	cite	VERB
ijpds-7762	428	20	this	this	DET
ijpds-7762	428	21	article	article	NOUN
ijpds-7762	428	22	:	:	PUNCT
ijpds-7762	428	23	agrawal	agrawal	PROPN
ijpds-7762	428	24	r	r	PROPN
ijpds-7762	428	25	,	,	PUNCT
ijpds-7762	428	26	kulkarni	kulkarni	PROPN
ijpds-7762	428	27	m.	m.	NOUN
ijpds-7762	428	28	application	application	NOUN
ijpds-7762	428	29	of	of	ADP
ijpds-7762	428	30	artificial	artificial	ADJ
ijpds-7762	428	31	intelligence	intelligence	NOUN
ijpds-7762	428	32	in	in	ADP
ijpds-7762	428	33	drug	drug	NOUN
ijpds-7762	428	34	discovery	discovery	NOUN
ijpds-7762	428	35	,	,	PUNCT
ijpds-7762	428	36	designing	designing	NOUN
ijpds-7762	428	37	,	,	PUNCT
ijpds-7762	428	38	clinical	clinical	ADJ
ijpds-7762	428	39	trials	trial	NOUN
ijpds-7762	428	40	and	and	CCONJ
ijpds-7762	428	41	repurposing	repurposing	NOUN
ijpds-7762	428	42	.	.	PUNCT
ijpds-7762	429	1	indian	indian	PROPN
ijpds-7762	429	2	j	j	PROPN
ijpds-7762	429	3	pharm	pharm	PROPN
ijpds-7762	429	4	drug	drug	PROPN
ijpds-7762	429	5	studies	study	NOUN
ijpds-7762	429	6	.	.	PUNCT
ijpds-7762	430	1	2025	2025	NUM
ijpds-7762	430	2	;	;	PUNCT
ijpds-7762	430	3	online	online	ADJ
ijpds-7762	430	4	first	first	ADJ
ijpds-7762	430	5	.	.	PUNCT
ijpds-7762	431	1	funding	funding	NOUN
ijpds-7762	431	2	:	:	PUNCT
ijpds-7762	431	3	none	none	NOUN
ijpds-7762	431	4	;	;	PUNCT
ijpds-7762	431	5	conflicts	conflict	NOUN
ijpds-7762	431	6	of	of	ADP
ijpds-7762	431	7	interest	interest	NOUN
ijpds-7762	431	8	:	:	PUNCT
ijpds-7762	431	9	none	none	NOUN
ijpds-7762	431	10	stated	state	VERB
ijpds-7762	431	11	http://dx.doi.org/10.48550/arxiv.1807.09741	http://dx.doi.org/10.48550/arxiv.1807.09741	NOUN
ijpds-7762	431	12	https://doi.org/10.1093/bioinformatics/btz111	https://doi.org/10.1093/bioinformatics/btz111	NOUN